
<html lang="en"     class="pb-page"  data-request-id="545901af-459e-48b1-9e17-7027fe5262b4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.6b00619"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor" /></meta><meta name="dc.Creator" content="Jean-Marc  Lapierre" /></meta><meta name="dc.Creator" content="Sudharshan  Eathiraj" /></meta><meta name="dc.Creator" content="David  Vensel" /></meta><meta name="dc.Creator" content="Yanbin  Liu" /></meta><meta name="dc.Creator" content="Cathy O.  Bull" /></meta><meta name="dc.Creator" content="Susan  Cornell-Kennon" /></meta><meta name="dc.Creator" content="Shin  Iimura" /></meta><meta name="dc.Creator" content="Eugene W.  Kelleher" /></meta><meta name="dc.Creator" content="Darin E.  Kizer" /></meta><meta name="dc.Creator" content="Steffi  Koerner" /></meta><meta name="dc.Creator" content="Sapna  Makhija" /></meta><meta name="dc.Creator" content="Akihisa  Matsuda" /></meta><meta name="dc.Creator" content="Magdi  Moussa" /></meta><meta name="dc.Creator" content="Nivedita  Namdev" /></meta><meta name="dc.Creator" content="Ronald E.  Savage" /></meta><meta name="dc.Creator" content="Jeff  Szwaya" /></meta><meta name="dc.Creator" content="Erika  Volckova" /></meta><meta name="dc.Creator" content="Neil  Westlund" /></meta><meta name="dc.Creator" content="Hui  Wu" /></meta><meta name="dc.Creator" content="Brian  Schwartz" /></meta><meta name="dc.Description" content="The work in this paper describes the optimization of the 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine chemical series as potent, selective allosteric inhibitors of AKT kinases, leading..." /></meta><meta name="Description" content="The work in this paper describes the optimization of the 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine chemical series as potent, selective allosteric inhibitors of AKT kinases, leading..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 29, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00619" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00619" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00619" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00619" /></link>
        
    
    

<title>Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00619" /></meta><meta property="og:title" content="Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0014.jpeg" /></meta><meta property="og:description" content="The work in this paper describes the optimization of the 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine chemical series as potent, selective allosteric inhibitors of AKT kinases, leading to the discovery of ARQ 092 (21a). The cocrystal structure of compound 21a bound to full-length AKT1 confirmed the allosteric mode of inhibition of this chemical class and the role of the cyclobutylamine moiety. Compound 21a demonstrated high enzymatic potency against AKT1, AKT2, and AKT3, as well as potent cellular inhibition of AKT activation and the phosphorylation of the downstream target PRAS40. Compound 21a also served as a potent inhibitor of the AKT1-E17K mutant protein and inhibited tumor growth in a human xenograft mouse model of endometrial adenocarcinoma." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00619"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00619">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00619&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00619&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00619&amp;href=/doi/10.1021/acs.jmedchem.6b00619" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 6455-6469</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00628" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00653" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Marc++Lapierre">Jean-Marc Lapierre</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sudharshan++Eathiraj">Sudharshan Eathiraj</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Vensel">David Vensel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yanbin++Liu">Yanbin Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cathy+O.++Bull">Cathy O. Bull</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan++Cornell-Kennon">Susan Cornell-Kennon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shin++Iimura">Shin Iimura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eugene+W.++Kelleher">Eugene W. Kelleher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Darin+E.++Kizer">Darin E. Kizer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steffi++Koerner">Steffi Koerner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sapna++Makhija">Sapna Makhija</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Akihisa++Matsuda">Akihisa Matsuda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Magdi++Moussa">Magdi Moussa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nivedita++Namdev">Nivedita Namdev</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronald+E.++Savage">Ronald E. Savage</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff++Szwaya">Jeff Szwaya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erika++Volckova">Erika Volckova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neil++Westlund">Neil Westlund</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hui++Wu">Hui Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Schwartz">Brian Schwartz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Daiichi Sankyo Co., Shinagawa R&D Center, 1-2-58, Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan</span></div><div class="corresp-info"><strong>*</strong>Phone: 781-994-0625. E-mail: <a href="/cdn-cgi/l/email-protection#c0aaadaca1b0a9a5b2b2a580a1b2b1b5aca5eea3afad"><span class="__cf_email__" data-cfemail="dbb1b6b7baabb2bea9a9be9bbaa9aaaeb7bef5b8b4b6">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00619&amp;href=/doi/10.1021%2Facs.jmedchem.6b00619" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 6455–6469</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 15, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 April 2016</li><li><span class="item_label"><b>Published</b> online</span>29 June 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 July 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00619" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00619</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6455%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJean-Marc%2BLapierre%252C%2BSudharshan%2BEathiraj%252C%2BDavid%2BVensel%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D13%26contentID%3Dacs.jmedchem.6b00619%26title%3DDiscovery%2Bof%2B3-%25283-%25284-%25281-Aminocyclobutyl%2529phenyl%2529-5-phenyl-3H-imidazo%255B4%252C5-b%255Dpyridin-2-yl%2529pyridin-2-amine%2B%2528ARQ%2B092%2529%253A%2BAn%2BOrally%2BBioavailable%252C%2BSelective%252C%2Band%2BPotent%2BAllosteric%2BAKT%2BInhibitor%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6469%26publicationDate%3DJuly%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00619"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2652</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">36</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00619" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jean-Marc&quot;,&quot;last_name&quot;:&quot;Lapierre&quot;},{&quot;first_name&quot;:&quot;Sudharshan&quot;,&quot;last_name&quot;:&quot;Eathiraj&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Vensel&quot;},{&quot;first_name&quot;:&quot;Yanbin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Cathy&quot;,&quot;last_name&quot;:&quot;O. Bull&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;Cornell-Kennon&quot;},{&quot;first_name&quot;:&quot;Shin&quot;,&quot;last_name&quot;:&quot;Iimura&quot;},{&quot;first_name&quot;:&quot;Eugene&quot;,&quot;last_name&quot;:&quot;W. Kelleher&quot;},{&quot;first_name&quot;:&quot;Darin&quot;,&quot;last_name&quot;:&quot;E. Kizer&quot;},{&quot;first_name&quot;:&quot;Steffi&quot;,&quot;last_name&quot;:&quot;Koerner&quot;},{&quot;first_name&quot;:&quot;Sapna&quot;,&quot;last_name&quot;:&quot;Makhija&quot;},{&quot;first_name&quot;:&quot;Akihisa&quot;,&quot;last_name&quot;:&quot;Matsuda&quot;},{&quot;first_name&quot;:&quot;Magdi&quot;,&quot;last_name&quot;:&quot;Moussa&quot;},{&quot;first_name&quot;:&quot;Nivedita&quot;,&quot;last_name&quot;:&quot;Namdev&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;E. Savage&quot;},{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;Szwaya&quot;},{&quot;first_name&quot;:&quot;Erika&quot;,&quot;last_name&quot;:&quot;Volckova&quot;},{&quot;first_name&quot;:&quot;Neil&quot;,&quot;last_name&quot;:&quot;Westlund&quot;},{&quot;first_name&quot;:&quot;Hui&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Schwartz&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;6455-6469&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00619&quot;},&quot;abstract&quot;:&quot;The work in this paper describes the optimization of the 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine chemical series as potent, selective allosteric inhibitors of AKT kinases, leading to the discovery of ARQ 092 (21a). The cocrystal structure of compound 21a bound to full-length AKT1 confirmed the allosteric mode of inhibition of this chemical class and the role of the cyclobutylamine moiety. Compound 21a demonstrated high enzymatic potency against AKT1, AKT2, and AKT3, as well as potent cellular inhibition of AKT activation and the phosphorylation of the downstream target PRAS40. Compound 21a also served as a potent inhibitor of the AKT1-E17K mutant protein and inhibited tumor growth in a human xenograft mouse model of endometrial adenocarcinoma.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00619&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00619" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00619&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00619" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00619&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00619" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00619&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00619&amp;href=/doi/10.1021/acs.jmedchem.6b00619" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00619" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00619" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00619%26sid%3Dliteratum%253Aachs%26pmid%3D27305487%26genre%3Darticle%26aulast%3DLapierre%26date%3D2016%26atitle%3DDiscovery%2Bof%2B3-%25283-%25284-%25281-Aminocyclobutyl%2529phenyl%2529-5-phenyl-3H-imidazo%255B4%252C5-b%255Dpyridin-2-yl%2529pyridin-2-amine%2B%2528ARQ%2B092%2529%253A%2BAn%2BOrally%2BBioavailable%252C%2BSelective%252C%2Band%2BPotent%2BAllosteric%2BAKT%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D13%26spage%3D6455%26epage%3D6469%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/jmcmar.2016.59.issue-13/20160714/jmcmar.2016.59.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The work in this paper describes the optimization of the 3-(3-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine chemical series as potent, selective allosteric inhibitors of AKT kinases, leading to the discovery of ARQ 092 (<b>21a</b>). The cocrystal structure of compound <b>21a</b> bound to full-length AKT1 confirmed the allosteric mode of inhibition of this chemical class and the role of the cyclobutylamine moiety. Compound <b>21a</b> demonstrated high enzymatic potency against AKT1, AKT2, and AKT3, as well as potent cellular inhibition of AKT activation and the phosphorylation of the downstream target PRAS40. Compound <b>21a</b> also served as a potent inhibitor of the AKT1-E17K mutant protein and inhibited tumor growth in a human xenograft mouse model of endometrial adenocarcinoma.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48652" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48652" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The AGC kinases AKT1, AKT2, and AKT3 are key mediators of the PI3K/AKT/mTOR signaling pathway, which promotes diverse physiological processes such as proliferation, migration, antiapoptotic survival, and protein synthesis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The activation of the PI3K/AKT/mTOR signaling network is commonly observed in several human cancers and can be induced through a variety of mechanisms, including the overexpression of upstream receptors, PI3KCA-activating mutations, the loss of PTEN function, and the overexpression or mutational activation of AKT.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The serine/threonine AKT kinases represent a pivotal node connecting the PI3K and mTOR pathways, suggesting that AKT kinases are compelling targets for the treatment of human cancers and nononcology pathologies. Multiple efforts have been made to discover small molecule inhibitors of AKT, including both allosteric inhibitors that target full-length AKT and ATP-competitive inhibitors that are designed to bind the ATP binding pocket of the catalytic domain.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Allosteric inhibitors offer a unique advantage over ATP-competitive inhibitors in that very high kinase selectivity can be achieved by targeting a distinct allosteric pocket in AKT formed by the pleckstrin homology (PH) and kinase domains. In contrast to allosteric inhibitors, which inhibit the phosphorylation of Thr308 and Ser473 in AKT, ATP-competitive inhibitors paradoxically induce the hyperphosphorylation of these two regulatory sites in cells and in vivo; however, the clinical significance of this observation is not yet understood.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">We recently reported the preclinical characterization of ARQ 092 (<b>21a</b>),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> a highly selective, allosteric inhibitor of AKT.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Compound <b>21a</b> showed strong affinity for unphosphorylated full-length AKT1 and potently inhibited the phosphorylated form of full-length AKT isoforms. In a large panel of cell lines derived from various tumor types, <b>21a</b> showed potent antiproliferative activity in cell lines containing PIK3CA/PIK3R1 mutations compared to those with wild-type (wt) PIK3CA/PIK3R1 or PTEN loss. Moreover, <b>21a</b> also exhibited strong antitumor activity in mouse xenograft models implanted with cell lines carrying a PIK3CA mutation and in a patient-derived tumor mouse model harboring an AKT1-E17K activating mutation. Both animal studies demonstrated the desirable pharmacokinetic properties of <b>21a</b> which is under investigation in clinical trials targeting advanced solid tumors and recurrent malignant lymphoma. Compound <b>21a</b> is also being investigated for treatment of Proteus syndrome, a disease driven by AKT-E17K mutation.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">In our previous study, we demonstrated that optimizing activity against AKT1, AKT2, and AKT3 was critical to achieving cellular potency; however, the most potent benzamide analogs of the imidazo[4,5-<i>b</i>]pyridine series had very low exposure in the plasma and tumors in mouse xenograft models. Therefore, the final phase of the optimization was then focused on optimizing the pharmacokinetics and demonstrating in vivo activity in tumor xenografts. One critical optimization step in the early stage of discovery of this chemical series was the reduction to a methyl group (<b>4a)</b> from a 4-<i>tert</i>-butyl group observed in the initial hit (<b>4b</b>), followed by the addition of a primary amine to the methyl group (<b>6</b>). These two small side-chain modifications significantly improved the biochemical potency of the compounds (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) and incorporated the substituents necessary for further optimization. Compound <b>6</b> became the cornerstone from which an extensive optimization campaign was undertaken, part of which has been previously disclosed with a focus on substitutions at the 5- and 6-position of the imidazo[4,5-<i>b</i>]pyridine ring system, as well as the substitution of the benzylic amine amide.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical Results of Early Compounds<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">AKT1</th><th class="colsep0 rowsep0" align="center">AKT2</th><th class="colsep0 rowsep0" align="center">AKT3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.72</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Assay conducted with unphosphorylated enzymes.</p></div></div></div><div class="NLM_p last">In this communication, we describe the additional structure–activity relationships (SARs) that led to the discovery of <b>21a</b>, its characterization in vitro and in vivo, and its binding mode based on the cocrystallization of <b>21a</b> with AKT1. To probe the structural features associated with this highly biologically active scaffold, we previously reported the screening and early optimization of a series of 3-(3-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amines as potent AKT inhibitors.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The SAR-guided optimization of the imidazo[4,5-<i>b</i>]pyridine series using in vitro and in vivo assessments yielded highly selective AKT inhibitors. In vivo characterization employed both pharmacokinetic and pharmacodynamic analyses, and the lead inhibitors demonstrated oral bioavailability in mice and were well tolerated, with robust inhibition of AKT activation, as well as downstream AKT signaling. The screening paradigm in our previous study used a biophysical thermal shift assay to identify binders of AKT1,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> followed by a biochemical assay using the unphosphorylated AKT1 protein to recapitulate the binding event measured by the thermal shift assay. This was achieved by preincubating the test compounds with the unphosphorylated protein, followed by in situ activation. AKT activation entails the translocation of the protein to the cell membrane and the binding of the PH domain of AKT to phosphoinositides, upon which a conformational change permits the phosphorylation of Thr308 (for AKT1) in the activation loop by phosphoinositide-dependent kinase 1 (PDK1).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The full activation of AKT is achieved when Ser473 (for AKT1) in the hydrophobic motif (HM) domain is phosphorylated by the mTORC2 complex.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> For the biochemical assay, unphosphorylated full-length proteins (AKT1 (1–480), AKT2 (1–481), and AKT3 (1–479)) were preincubated with the test compounds, followed by the successive addition of the activating proteins PDK1 and MAPKAPK2 (a Ser473-phosphorylating kinase that replaces the mTORC2 complex), lipid vesicles, and ATP before addition of the substrate, biotinylated crosstide. The biochemical activities of the test compounds described in this work against the two activating kinases (PDK1 and MAPKAPK2) were determined to ascertain whether the observed AKT inhibition was due specifically to AKT binding.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Additionally, the biochemical inhibition of full-length, preactivated AKT1, AKT2, and AKT3 was probed for all compounds to further validate the inhibitory potency.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Synthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">From commercially available 2-chloro-3-nitropyridine (<b>1a</b>) and substituted 2-chloro-3-nitropyridines (<b>1b</b>–<b>f</b>), the displacement of the chlorine atom with substituted anilines in DMSO or 1,4-dioxane in the presence of a mild base (diisopropylethylamine or trimethylamine), under heating, provided compounds <b>2a</b>–<b>c</b> and <b>3a</b>–<b>e</b> with good yields (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). A one-pot condensation/cyclization of the substituted 2-anilino-3-nitropyridines (<b>2a</b>–<b>c</b>, <b>3a</b>–<b>e</b>) with 2-aminonicotinaldehyde under reducing conditions using sodium hydrosulfite in a DMSO/methanol mixture (2:1) at 100 °C afforded compounds <b>4a</b>–<b>c</b> and <b>5a</b>–<b>e</b> with yields varying from 25% to 75%. Intermediates <b>4c</b> and <b>5a</b>–<b>e</b> were Boc-deprotected using 4 M HCl in 1,4-dioxane at room temperature, producing <b>6</b> and <b>7a</b>–<b>e</b> in quantitative yields as HCl salts.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) substituted anilines, DIEA, DMSO or 1,4-dioxane, 80 °C, overnight; (b) 2-aminonicotinaldehyde, Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, DMSO, MeOH, 100 °C, overnight; (c) 4.0 M HCl in 1,4-dioxane, 1,4-dioxane, room temperature, overnight.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>tert</i>-butyl (4-aminobenzyl)carbamate, DIEA, DMSO or 1,4-dioxane, 80 °C, overnight; (b) 2-aminonicotinaldehyde, Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, DMSO, MeOH, 100 °C, overnight; (c) 4.0 M HCl in 1,4-dioxane, 1,4-dioxane, room temperature, overnight.</p></p></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, intermediate <b>5d</b> was reacted with phenylboronic acid, 3-acetamidophenylboronic acid, 4-acetamidophenylboronic acid or (1<i>H</i>-pyrazol-4-yl)-boronic acid in a Suzuki coupling reaction, affording compounds <b>8a</b>–<b>d</b> with good yields.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Standard Boc-deprotection with HCl produced compounds <b>9a</b>–<b>d</b> in quantitative yields as HCl salts. Alternatively, intermediate <b>5e</b> was reacted with (pyridin-3-yl)boronic acid under the same Suzuki conditions, affording the Boc-protected compound <b>8e</b> with a substituent at the 6-position. Standard deprotection with HCl yielded <b>9e</b>.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) aryl/heteroarylboronic acid, toluene, EtOH, aq NaHCO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 100 °C, overnight; (b) 4.0 M HCl in 1,4-dioxane, 1,4-dioxane, room temperature, overnight.</p></p></figure><div class="NLM_p">Synthesis of the gem-dimethyl compound <b>17</b> is depicted in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Racemic 2-methyl-2-propanesulfinamide (<b>10</b>) was reacted with acetone in the presence of Ti(OEt)<sub>4</sub>, affording the <i>N</i>-propan-2-ylidene <b>11</b> with a 47% yield.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Halogen–metal exchange using 4-bromo-<i>N</i>,<i>N</i>-bis(trimethylsilyl)aniline and BuLi at a low temperature generated the 4-lithio species, which was trapped with <b>11</b>. In situ cleavage of the Si–N bonds afforded the aniline <b>12</b> with a modest yield.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Following a displacement reaction using <b>1e</b>, the resulting compound <b>13</b> was subjected to a deprotection/reprotection sequence, yielding the Boc-protected intermediate <b>14</b> with excellent yields. Cyclization of <b>14</b> with 2-aminonicotinaldehyde under reducing conditions produced <b>15</b> with moderate yields. As described above, a Suzuki coupling reaction yielded <b>16</b>, and a standard Boc-deprotection using HCl gave the final product <b>17</b>.</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a)Ti(OEt)<sub>4</sub>, acetone, THF; (b) 4-bromo-<i>N</i>,<i>N</i>-bis(trimethylsilyl)aniline, BuLi, THF, −78 °C; (c) <b>1e</b>, Et<sub>3</sub>N, DMA, 0–20 °C, overnight; (d) 4.0 M HCl in 1,4-dioxane, DCM, 30 min.; (e) di-<i>tert</i>-butyl dicarbonate, NaHCO<sub>3</sub>, THF; (f) 2-aminonicotinaldehyde, Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, DMSO, MeOH, 100 °C, overnight; (g) phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3 aq</sub>, EtOH, toluene, 100 °C, overnight; (h) 4.0 M HCl in 1,4-dioxane, 1,4-dioxane, room temperature, 1 h.</p></p></figure><div class="NLM_p">The synthesis of the aminocyclobutyl compounds <b>21a</b>–<b>c</b>, <b>22</b>, and <b>23</b> is shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. The preparation of <i>tert</i>-butyl (1-(4-aminophenyl)cyclobutyl)carbamate is described<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and is now commercially available. Using the starting nitropyridine <b>1e</b> and <i>tert</i>-butyl (1-(4-aminophenyl)cyclobutyl)carbamate in a displacement reaction produced <b>18</b> with moderate yields. Cyclization under reducing conditions with 2-aminonicotinaldehyde afforded the intermediate <b>19</b>. A Suzuki coupling reaction using phenylboronic acid, 3-acetamidophenylboronic acid, or 4-acetamidophenylboronic acid produced <b>20a</b>–<b>c</b> with good yields. Standard Boc-deprotection with HCl afforded the final compounds <b>21a</b>–<b>c</b> in quantitative yields. Compound <b>22</b> was the result of a conventional amine acylation using acetic anhydride in pyridine. Subjecting the deprotected compound <b>21b</b> to HCl in dioxane for an extended period (3 days at 50 °C) produced the deacylated compound <b>23</b>.</div><figure id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>tert</i>-butyl (1-(4-aminophenyl)cyclobutyl)carbamate, DIEA, DMSO or 1,4-dioxane, 80 °C, overnight; (b) 2-aminonicotinaldehyde, Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, DMSO, MeOH, 100 °C, overnight; (c) substituted phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3 aq.</sub>, EtOH, toluene, 100 °C, overnight; (d) 4.0 M HCl in 1,4-dioxane, 1,4-dioxane, room temperature, overnight; (e) Ac<sub>2</sub>O, pyridine, room temperature, overnight; (f) 4.0 M HCl in 1,4-dioxane, 1,4-dioxane, MeOH, 50 °C, 3 days.</p></p></figure><div class="NLM_p">The replacement of the amino group appending the four-membered ring with a carboxylic acid methyl ester (<b>26</b>) or a carboxamide (<b>27</b>) is shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. Suzuki coupling (<b>24</b> → <b>25</b>) was executed prior to the reductive cyclization with the 2-aminonicotinaldehyde, and compound <b>26</b> was obtained with a good overall yield (46% over three steps). Hydrolysis followed by EDC coupling produced <b>27</b> with a modest yield.</div><figure id="sch6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl 1-(4-aminophenyl)cyclobutane-1-carboxylate, DIEA, EtOH, 45 °C, overnight; (b) phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3 aq.</sub>, EtOH, toluene, 100 °C, overnight; (c) 2-aminonicotinaldehyde, Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, DMSO, MeOH, 100 °C, overnight; (d) NaOH 1N, THF, MeOH, 65 °C; (e) EDC, HOBt, TEA, ammonia, DMF.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The structure–activity-relationship described here was focused on two regions of the 3-(3-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine series: the substitution around the pyridine ring and substitution at the 4-position of the phenyl ring. The SAR of substitutions of the pyridine ring is shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. The introduction of a methyl group at the 7-position (<b>7a</b>) or 6-position (<b>7b</b>) led to improved potency; however, methyl groups at the 5- or 6-position (<b>7c</b>) were not tolerated. A similar effect was noticed in previous SAR studies using the benzylamine amides,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> which showed little difference between the two positions on the imidazo[4,5-<i>b</i>]pyridine core. Compounds <b>7a</b> and <b>7b</b> displayed very modest inhibitory activity against AKT2 and AKT3. The presence of a chlorine atom at the 5-position (<b>7d</b>) or a bromine atom at the 6-position (<b>7e</b>) did not significantly affect the potency against AKT1. Interestingly, the introduction of a phenyl ring at the 5-position dramatically improved the activity against all three isoforms, while a pyridyl substitution at the 6-position also increased potency against AKT1 but spared AKT2 and AKT3 by 100-fold and >300-fold, respectively.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure–Activity Relationship for Substitution on the Pyridine Ring<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">AKT1</th><th class="colsep0 rowsep0" align="center">AKT2</th><th class="colsep0 rowsep0" align="center">AKT3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">0.0037</td><td class="colsep0 rowsep0" align="left">0.033</td><td class="colsep0 rowsep0" align="left">0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-NHAc-Ph</td><td class="colsep0 rowsep0" align="left">0.013</td><td class="colsep0 rowsep0" align="left">0.024</td><td class="colsep0 rowsep0" align="left">0.086</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-NHAc-Ph</td><td class="colsep0 rowsep0" align="left">0.072</td><td class="colsep0 rowsep0" align="left">0.079</td><td class="colsep0 rowsep0" align="left">0.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1<i>H</i>-pyrazol-4-yl</td><td class="colsep0 rowsep0" align="left">0.017</td><td class="colsep0 rowsep0" align="left">0.014</td><td class="colsep0 rowsep0" align="left">0.065</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">pyridin-3-yl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.036</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details. NT means not tested.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Assay conducted with unphosphorylated enzymes.</p></div></div></div><div class="NLM_p">After identification of the key position for improving activity against the AKT isoforms, substitutions at the 5-position were further explored. A limited set of substitutions is exemplified with compounds <b>9b</b>, <b>9c</b>, and <b>9d</b>. The introduction of more polar groups at the para or meta position was well tolerated and offered similar levels of AKT inhibition and isozyme selectivity.</div><div class="NLM_p">Combining the SAR points from compounds <b>4b</b>, <b>6</b>, and <b>9a</b>, we were determined to make the hybrid compound <b>17</b>, which proved to be more arduous than anticipated. A small amount was finally isolated, and the compound showed potent inhibitory activity against AKT1 (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, IC<sub>50</sub> = 0.0054 μM). Further investigation into substituting the benzylic position led to compound <b>21a</b>, in which a cyclobutylamine replaces the gem-dimethyl substitution, and the potency against all three AKT isoforms remarkably improved. The role of the free amino group was confirmed when we tested the acetylated compound <b>22</b>, which showed a 10-fold loss of potency against AKT1. Replacing the acetamide group in <b>22</b> with a reverse acetamide (<b>27</b>) was tolerated and showed similar potency; however, the introduction of an ester moiety (<b>26</b>) at this position was deleterious. A similar SAR trend was observed in our previous study: the acetamide analogue of <b>6</b> was active compared to nonpolar or polar substituents that lacked hydrogen donors (compound <b>8d</b> of ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>, IC<sub>50</sub> = 0.81 μM).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Thus, the introduction of substituents at the benzylic position appeared to change the previously defined SAR when a basic nitrogen is present.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structure–Activity Relationship for Substitution at the Benzylic Position<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details. NT means not tested.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Assay conducted with unphosphorylated enzymes.</p></div></div><div></div></div><div class="NLM_p">The extension of the cyclobutylamine to compound <b>9b</b> to produce <b>21b</b> showed comparable inhibitory activity to that of <b>21a</b> against all AKT isozymes (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). The removal of the acetamide (<b>23</b>) did not change the IC<sub>50</sub> values against inactive AKT. Finally, introducing a pyridine nitrogen in the aromatic ring of the 5-position substituent (<b>21c</b>) modestly affected the activities against AKT2 and AKT3.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Structure–Activity Relationship of 5-Substituted Analogs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0012.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0013.gif" alt="" id="fx6" /></img><div></div></div><div class="NLM_p">The biochemical potencies of the compounds against inactive, unphosphorylated AKT were compared with those against active, phosphorylated AKT isoforms in the final stage of optimization. As shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, with the exception of <b>21c</b>, the compounds showed similar inhibitory potency for the enzymatically distinct forms of AKT. The presence of a nitrogen atom in the aromatic substituent at position 5 appeared to be detrimental to the activity against AKT2 and AKT3. In contrast, as reported in our previous study, the initial hits of this chemical series were preferentially highly active in the assay utilizing only the unphosphorylated form of AKT. Therefore, further lead optimization was continued with the same assay format. Finally, the fully optimized, highly potent inhibitors were capable of inhibiting both the active and inactive forms of AKT with equivalent potency, and we believe that this functionality in the inhibitors is necessary to target constitutive AKT kinase activity in cancer cells.</div><div class="NLM_p">To define the binding mode of these potent AKT inhibitors and to understand the interactions of the phenylcyclobutylamine and phenyl groups at the 5-position, the crystal structure of unphosphorylated AKT1 was determined in complex with compound <b>21a</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The overall conformation of AKT1 was very similar to the previously determined structure,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> adopting an identical autoinhibitory conformation,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and the inhibitor (<b>21a</b>) occupied an allosteric pocket at the interface between the kinase and PH domains. The aminopyridine moiety of the (3-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine core forms hydrogen bonds with the disordered αC-helix and the β4-strand, and the core forms a key hydrophobic interaction with Trp80 in the PH domain. The phenyl ring of phenylcyclobutylamine makes a direct hydrophobic contact with Tyr272 in the highly conserved YRD motif of the kinase domain. The primary amine of cyclobutylamine forms bidentate hydrogen bonds with the main chain carbonyl of Tyr272 and the carboxylate group of Asp274, and this interaction facilitates the steric orientation of the cyclobutyl group toward the hydrophobic side chain of Ile 84 and the methyl group of Thr82 in the PH domain. Therefore, a strong proton donor on the benzylic group is critical for the interaction; thus, replacing this side chain with either with a single proton donor group, such as an amide in <b>27</b>, or a strong proton acceptor, such as the methyl ester group in <b>26</b>, would be detrimental. The phenyl moiety at the 5-position contacts the acyl side chains of Gln79 and Asn53, and thus, polar substituents (<b>9b</b>, <b>9c</b>, <b>9d</b>, <b>21b</b>, and <b>23</b>) on this hydrophobic phenyl ring are well tolerated, as these groups project toward the solvent. The crystal structure further explains the advantage of these interactions that led to activity improvement at the 5-position but not at the 6- or 7-positions, which is exemplified by <b>7a</b>, <b>7b</b>, and <b>7c</b>, where the methyl substituents are directly exposed to the highly polar solvent region.</div><figure id="fig1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cocrystal structure of <b>21a</b> with AKT1 (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KCV">5KCV</a>). Compound <b>21a</b> binds to the allosteric pocket formed by the kinase and PH domains. The aminopyrimidine group of the core moiety forms a bidentate hydrogen bonding interaction with the main chain atoms of loop of β4-strand and αC-helix. The phenylcyclobutylamine side chain associates with the conserved YRD motif of kinase domain by polar and nonpolar interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next examined the in vitro antiproliferative activity of the compounds in multiple cell lines where the PI3K/AKT pathway is upregulated due to mutational activation; A2780 (ovarian carcinoma), AN3CA (endometrial adenocarcinoma), IGROV-1 (ovarian adenocarcinoma), and LNCaP (prostate adenocarcinoma) were all monitored using a standard MTS assay. Compound <b>9a</b> exhibited micromolar antiproliferative activity (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>), while its cyclobutylamine analog showed a 10- to 35-fold increase in activity, being most potent against the IGROV-1 cell line. The acetamide analog <b>21b</b> was less active against the A2780, AN3CA, and LNCaP cell line and yet was best at inhibiting the proliferation of IGROV-1 ovarian cells (IC<sub>50</sub> = 0.16 μM). The corresponding amine <b>23</b> was also very potent in the MTS assay. Consistent with its biochemical inhibition of AKT, the pyridine analog <b>21c</b> was markedly less active in the cell lines, with the exception of IGROV-1 cells.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Antiproliferative Activity of Selected Compounds<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">MTS cell proliferation, IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">A2780</th><th class="colsep0 rowsep0" align="center">AN3CA</th><th class="colsep0 rowsep0" align="center">IGROV-1</th><th class="colsep0 rowsep0" align="center">LNCAP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="left">0.73</td><td class="colsep0 rowsep0" align="left">0.71</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">0.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b></td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">0.59</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21c</b></td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">6.1</td><td class="colsep0 rowsep0" align="left">0.40</td><td class="colsep0 rowsep0" align="left">13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details. NT means Not Tested.</p></div></div></div><div class="NLM_p">We assessed the ability of compounds <b>21a</b>–<b>c</b> to inhibit AKT1 phosphorylation at residues S473 and T308, as well as the downstream PRAS40 residue T246 in cells using Western blot analysis. Compounds <b>21a</b> and <b>21b</b> showed excellent inhibition of p-AKT (S473) and p-AKT (T308) in both AN3CA and A2780 cells (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). The inhibition of the downstream protein p-PRAS40 (T246) was observed with <b>21a</b> (IC<sub>50</sub> = 0.31 μM), whereas <b>21b</b> did not significantly inhibit the phosphorylation of PRAS40 (IC<sub>50</sub> ≥ 3 μM).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Cellular PD of Selected Compounds in AN3CA Cells<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">p-AKT (S473)</th><th class="colsep0 rowsep0" align="center">p-AKT (T308)</th><th class="colsep0 rowsep0" align="center">p-PRAS40 (T246)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="left">0.040</td><td class="colsep0 rowsep0" align="left">0.061</td><td class="colsep0 rowsep0" align="left">0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b></td><td class="colsep0 rowsep0" align="left">0.041<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.037<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>3.0<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21c</b></td><td class="colsep0 rowsep0" align="left">0.056</td><td class="colsep0 rowsep0" align="left">0.063</td><td class="colsep0 rowsep0" align="left">0.64</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">In A2780 cell line.</p></div></div></div><div class="NLM_p"><a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a> shows CYP450 isoform inhibition and microsomal stability using human, mouse, and dog liver microsome preparations. Compounds <b>9a</b>,<b>b</b>, <b>21a</b>–<b>c</b>, and <b>23</b> did not significantly inhibit CYP450 1A2, 2C8, 2D6, and 3A4. Compounds <b>9a</b> and <b>9b</b> inhibited CYP450 2C9 with a submicromolar IC<sub>50</sub> value, while <b>9a</b> also inhibited CYP450 2C19 (IC<sub>50</sub> ≤ 1 μM). All compounds were adequately stable in liver microsomes (human, mouse, and dog). In general, we found that compounds from this chemical series possess adequate in vitro ADME properties, and compound <b>21a</b> in particular showed good biochemical inhibition, cellular knockdown of AKT phosphorylation, and ADME properties. In a mouse pharmacokinetic study (po at 100 mg/kg, iv at 5 mg/kg), compound <b>21a</b> showed an oral bioavailability of 23%. An in vivo pharmacodynamic assessment of <b>21a</b> using NCr-M nude mice implanted with AN3CA tumor xenografts was reported in our recent publication.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Compound <b>21a</b> resulted in 99%, 95%, and 58% reductions in p-AKT (S473), p-AKT (T306), and p-PRAS40 (T246), respectively, after tumor-bearing mice were treated with 100 mg/kg po (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). The inhibition of phosphorylation was sustained at 8 h. The plasma concentration of compound <b>21a</b> at 1 h was 2.1 μM and decreased to 0.26 μM at 8 h, while in the tumor, the concentration was 21.0 μM at 1 h and 9.6 μM at 8 h. The concentrations in the tumor tissues were significantly higher than in the plasma, indicating a marked preference for tissue accumulation compared with the vasculature compartment.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vitro ADME Properties of Selected Compounds<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">CYP 450, IC<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" colspan="3" align="center">liver microsomal stability at 1.0 μM, <i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">1A2</th><th class="colsep0 rowsep0" align="center">2C8</th><th class="colsep0 rowsep0" align="center">2C9</th><th class="colsep0 rowsep0" align="center">2C19</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center">HLM</th><th class="colsep0 rowsep0" align="center">MLM (F/M)</th><th class="colsep0 rowsep0" align="center">DLM (F/M)</th><th class="colsep0 rowsep0" align="center">solubility (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">188</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">45/>60</td><td class="colsep0 rowsep0" align="left">>60/>60</td><td class="colsep0 rowsep0" align="left">≥200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left">18/17</td><td class="colsep0 rowsep0" align="left">28/31</td><td class="colsep0 rowsep0" align="left">170</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1–10</td><td class="colsep0 rowsep0" align="left">1–10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1–10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60/>60</td><td class="colsep0 rowsep0" align="left">50/>60</td><td class="colsep0 rowsep0" align="left">160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60/>60</td><td class="colsep0 rowsep0" align="left">>60/>60</td><td class="colsep0 rowsep0" align="left">138</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21c</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">37/31</td><td class="colsep0 rowsep0" align="left">21/>30</td><td class="colsep0 rowsep0" align="left">178</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details. NT means not tested.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. In Vivo Pharmacokinetic and Pharmacodynamic Results for <b>21a</b> in Tumor Bearing Mice (AN3CA Cell Line)<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">% inhibition</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">concn (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">po dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">time (h)</th><th class="colsep0 rowsep0" align="center" char=".">p-AKT (S473)</th><th class="colsep0 rowsep0" align="center" char=".">p-AKT (T308)</th><th class="colsep0 rowsep0" align="center" char=".">p-PRAS40 (T246)</th><th class="colsep0 rowsep0" align="center" char=".">plasma</th><th class="colsep0 rowsep0" align="center" char=".">tumor</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">99.2</td><td class="colsep0 rowsep0" align="char" char=".">95.0</td><td class="colsep0 rowsep0" align="char" char=".">57.7</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">21.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">98.6</td><td class="colsep0 rowsep0" align="char" char=".">96.3</td><td class="colsep0 rowsep0" align="char" char=".">35.9</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">99.2</td><td class="colsep0 rowsep0" align="char" char=".">93.3</td><td class="colsep0 rowsep0" align="char" char=".">50.5</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">35.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">99.7</td><td class="colsep0 rowsep0" align="char" char=".">90.8</td><td class="colsep0 rowsep0" align="char" char=".">42.5</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">27.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div></div></div><div class="NLM_p">The efficacy of compound <b>21a</b> has been probed in a previous communication, in which it was shown to have strong tumor growth inhibition in mouse xenografts of endometrial, breast cancer cell lines, and patient-derived tumor models.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Definitive single dose pharmacokinetic studies were conducted in rats and monkeys (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>). Compound <b>21a</b> showed good absolute oral bioavailability in rats and monkeys with <i>F</i> values of 62% and 49%, respectively. The compound was more slowly absorbed in rats compared to monkeys with <i>T</i><sub>max</sub> values of 8.0 h for rats versus 4.3 h for monkeys. The half-life was also longer in rats compared to monkeys with <i>t</i><sub>1/2</sub> values of 17 h in rats versus 7 h in monkeys. The <i>C</i><sub>max</sub> was 198 and 258 ng/mL and the AUC<sub>inf</sub> was 5496 and 2960 h·ng/mL in rats and monkeys, respectively.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Single Dose Pharmacokinetic Results for <b>21a</b> in Rats and Monkeys</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK parameter</th><th class="colsep0 rowsep0" align="center">rat (5 mg/kg)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">monkey (10 mg/kg)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">198</td><td class="colsep0 rowsep0" align="left">258</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>inf</sub> (h·ng/mL)</td><td class="colsep0 rowsep0" align="left">5496</td><td class="colsep0 rowsep0" align="left">2960</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">49</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Dosed in a solution formulation (compound <b>21a</b> in 0.01 M phosphoric acid).</p></div></div></div><div class="NLM_p last">In summary, compound <b>21a</b> is a highly optimized drug candidate with desirable biochemical potency and cellular inhibitory activity across multiple tumor types, as well as sustained in vivo target inhibition and good oral bioavailability. Consistent with targeting a distinct allosteric site, as revealed by its cocrystal structure with AKT1, <b>21a</b> demonstrated a very high selectivity when profiled against a large panel of kinases.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry</h3><div class="NLM_p last">All reagents and solvents were purchased from commercially available sources and used without further purification. All reactions were carried out according to the indicated procedures and conditions. Reactions were monitored by LC/MS analysis and/or thin-layer chromatography (TLC) on silica-coated glass plates (EMD silica gel 60 F<sub>254</sub>) with the indicated eluent. The compounds were visualized using UV light (254 nm). LC/MS analysis was performed on a Shimadzu HPLC/UV (214 nm and/or 254 nm wavelength) system coupled to ELSD (Sedex 75, Sedere) and MS (ZQ, Micromass) detectors. Compounds were dissolved in 100% DMSO and separated on a Zorbax SB-C8 rapid resolution cartridge (30 mm × 4.6 mm, 3.5 μm, 3 mL/min flow rate) using acetonitrile/water as the mobile phase with 0.1% TFA as a modifier. The gradient started at 5% acetonitrile and increased linearly to 95% acetonitrile over 1.9 min, with a 0.3 min hold at 95%, and the cartridge was re-equilibrated to the original conditions in a total of 2.5 min. The purity of the compounds selected for the in vivo studies was determined using an Agilent HP1100 system with a YMC C18 column (4.6 mm × 100 mm, 5 μm, 1 mL/min flow rate) and acetonitrile/water as the mobile phase with 0.1% TFA as a modifier. The gradient started at 2% acetonitrile and increased linearly to 30% acetonitrile over 7 min, followed by a linear increase to 80% acetonitrile by 12 min and a hold at 80% for 16 min. Purity was determined at 254 nm and was found to be >95%. Library compounds were purified by reverse phase chromatography on a preparative LC/UV/MS system (high throughput purification) using a mass-triggered fractionation method. Compounds were eluted from the HPLC column (MACCEL 120-10-C18 SH, 10 μm, 20 mm i.d. × 50 mm) at 88 mL/min with an acetonitrile/water gradient using 0.1% TFA as a modifier. Nuclear magnetic resonance (<sup>1</sup>H NMR<b>)</b> spectra were recorded on a Varian Mercury Plus NMR spectrometer operating at 400.13 MHz for <sup>1</sup>H using a 5 mm ASW PFG probe capable of detecting <sup>1</sup>H, <sup>13</sup>C, <sup>31</sup>P, and <sup>15</sup>N nuclei. The proton chemical shifts (ppm) were in reference to the tetramethylsilane standard (0 ppm). The NMR data are reported with these descriptions: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; and br, broad peak.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 3-Nitro-<i>N</i>-(<i>p</i>-tolyl)pyridin-2-amine (<b>2a</b>)</h3><div class="NLM_p last">2-Chloro-3-nitropyridine <b>1</b> (100 mg, 0.63 mmol) was dissolved in dioxane (4 mL) in a round-bottom flask. <i>p</i>-Tolylaniline (68 mg, 0.63 mmol) was then added, followed by DIEA (0.22 mL) addition. The reaction mixture was heated to 80 °C for 24 h, and the reaction was stopped when complete as observed by LCMS. After cooling to room temperature, the solvent was removed under reduced pressure to afford an oily residue. The residue was dissolved in ethyl acetate (20 mL) and washed with water and brine (5 mL each). The organic phase was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. After filtration, the solvent was removed under reduced pressure. The crude product was carried on to the next step without further purification. MS <i>m</i>/<i>z</i> 230 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>N</i>-(4-(<i>tert</i>-Butyl)phenyl)-3-nitropyridin-2-amine (<b>2b</b>)</h3><div class="NLM_p last"><b>2b</b> was prepared from <b>1</b> as described for <b>2a</b> using 4-(<i>tert</i>-butyl)aniline. The crude product was purified by column chromatography (1% MeOH/DCM, silica gel) to give <b>2b</b> (1.55 g, 89%) as a red solid. Mp 156–158 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.92 (s, 1H), 8.51 (dd, <i>J</i> = 14.5, 5.6 Hz, 1H), 7.54 (d, <i>J</i> = 8.4 Hz, 1H), 7.38 (d, <i>J</i> = 8.5 Hz, 1H), 6.96 (dd, <i>J</i> = 8.1, 4.6 Hz, 1H), 1.29 (s, 9H); MS <i>m</i>/<i>z</i> 272 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>tert</i>-Butyl (4-((3-Nitropyridin-2-yl)amino)benzyl)carbamate (<b>2c</b>)</h3><div class="NLM_p last"><b>2c</b> was prepared from <b>1</b> as described for <b>2a</b> using <i>tert</i>-butyl (4-aminobenzyl)carbamate. The crude product was purified by column chromatography (1% MeOH/DCM, silica gel). MS <i>m</i>/<i>z</i> 345 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>tert</i>-Butyl (4-((4-Methyl-3-nitropyridin-2-yl)amino)benzyl)carbamate (<b>3a</b>)</h3><div class="NLM_p last"><b>3a</b> was prepared from 2-chloro-4-methyl-3-nitropyridine (<b>1b)</b> as described for <b>2a</b> using <i>tert</i>-butyl (4-aminobenzyl)carbamate. The crude product was used directly in the next step without purification. MS <i>m</i>/<i>z</i> 359 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>tert</i>-Butyl (4-((5-Methyl-3-nitropyridin-2-yl)amino)benzyl)carbamate (<b>3b</b>)</h3><div class="NLM_p last"><b>3b</b> was prepared from 2-chloro-5-methyl-3-nitropyridine (<b>1c)</b> as described for <b>2a</b> using <i>tert</i>-butyl (4-aminobenzyl)carbamate. The crude product was used directly in the next step without purification. MS <i>m</i>/<i>z</i> 359 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>tert</i>-Butyl (4-((5,6-Dimethyl-3-nitropyridin-2-yl)amino)benzyl)carbamate (<b>3c</b>)</h3><div class="NLM_p last"><b>3c</b> was prepared from 2-chloro-5,6-dimethyl-3-nitropyridine (<b>1d)</b> as described for <b>2a</b> using <i>tert</i>-butyl (4-aminobenzyl)carbamate. The crude product was used directly in the next step without purification. MS <i>m</i>/<i>z</i> 373 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>tert</i>-Butyl (4-((6-Chloro-3-nitropyridin-2-yl)amino)benzyl)carbamate (<b>3d</b>)</h3><div class="NLM_p last"><b>3d</b> was prepared from 2,6-dichloro-3-nitropyridine (<b>1e)</b> as described for <b>2a</b> using <i>tert</i>-butyl (4-aminobenzyl)carbamate. The crude product was used directly in the next step without purification. MS <i>m</i>/<i>z</i> 378 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>tert</i>-Butyl (4-((5-Bromo-3-nitropyridin-2-yl)amino)benzyl)carbamate (<b>3e</b>)</h3><div class="NLM_p last"><b>3e</b> was prepared from 5-bromo-2-chloro-3-nitropyridine (<b>1f)</b> as described for <b>2a</b> using <i>tert</i>-butyl (4-aminobenzyl)carbamate. The crude product was used directly in the next step without purification. Mp 178–180 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.95 (s, 1H), 8.65 (m, 1H), 8.54 (s, 1H), 7.51 (d, <i>J</i> = 6.4 Hz, 2H), 7.23 (d, <i>J</i> = 6.4 Hz, 2H), 4.21–4.12 (m, 2H), 1.41 (s, 9H); MS <i>m</i>/<i>z</i> 367, 369 [M(− <i>t</i>-Bu) + H, M(−<i>t</i>-Bu) + 2 + H]<sup>+</sup>.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 3-(3-(<i>p</i>-Tolyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine (<b>4a</b>)</h3><div class="NLM_p last">Crude 3-nitro-<i>N</i>-(<i>p</i>-tolyl)pyridin-2-amine <b>2a</b> was dissolved in DMSO (4 mL) and MeOH (2 mL) in a round-bottom flask. 2-Aminonicotinaldehyde 4 (77 mg, 1.1 equiv) and Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub> (274 mg) were added to the flask. The reaction mixture was heated to 100 °C for 18 h. After cooling to room temperature, the reaction mixture was diluted with dichloromethane (50 mL) and washed with water and brine. The organic phase was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. After filtration, the solvent was removed under reduced pressure. The crude product was purified by silica gel chromatography (EtOAc/hexane) to afford 20 mg of 3-(3-(<i>p</i>-tolyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine (<b>4a</b>) as an off-white solid. Mp 186–188 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29–8.28 (dd, <i>J</i> = 5.0, 1.6 Hz, 1H), 8.18–8.15 (dd, <i>J</i> = 7.8, 1.1 Hz, 1H), 7.96–7.95 (dd, <i>J</i> = 4.7, 1.6 Hz, 1H), 7.37–7.33 (dd, <i>J</i> = 8.21, 5.09 Hz, 1H), 7.31–7.26 (m, 4H), 7.20–7.17 (dd, <i>J</i> = 7.8, 1.9 Hz, 1H), 6.96 (s, 2H), 6.39–6.36 (dd, <i>J</i> = 7.8, 4.6 Hz, 1H), 2.36 (s, 3H); MS <i>m</i>/<i>z</i> 302 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 3-(3-(4-(<i>tert</i>-Butyl)phenyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine (<b>4b</b>)</h3><div class="NLM_p last"><b>4b</b> was prepared as described for <b>4a</b> using <b>2b</b> and 2-aminonicotinaldehyde. Mp 175–180 °C; <sup>1</sup>H NMR (400 M Hz, acetone-<i>d</i><sub>6</sub>) δ 8.44–8.42 (dd, <i>J</i> = 4.7, 1.2 Hz, 1H), 8.26–8.23 (dd, <i>J</i> = 8.2,1.6 Hz, 1H), 8.05–8.02 (dd, <i>J</i> = 6.3, 1.6 Hz, 1H), 7.75–7.73 (dd, <i>J</i> = 7.8, 1.6 Hz, 1H), 7.70–7.68 (dd, <i>J</i> = 6.6, 2.3 Hz, 2H), 7.57–7.55 (dd, <i>J</i> = 8.6, 1.9 Hz, 2H), 7.48–7.44 (dd, J = 8.2, 4.7 Hz, 1H), 6.82–6.78 (dd, <i>J</i> = 7.8, 6.3 Hz, 1H), 1.41 (s, 9H). MS <i>m</i>/<i>z</i> 344 [M + H]<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>21</sub>N<sub>5</sub>·1.5TFA·0.1 acetone) calcd: C, 56.10; H, 4.48; N 13.46. Found: C, 56.32; H, 4.25; N, 13.70.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>tert</i>-Butyl (4-(2-(2-Aminopyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)benzyl)carbamate (<b>4c</b>)</h3><div class="NLM_p last"><b>4c</b> was prepared as described for <b>4a</b> using <b>2c</b> and 2-aminonicotinaldehyde. Mp 172–173 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 8.20 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.99 (dd, <i>J</i> = 4.8, 1.8 Hz, 1H), 7.49 (t, <i>J</i> = 6.3 Hz, 1H), 7.43–7.32 (m, 5H), 7.20 (dd, <i>J</i> = 7.7, 1.9 Hz, 1H), 6.99 (s, 2H), 6.39 (dd, <i>J</i> = 7.7, 4.8 Hz, 1H), 4.21 (d, <i>J</i> = 6.2 Hz, 2H), 1.41 (s, 9H); MS <i>m</i>/<i>z</i> 417 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>tert</i>-Butyl (4-(2-(2-Aminopyridin-3-yl)-7-methyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)benzyl)carbamate (<b>5a</b>)</h3><div class="NLM_p last"><b>5a</b> was prepared from <b>3a</b> as described for <b>4a</b>. Mp 160–162 °C; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.17 (d, <i>J</i> = 5.1 Hz, 1H), 7.96 (dt, <i>J</i> = 5.1, 1.4 Hz, 1H), 7.45 (d, <i>J</i> = 7.8 Hz, 2H), 7.37–7.31 (m, 3H), 7.24 (d, <i>J</i> = 5.1 Hz, 1H), 6.49–6.45 (m, 1H), 4.31 (br s, 2H), 2.74 (s, 3H), 1.46 (s, 9H); MS <i>m</i>/<i>z</i> 431 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>tert</i>-Butyl (4-(2-(2-Aminopyridin-3-yl)-6-methyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)benzyl)carbamate (<b>5b</b>)</h3><div class="NLM_p last"><b>5b</b> was prepared from <b>3b</b> as described for <b>4a</b>. Mp 211–212 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (dd, <i>J</i> = 2.0, 0.8 Hz, 1H), 8.04–7.95 (m, 2H), 7.49 (t, <i>J</i> = 6.2 Hz, 1H), 7.36 (s, 4H), 7.17 (dd, <i>J</i> = 7.7, 1.9 Hz, 1H), 7.02 (s, 2H), 6.38 (dd, <i>J</i> = 7.7, 4.8 Hz, 1H), 4.21 (d, <i>J</i> = 6.2 Hz, 2H), 2.45 (d, <i>J</i> = 0.8 Hz, 3H), 1.41 (s, 9H), 1.34; MS <i>m</i>/<i>z</i> 431 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>tert</i>-Butyl (4-(2-(2-Aminopyridin-3-yl)-5,6-dimethyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)benzyl)carbamate (<b>5c</b>)</h3><div class="NLM_p last"><b>5c</b> was prepared from <b>3c</b> as described for <b>4a</b>. The crude product was used without purification. MS <i>m</i>/<i>z</i> 445 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>tert</i>-Butyl (4-(2-(2-Aminopyridin-3-yl)-5-chloro-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)benzyl)carbamate (<b>5d</b>)</h3><div class="NLM_p last"><b>5d</b> was prepared from <b>3d</b> as described for <b>4a</b>. Mp 235–237 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.26 (d, <i>J</i> = 8.6 Hz, 1H), 7.99 (dd, <i>J</i> = 4.7, 2.0, 1H), 7.49 (t, <i>J</i> = 6.1 Hz, 1H), 7.45 (d, <i>J</i> = 8.2 Hz, 1H), 7.42–7.35 (m, 4H), 7.21 (dd, <i>J</i> = 7.8, 2.0 Hz, 1H), 6.92 (s, 2H), 6.41 (dd, <i>J</i> = 7.4, 4.7 Hz, 1H), 4.22 (d, <i>J</i> = 6.1 Hz, 2H), 1.41 (s, 9H); MS <i>m</i>/<i>z</i> 451 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>tert</i>-Butyl 4-(2-(2-Aminopyridin-3-yl)-6-bromo-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-3-yl)benzylcarbamate (<b>5e</b>)</h3><div class="NLM_p last"><b>5e</b> was prepared from <b>3e</b> as described for <b>4a</b>. The product was purified by column chromatography (1–5% methanol in dichloromethane) followed by recrystallization in 1:1 ethyl acetate/hexanes. Mp 176–178 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.50 (d, <i>J</i> = 2.0 Hz, 1H), 8.40 (d, <i>J</i> = 2.4 Hz, 1H), 7.99 (dd, <i>J</i> = 4.7, 2.0 Hz, 1H), 7.48 (t, <i>J</i> = 5.6 Hz, 1H), 7.40–7.31 (m, 3H), 7.23 (dd, <i>J</i> = 7.8, 2.0 Hz, 1H), 6.97 (s, 2H), 6.40 (dd, <i>J</i> = 7.7, 4.4 Hz, 1H), 4.121 (d, <i>J</i> = 6.2 Hz, 2H), 1.41 (s, 9H). MS <i>m</i>/<i>z</i> 495, 497 [M + H, M + 2 + H]<sup>+</sup>.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-(3-(4-(Aminomethyl)phenyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine (<b>6</b>)</h3><div class="NLM_p last">HCl (4 M in dioxane, 7.2 mL, 28.8 mmol) was added to a solution of <b>4c</b> (0.7 g, 1.7 mmol) in methanol (5 mL), and the mixture was stirred at room temperature for 4 h. The solution was concentrated under reduced pressure to yield <b>6</b> (0.82 g, quantitative yield) as a hydrochloric acid salt. Mp 255–257 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.44 (m, 3H), 8.30 (dd, <i>J</i> = 8.0, 1.4 Hz, 1H), 8.12 (dd, <i>J</i> = 6.2, 1.6 Hz, 1H), 7.87 (d, <i>J</i> = 6.6 Hz, 1H), 7.65 (d, <i>J</i> = 8.4 Hz, 2H), 7.57 (d, <i>J</i> = 8.4 Hz, 2H), 7.48 (dd, <i>J</i> = 8.0, 4.7 Hz, 1H), 6.85 (dd, <i>J</i> = 7.1, 6.6 Hz, 1H), 4.12 (d, <i>J</i> = 5.6 Hz, 2H), 3.81 (s, 2H). MS <i>m</i>/<i>z</i> 317 [M + H]<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>16</sub>N<sub>6</sub>·4.6HCl·4.2H<sub>2</sub>O·0.8Et<sub>2</sub>O) calcd: C, 41.13; H, 6.02; N, 13.58. Found: C, 41.12; H, 6.02; N, 13.58.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-(3-(4-(Aminomethyl)phenyl)-7-methyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine Hydrochloride (<b>7a</b>)</h3><div class="NLM_p last"><b>7a</b> was prepared from <b>5a</b> as described for <b>6</b>. Mp 210–212 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.52 (s, 3H), 8.45 (s, 2H), 8.27 (d, <i>J</i> = 4.7 Hz, 1H), 8.14 (dd, <i>J</i> = 6.3, 1.6 Hz, 1H), 7.91 (dd, <i>J</i> = 7.4, 1.6 Hz, 1H), 7.67–7.64 (m, 2H), 7.57–7.53 (m, 2H), 7.31 (d, <i>J</i> = 5.4 Hz, 1H), 6.88 (dd, <i>J</i> = 7.4, 6.2 Hz, 1H), 4.10 (m, 2H), 2.70 (s, 3H); MS <i>m</i>/<i>z</i> 331 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-(3-(4-(Aminomethyl)phenyl)-6-methyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine Hydrochloride (<b>7b</b>)</h3><div class="NLM_p last"><b>7b</b> was prepared from <b>5b</b> as described for <b>6</b>. Mp 220–230 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.65 (s, 3H), 8.53 (s, 2H), 8.29 (dd, <i>J</i> = 2.0, 0.7 Hz, 1H), 8.16 (dd, <i>J</i> = 6.2, 1.7 Hz, 1H), 8.12 (dd, <i>J</i> = 2.0, 0.9 Hz, 1H), 7.91 (dd, <i>J</i> = 7.5, 1.6 Hz, 1H), 7.75–7.64 (m, 2H), 7.62–7.48 (m, 2H), 6.90 (dd, <i>J</i> = 7.5, 6.2 Hz, 1H), 4.10 (q, <i>J</i> = 5.8 Hz, 2H), 2.49 (s, 3H); MS <i>m</i>/<i>z</i> 331 [M + H]<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>18</sub>N<sub>6</sub>·3.43HCl·0.43EtOAc) calcd: C, 50.45; H, 5.08; N, 17.04. Found: C, 50.42; H, 5.21; N, 17.07.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 3-(3-(4-(Aminomethyl)phenyl)-5,6-dimethyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine Hydrochloride (<b>7c</b>)</h3><div class="NLM_p last"><b>7c</b> was prepared from <b>5c</b> as described for <b>6</b>. Mp 103–112 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.91 (s, 2H), 7.45–7.40 (m, 2H), 7.32–7.26 (m, 2H), 7.11 (d, <i>J</i> = 7.2 Hz, 1H), 6.99 (m, 2H), 6.38 (dd, <i>J</i> = 7.2, 6.3 Hz, 1H), 3.80 (s, 2H), 3.40–3.15 (br.s, 3H), 2.41 (s, 3H), 2.35 (s, 3H); MS <i>m</i>/<i>z</i> 345 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-(3-(4-(Aminomethyl)phenyl)-5-chloro-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine Hydrochloride (<b>7d</b>)</h3><div class="NLM_p last"><b>7d</b> was prepared from <b>5d</b> as described for <b>6</b>. Mp 208–211 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.55 (s, 3H), 8.37 (dd, <i>J</i> = 8.4, 1.0 Hz, 1H), 8.18–8.12 (m, 1H), 7.97–7.91 (m, 1H), 7.69 (d, <i>J</i> = 8.0 Hz, 2H), 7.61–7.51 (m, 3H), 6.90 (t, <i>J</i> = 6.9 Hz, 1H), 4.11 (d, <i>J</i> = 5.9 Hz, 2H), 3.57 (s, 2H); MS <i>m</i>/<i>z</i> 351 [M + H]<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>15</sub>N<sub>6</sub>Cl·2.58HCl·0.16EtOAc) calcd: C, 48.78; H, 4.14; N, 18.31. Found: C, 48.80; H, 4.32; N, 18.31.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-(3-(4-(Aminomethyl)phenyl)-6-bromo-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine Hydrochloride (<b>7e</b>)</h3><div class="NLM_p last"><b>7e</b> was prepared from <b>5e</b> as described for <b>6</b>. Mp. 221–223 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) 400 M Hz δ 8.60 (d, <i>J</i> = 2.0 Hz, 1H), 8.56 (bs, 2H), 8.51 (d, <i>J</i> = 2.4 Hz, 1H), 8.38 (bs, 2H), 8.13 (dd, <i>J</i> = 2.0 and 4.7 Hz, 1H), 7.95 (dd, <i>J</i> = 1.6 and 7.4 Hz, 1H), 7.63 (d, <i>J</i> = 8.6 Hz, 2H), 7.53 (d, <i>J</i> = 8.6 Hz, 2H), 6.89 (dd, <i>J</i> = 6.2 and 7.4 Hz, 1H), 4.17 (app q, <i>J</i> = 5.5 Hz, 1H); MS <i>m</i>/<i>z</i> 394, 396 [M + H, M + 2 + H]<sup>+</sup>.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>tert</i>-Butyl (4-(2-(2-Aminopyridin-3-yl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)benzyl)carbamate (<b>8a</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl (4-(2-(2-aminopyridin-3-yl)-5-chloro-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)benzyl)carbamate (<b>5d</b>) (5.1 g, 11.33 mmol) and phenylboronic acid (2.76 g, 22.6 mmol) in suspension (200 mL of toluene/200 mL of EtOH) were treated with saturated aqueous NaHCO<sub>3</sub> (33 mL), and the mixture was degassed for 5 min. The catalyst Pd(PPh<sub>3</sub>)<sub>4</sub> (0.51 g, 0.44 mmol) was added, and the reaction mixture was stirred overnight at 100 °C. Upon cooling to room temperature, the mixture was extracted with DCM (3 × 100 mL). The combined organic extracts were washed with sat. aq NaHCO<sub>3</sub> and then with water. The solution was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude product was purified by column chromatography (hexanes/ethyl acetate, 5:95). The <i>tert</i>-butyl (4-(2-(2-aminopyridin-3-yl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)benzyl)carbamate (<b>8a</b>) was obtained as dark red crystals (4.7 g, 84%). Mp 209–212 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 8.04–7.94 (m, 4H), 7.50–7.33 (m, 8H), 7.20 (dd, <i>J</i> = 7.8, 1.9 Hz, 1H), 7.00 (s, 2H), 6.40 (dd, <i>J</i> = 7.6, 4.9 Hz, 1H), 4.22 (d, <i>J</i> = 6.2 Hz, 2H), 1.39 (s, 9H); MS <i>m</i>/<i>z</i> 493 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>tert</i>-Butyl (4-(5-(3-Acetamidophenyl)-2-(2-aminopyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)benzyl)carbamate (<b>8b</b>)</h3><div class="NLM_p last"><b>8b</b> was prepared from <b>5d</b> as described for <b>8a</b> using (3-acetamidophenyl)boronic acid. The crude product was purified by column chromatography (95:5 ethyl acetate/methanol). MS <i>m</i>/<i>z</i> 550 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>tert</i>-Butyl (4-(5-(4-Acetamidophenyl)-2-(2-aminopyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)benzyl)carbamate (<b>8c</b>)</h3><div class="NLM_p last"><b>8c</b> was prepared from <b>5d</b> as described for <b>8a</b>, using (4-acetamidophenyl)boronic acid. The crude product was purified by column chromatography (5:95 hexanes/ethyl acetate). MS <i>m</i>/<i>z</i> 550 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>tert</i>-Butyl (4-(2-(2-Aminopyridin-3-yl)-5-(1<i>H</i>-pyrazol-4-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)benzyl)carbamate (<b>8d</b>)</h3><div class="NLM_p last"><b>8d</b> was prepared from <b>5d</b> as described for <b>8a</b> using (1<i>H</i>-pyrazol-4-yl)boronic acid. Mp. 243–244 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12,99 (s, 1H), 8.19 (s, 1H), 8.12 (d, <i>J</i> = 8.8 Hz, 1H), 7.95 (d, <i>J</i> = 5.2 Hz, 1H), 7.92 (s, 1H), 7.68 (d, <i>J</i> = 8.4 Hz, 1H), 7.47 (t, <i>J</i> = 5.6 Hz, 1H), 7.40–7.33 (m, 4H), 7.13 (d, <i>J</i> = 7.2 Hz, 1H), 6.94 (s, 2H), 6.36 (t, <i>J</i> = 6.0 Hz, 1H), 4.20 (d, <i>J</i> = 6.4 Hz, 2H), 1.39 (s, 9H); MS <i>m</i>/<i>z</i> 483 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>tert</i>- Butyl (4-(2-(2-Aminopyridin-3-yl)-6-(pyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)benzyl)carbamate (<b>8e</b>)</h3><div class="NLM_p last"><b>8e</b> was prepared from <b>5e</b> as described for <b>8a</b> using (pyridin-3-yl)boronic acid. The crude residue was purified by silica gel chromatography (2–20% methanol in ethyl acetate), yielding 3.9 g of <b>8e</b> (7.9 mmol, 99% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.98 (d, <i>J</i> = 1.9 Hz, 1H), 8.64 (d, <i>J</i> = 2.0 Hz, 1H), 8.59 (dd, <i>J</i> = 1.6 and 4.7 Hz, 1H), 8.54 (d, <i>J</i> = 2.0 Hz, 1H), 8.20 (m, 1H), 7.98 (m, 1H), 7.52 (m, 2H), 7.48–7.34 (m, 4H), 7.23 (m, 1H), 7.01 (s, br, 2H), 6.38 (m, 1H), 4.19 (m, 2H), 1.38 (s, 9H); MS <i>m</i>/<i>z</i> 438, 494, [M – (<i>t</i>-Bu) + H, M + H]<sup>+</sup>.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3-(3-(4-(Aminomethyl)phenyl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine Hydrochloride (<b>9a</b>)</h3><div class="NLM_p last"><b>9a</b> was prepared from <b>8a</b> as described for <b>6</b>. Mp 215–218 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.52 (s, 3H), 8.35 (d, <i>J</i> = 8.2 Hz, 1H), 8.16–8.11 (m, 1H), 8.05 (t, <i>J</i> = 8.5 Hz, 3H), 7.90 (d, <i>J</i> = 7.0 Hz, 1H), 7.68 (d, <i>J</i> = 7.8 Hz, 2H), 7.65–7.59 (m, 2H), 7.50–7.37 (m, 3H), 6.88 (q, <i>J</i> = 5.7, 4.9 Hz, 1H), 4.68 (s, 2H), 4.11 (d, <i>J</i> = 5.9 Hz, 2H); MS <i>m</i>/<i>z</i> 393 [M + H]<sup>+</sup>. Anal. (C<sub>24</sub>H<sub>20</sub>N<sub>6</sub>·3.14HCl·0.45EtOAc) calcd: C, 56.69; H, 4.93; N, 15.38. Found: C, 56.68; H, 5.18; N, 15.37.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(3-(3-(4-(Aminomethyl)phenyl)-2-(2-aminopyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-5-yl)phenyl)acetamide Hydrochloride (<b>9b</b>)</h3><div class="NLM_p last"><b>9b</b> was prepared from <b>8b</b> as described for <b>6</b>. Mp 245–248 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.16 (s, 1H), 8.47 (s, 3H), 8.39 (s, 2H), 8.35 (d, <i>J</i> = 8.1 Hz, 1H), 8.18 (d, <i>J</i> = 2.6 Hz, 1H), 8.15–8.08 (m, 1H), 7.89 (d, <i>J</i> = 8.1 Hz, 2H), 7.63 (dt, <i>J</i> = 11.8, 7.5 Hz, 5H), 7.36 (t, <i>J</i> = 7.9 Hz, 1H), 6.87 (t, <i>J</i> = 6.6 Hz, 1H), 4.10 (d, <i>J</i> = 5.9 Hz, 2H), 2.04 (s, 3H); MS <i>m</i>/<i>z</i> 450 [M + H]<sup>+</sup>. Anal. (C<sub>26</sub>H<sub>23</sub>N<sub>7</sub>O·3.35 HCl) calcd: C, 54.63; H, 4.65; N, 17.15. Found: C, 54.62; H, 4.67; N, 16.81.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(4-(3-(4-(Aminomethyl)phenyl)-2-(2-aminopyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-5-yl)phenyl)acetamide Hydrochloride (<b>9c</b>)</h3><div class="NLM_p last"><b>9c</b> was prepared from <b>8c</b> as described for <b>6</b>. Mp 227–230 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.25 (s, 1H), 8.58 (s, 3H), 8.33 (d, <i>J</i> = 8.4 Hz, 1H), 8.16 (dd, <i>J</i> = 6.4, 1.7 Hz, 1H), 8.01 (t, <i>J</i> = 7.9 Hz, 3H), 7.90 (dd, <i>J</i> = 7.6, 1.7 Hz, 1H), 7.75–7.59 (m, 6H), 6.90 (t, <i>J</i> = 6.9 Hz, 1H), 5.80 (s, 2H), 4.13 (d, <i>J</i> = 5.8 Hz, 2H), 2.07 (s, 3H); MS <i>m</i>/<i>z</i> 450 [M + H]<sup>+</sup>. Anal. (C<sub>26</sub>H<sub>23</sub>N<sub>7</sub>O·3.35HCl·0.28EtOAc·0.3H<sub>2</sub>O) calcd: C, 54.33; H, 4.90; N, 16.35. Found: C, 54.35; H, 4.96; N, 16.11.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-(3-(4-(Aminomethyl)phenyl)-5-(1<i>H</i>-pyrazol-4-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine Hydrochloride (<b>9d</b>)</h3><div class="NLM_p last"><b>9d</b> was prepared from <b>8d</b> as described for <b>6</b>. Mp. 264–269 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.50 (br, 4H), 8.43 (br, 1H), 8.22 (d, <i>J</i> = 8.4 Hz, 1H), 8.13–8.09 (m, 3H), 7.85 (d, <i>J</i> = 7.6 Hz, 1H), 7.77 (d, <i>J</i> = 8.8 Hz, 1H), 7.66 (d, <i>J</i> = 8.0 Hz, 2H), 7.58 (d, <i>J</i> = 8.8 Hz, 2H), 6.86 (t, <i>J</i> = 7.2 Hz, 1H), 4.10 (q, <i>J</i> = 5.2 Hz, 2H); MS <i>m</i>/<i>z</i> 383 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-(3-(4-(Aminomethyl)phenyl)-6-(pyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine Hydrochloride (<b>9e</b>)</h3><div class="NLM_p last"><b>9e</b> was prepared from <b>8e</b> as described for <b>6</b>. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>OD) δ 9.38 (d, <i>J</i> = 2.0 Hz, 1H), 9.11 (d, <i>J</i> = 2.0 Hz, 1H), 8.95–8.93 (m, 1H), 8.89 (d, <i>J</i> = 2.0 Hz, 1H), 8.78 (m, 1H), 8.83–8.25 (m, 1H), 8.06–8.04 (m, 1H), 7.88–7.86 (m, 1H), 7.77–7.66 (m, 4H), 6.86–6.83 (m, 1H), 4.23 (m, 2H), MS <i>m</i>/<i>z</i> 394 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-Methyl-<i>N</i>-(propan-2-ylidene)propane-2-sulfinamide (<b>11</b>)</h3><div class="NLM_p last">Ti(OEt)<sub>4</sub> (5.36 mL) was added dropwise over the course of 15 min to a solution of 2-methyl-2-propanesulfinamide (<b>10</b>) (1.47 g, 12.1 mmol) and acetone (0.98 mL) in THF (24 mL) chilled to 0 °C. After being stirred at room temperature for 3 days, the reaction mixture was quenched by the rapid addition of an ice-cooled saturated sodium bicarbonate solution. The suspension was filtered through glass-fiber filter paper and was washed with ethyl acetate. The filtrate was washed with sat. aq NaHCO<sub>3</sub> solution and brine. The organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Purification by column chromatography (10–60% ethyl acetate in hexanes) yielded 2-methyl-<i>N</i>-(propan-2-ylidene)propane-2-sulfinamide (<b>11</b>) (0.92 g, 47%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.34 (s, 3H), 2.18 (s, 3H), 1.23 (s, 9H).</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-(2-(4-Aminophenyl)propan-2-yl)-2-methylpropane-2-sulfinamide (<b>12</b>)</h3><div class="NLM_p last">A solution of <i>n</i>-butyllithium in hexanes (1.65 M, 5.2 mL) was added dropwise to a solution of 4-bromo-<i>N</i>,<i>N</i>-bis(trimethylsilyl)aniline (2.55 mL) in THF (14 mL) at −78 °C. The resulting mixture was stirred for 1.5 h at −78 °C, after which a solution of <i>N</i>-isopropylidene-2-methylpropane-2-sulfinamide (<b>11</b>) in THF (2.8 mL) was added dropwise at −78 °C. The reaction mixture was stirred for an additional 1 h at −78 °C and then allowed to warm to room temperature. After being stirred for 18 h at room temperature, the reaction mixture was poured into an ice-cooled sat. aq NaHCO<sub>3</sub> solution. The aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with a sat. aq NaHCO<sub>3</sub> solution and brine and then dried over Na<sub>2</sub>SO<sub>4</sub>. The dried solution was filtered, and the filtrate was concentrated to dryness. The residue was diluted with diisopropyl ether and extracted with a 1 M citric acid solution. The aqueous extracts were combined and alkalinized with solid sodium bicarbonate to pH > 7. The basic aqueous layer was extracted with ethyl acetate, and the organic layer was washed with brine. The organics were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Purification by column chromatography (50–100% ethyl acetate in hexanes) produced <i>N</i>-(2-(4-aminophenyl)propan-2-yl)-2-methylpropane-2-sulfinamide (<b>12</b>) (173 mg, 12%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.26 (d, <i>J</i> = 8.7 Hz, 2H), 6.65 (d, <i>J</i> = 8.7 Hz, 2H), 3.66 (brs, 1H), 3.31 (s, 1H), 1.67 (s, 3H), 1.64 (s, 3H), 1.20 (s, 9H).</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-(2-(4-((6-Chloro-3-nitropyridin-2-yl)amino)phenyl)propan-2-yl)-2-methylpropane-2-sulfinamide (<b>13</b>)</h3><div class="NLM_p last"><b>13</b> was prepared from 2,6-dichloro-3-nitropyridine (<b>1e)</b> as described for <b>2a</b> using <i>N</i>-(2-(4-aminophenyl)propan-2-yl)-2-methylpropane-2-sulfinamide (<b>12</b>). The crude product was purified by column chromatography (30–100% ethyl acetate in hexanes). MS <i>m</i>/<i>z</i> 411 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>tert</i>-Butyl (2-(4-((6-Chloro-3-nitropyridin-2-yl)amino)phenyl)propan-2-yl)carbamate (<b>14</b>)</h3><div class="NLM_p last">A solution of HCl in dioxane (4 M, 130 μL) was added dropwise to a solution of <i>N</i>-(1-(4-((6-chloro-3-nitropyridin-2-yl)amino)phenyl)-1-methylethyl)-2-methylpropane-2-sulfinamide (<b>13</b>) (107 mg, 0.26 mmol) in DCM (5 mL) at room temperature. The reaction mixture was stirred for 30 min. Hexane was added to the suspension, and the solid was filtered to yield an <i>N</i>-(4-(1-amino-1-methylethyl)phenyl)-6-chloro-3-nitropyridin-2-amine hydrochloride intermediate. Sat. aq NaHCO<sub>3</sub> solution (6 mL) was added to a suspension of <i>N</i>-(4-(1-amino-1-methylethyl)phenyl)-6-chloro-3-nitropyridin-2-amine hydrochloride in THF (3 mL) chilled to 0 °C, followed by dropwise addition of a solution of di-<i>tert</i>-butyl dicarbonate (167 mg) in THF (3 mL). After being stirred at room temperature overnight, the reaction mixture was extracted with ethyl acetate. The organic layer was washed with sat. aq NaHCO<sub>3</sub> solution and brine. The organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Purification by column chromatography (3–30% ethyl acetate in hexanes) produced <i>tert</i>-butyl (2-(4-((6-chloro-3-nitropyridin-2-yl)amino)phenyl)propan-2-yl)carbamate (<b>14</b>) (99 mg, 2 steps 93%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.25 (br.s, 1H), 8.46 (d, <i>J</i> = 8.7 Hz, 1H), 7.61 (d, <i>J</i> = 8.7 Hz, 2H), 7.43 (d, <i>J</i> = 8.7 Hz, 2H), 6.79 (d, <i>J</i> = 8.7 Hz, 1H), 4.94 (brs, 1H), 1.64 (s, 6H), 1.50–1.00 (m, 9H); MS <i>m</i>/<i>z</i> 351 [M – (<i>t</i>-Bu) + H].</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>tert</i>-Butyl (2-(4-(2-(2-Aminopyridin-3-yl)-5-chloro-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)propan-2-yl)carbamate (<b>15</b>)</h3><div class="NLM_p last"><b>15</b> was prepared as described for <b>4a</b> using <b>14</b> and 2-aminonicotinaldehyde. Purification by column chromatography (10–100% ethyl acetate in hexanes) produced <i>tert</i>-butyl (2-(4-(2-(2-aminopyridin-3-yl)-5-chloro-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)propan-2-yl)carbamate (<b>15</b>) (30 mg, 26%). MS <i>m</i>/<i>z</i> 479 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>tert</i>-Butyl (2-(4-(2-(2-Aminopyridin-3-yl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)propan-2-yl)carbamate (<b>16</b>)</h3><div class="NLM_p last"><b>16</b> was prepared as described for <b>8a</b> using <b>15</b> and phenylboronic acid. Purification by column chromatography (30–100% ethyl acetate in hexanes) yielded <i>tert</i>-butyl (2-(4-(2-(2-aminopyridin-3-yl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)propan-2-yl)carbamate (<b>16</b>) (27 mg, 81%). MS <i>m</i>/<i>z</i> 521 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 3-(3-(4-(2-Aminopropan-2-yl)phenyl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine (<b>17</b>)</h3><div class="NLM_p last"><b>17</b> was prepared from <b>16</b> as described for <b>6</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.90–8.70 (m, 3H), 8.37 (d, <i>J</i> = 8.3 Hz, 2H), 8.15 (dd, <i>J</i> = 6.0 and 1.8 Hz, 1H), 8.08–8.03 (m, 3H), 7.86 (dd, <i>J</i> = 7.3 and 1.4 Hz, 1H), 7.79 (d, <i>J</i> = 8.7 Hz, 2H), 7.67 (d, <i>J</i> = 8.7 Hz, 2H), 7.52–7.47 (m, 2H), 7.46–7.41 (m, 1H), 6.89 (dd, <i>J</i> = 7.3 and 6.4 Hz, 1H), 1.70 (s, 6H); MS <i>m</i>/<i>z</i> 421 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>tert</i>-Butyl (1-(4-((6-Chloro-3-nitropyridin-2-yl)amino)phenyl)cyclobutyl)carbamate (<b>18</b>)</h3><div class="NLM_p last">A solution of 2,6-dichloro-3-nitropyridine (<b>1e</b>) (5.11 g, 26.4 mmol) in DMA (50 mL) and triethylamine (5 mL) cooled to 0 °C was added dropwise to a solution of <i>tert</i>-butyl (1-(4-aminophenyl)cyclobutyl)carbamate (6.3 g, 24.0 mmol)) in DMA (25 mL). The reaction mixture was stirred at 0 °C for 1 h and then at room temperature overnight. The reaction mixture was then diluted with water (250 mL) and extracted with ethyl acetate (2 × 200 mL). The organics were combined and washed with a sat. aq NaHCO<sub>3</sub> solution, water, and brine. The organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Purification by column chromatography (15% ethyl acetate in hexanes) produced <i>tert</i>-butyl (1-(4-((6-chloro-3-nitropyridin-2-yl)amino)phenyl)cyclobutyl)carbamate (<b>18</b>) as an orange solid (5.05 g, 50%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.05 (s, 1H), 8.52 (d, <i>J</i> = 8.8 Hz, 1H), 7.56–7.52 (m, 2H), 7.42–7.37 (m, 3H), 6.98 (d, <i>J</i> = 8.8 Hz, 1H), 2.47–2.34 (m, 4H), 2.04–1.96 (m, 1H), 1.84–1.74 (m, 1H), 1.30 (bs, 9H); MS <i>m</i>/<i>z</i> 419 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>tert</i>-Butyl (1-(4-(2-(2-Aminopyridin-3-yl)-5-chloro-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)cyclobutyl)carbamate (<b>19</b>)</h3><div class="NLM_p last"><b>19</b> was prepared as described for <b>6</b> using <b>18</b> and 2-aminonicotinaldehyde. <sup>1</sup>H NMR (400 M Hz, DMSO-<i>d</i><sub>6</sub>) δ 8.26 (d, <i>J</i> = 8.0 Hz, 1H), 8.00–7.96 (m, 1H), 7.69 (bs, 1H), 7.54–7.35 (m, 5H), 7.24–7.08 (m, 1H), 7.04–6.96 (m, 2H), 6.32–6.28 (m, 1H), 2.48–2.35 (m, 4H), 2.06–1.96 (m, 1H), 1.86–1.76 (m, 1H), 1.40–1.06 (m, 9H); MS <i>m</i>/<i>z</i> 491 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>tert</i>-Butyl (1-(4-(2-(2-Aminopyridin-3-yl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)cyclobutyl)carbamate (<b>20a</b>)</h3><div class="NLM_p last"><b>20a</b> was prepared from <b>19</b> as described for <b>8a</b> using phenylboronic acid. The crude product was purified by column chromatography (10–100% ethyl acetate in hexanes), yielding <b>20a</b> with some impurities. The solid was recrystallized from ethyl acetate, affording an off-white solid (7.2 g). Mp 111–116 °C; <sup>1</sup>H NMR (400 M Hz, DMSO-<i>d</i><sub>6</sub>) δ 8.23 (d, <i>J</i> = 8.0 Hz, 1H), 8.04–7.98 (m, 3H), 7.94 (d, <i>J</i> = 8.0 Hz, 1H), 7.55 (d, <i>J</i> = 8.8 Hz, 2H), 7.46–7.35 (m, 6H), 7.18–7.14 (m, 1H), 6.90 (bs, 1H), 6.33 (dd, <i>J</i> = 7.6 and 4.4 Hz, 1H), 2.48–2.40 (m, 4H), 2.09–2.00 (m, 1H), 1.89–1.79 (m, 1H), 1.30 (m, 9H); MS <i>m</i>/<i>z</i> 533 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>tert</i>-Butyl (1-(4-(5-(3-Acetamidophenyl)-2-(2-aminopyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)cyclobutyl)carbamate (<b>20b</b>)</h3><div class="NLM_p last"><b>20b</b> was prepared from <b>19</b> as described for <b>8a</b> using (3-acetamidophenyl)boronic acid. Purification by column chromatography (0–10% methanol in dichloromethane) yielded <b>20b</b> as a brown solid with some coeluting impurities. The fractions with the product were combined and concentrated to produce a dark brown solid. The solid was triturated with ethyl acetate to afford a tan solid (2.6 g, 70%). Mp 160–163 °C; <sup>1</sup>H NMR (400 M Hz, DMSO-<i>d</i><sub>6</sub>) δ 8.23 (d, <i>J</i> = 8.0 Hz, 1H), 8.04–7.98 (m, 3H), 7.94 (d, <i>J</i> = 8.0 Hz, 1H), 7.55 (d, <i>J</i> = 8.8 Hz, 2H), 7.46–7.35 (m, 6H), 7.18–7.14 (m, 1H), 6.90 (bs, 1H), 6.33 (dd, <i>J</i> = 7.6 and 4.4 Hz, 1H), 2.48–2.40 (m, 4H), 2.09–2.00 (m, 1H), 1.89–1.79 (m, 1H), 1.30 (m, 9H); MS <i>m</i>/<i>z</i> 590 [M + H]<sup>+</sup>. Anal. (C<sub>34</sub>H<sub>35</sub>N<sub>7</sub>O<sub>3</sub>·0.18EtOAc) calcd: C, 68.87; H, 6.07; N, 16.19. Found: C, 69.12; H, 6.34; N, 15.94.</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>tert</i>-Butyl (1-(4-(2-(2-Aminopyridin-3-yl)-5-(pyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)cyclobutyl)carbamate (<b>20c</b>)</h3><div class="NLM_p last"><b>20c</b> was prepared from <b>19</b> as described for <b>8a</b> using pyridin-3-ylboronic acid. Purification by column chromatography (0–10% methanol in dichloromethane) produced <b>20c</b> with some impurities. The solid was triturated with ethyl acetate to yield a yellow solid (0.084 g, 79%). Mp 163–164 °C; <sup>1</sup>H NMR (400 M Hz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (dd, <i>J</i> = 2.4, 0.8 Hz, 1H), 8.56 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 8.34 (ddd, <i>J</i> = 8.1, 2.3, 1.6 Hz, 1H), 8.29 (d, <i>J</i> = 8.3 Hz, 1H), 8.05 (d, <i>J</i> = 8.4 Hz, 1H), 7.97 (dd, <i>J</i> = 4.8, 1.9 Hz, 1H), 7.55–7.48 (m, 2H), 7.45 (dt, <i>J</i> = 11.8, 4.2 Hz, 3H), 7.04 (s, 2H), 6.31 (dd, <i>J</i> = 7.7, 4.8 Hz, 1H),4.45–2.40 (m, 4H), 2.10–1.90 (m, 1H), 1.85–1.75 (s, 1H), 1.33 (s, 9H); MS <i>m</i>/<i>z</i> 534 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine Hydrochloride (<b>21a</b>)</h3><div class="NLM_p last"><b>21a</b> was prepared from <b>20a</b> as described for <b>6</b>. The product was suspended in Et<sub>2</sub>O and then filtered off, producing 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine hydrochloride (<b>21a</b>) as a white solid. Mp 280–285 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.94 (s, 3H), 8.47 (bs, 1H) 8.38 (d, <i>J</i> = 8.8 Hz, 1H), 8.19–8.15 (m, 1H), 8.10–8.03 (m, 3H), 7.93–7.88 (m, 1H), 7.76 (d, <i>J</i> = 8.4 Hz, 1H), 7.69 (d, <i>J</i> = 8.4 Hz, 2H), 7.52–7.40 (m, 3H), 6.92 (t, <i>J</i> = 7.6 Hz, 1H), 2.70–2.57 (m, 4H), 2.29–2.20 (m, 1H), 1.90–1.80 (m, 1H); MS <i>m</i>/<i>z</i> 433 [M + H]<sup>+</sup>. Anal. (C<sub>27</sub>H<sub>24</sub>N<sub>6</sub>·3.06 HCl·0.01 dioxane·0.03 diethyl ether) calcd: C, 59.61; H, 5.28; N, 15.36. Found: C, 59.62; H, 5.05; N, 15.36.</div></div><div id="sec4_1_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-(3-(3-(4-(1-Aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-5-yl)phenyl)acetamide Hydrochloride (<b>21b</b>)</h3><div class="NLM_p last"><b>21b</b> was prepared from <b>20b</b> as described for <b>6</b>. The product was suspended in Et<sub>2</sub>O and then filtered off, producing <i>N</i>-(3-(3-(4-(1-aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-5-yl)phenyl)acetamide hydrochloride (<b>21b</b>) as a yellow solid. Mp 233–237 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.25 (s, 1H), 8.98 (bs, 3H), 8.56–8.43 (m, 2H), 8.38 (d, <i>J</i> = 8.4 Hz, 1H), 8.24–8.22 (m, 1H), 8.18 (dd, <i>J</i> = 4.8 and 1.6 Hz, 1H), 7.96–7.92 (m, 1H), 7.79–7.66 (m, 6H), 7.33 (t, <i>J</i> = 8.0 Hz, 1H), 6.93 (dd, <i>J</i> = 7.6 and 6.0 Hz 1H), 2.70–2.58 (m, 4H), 2.32–2.20 (m, 1H), 2.08 (s, 3H), 1.92–1.82 (m, 1H); MS <i>m</i>/<i>z</i> 433 [M + H]<sup>+</sup>. Anal. (C<sub>29</sub>H<sub>27</sub>N<sub>7</sub>O·3.36HCl·0.23 dioxane·0.06 diethyl ether) calcd: C, 56.89; H, 5.19; N, 15.40. Found: C, 56.89; H, 5.18; N, 15.40.</div></div><div id="sec4_1_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-(pyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine Hydrochloride (<b>21c</b>)</h3><div class="NLM_p last"><b>21c</b> was prepared from <b>20c</b> as described for <b>6</b>. The product was suspended in Et<sub>2</sub>O and then filtered off, yielding 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-(pyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine hydrochloride (<b>21c</b>) as a yellow solid. Mp 283–287 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.45 (s, 1H), 9.10–9.00 (m, 4H), 8.90 (d, <i>J</i> = 4.8 Hz, 1H), 8.59–8.49 (m, 3H), 8.33 (d, <i>J</i> = 8.8 Hz, 1H), 8.20 (d, <i>J</i> = 6.0 Hz, 1H), 8.10–8.04 (m, 1H), 7.94 (d, <i>J</i> = 7.6 Hz, 1H), 7.79 (d, <i>J</i> = 8.4 Hz, 2H), 7.71 (d, <i>J</i> = 8.8 Hz, 2H), 6.95 (t, <i>J</i> = 6.4 Hz, 1H), 2.64 (t, <i>J</i> = 8.0 Hz, 4H), 2.32–2.20 (m, 1H), 1.92–1.82 (m, 1H); MS <i>m</i>/<i>z</i> 434 [M + H]<sup>+</sup>. Anal. (C<sub>26</sub>H<sub>23</sub>N<sub>7</sub>O·3.94HCl·0.26 dioxane) calcd: C, 54.12; H, 4.87; N, 16.34. Found: C, 54.12; H, 5.11; N, 16.33.</div></div><div id="sec4_1_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>-(1-(4-(2-(2-Aminopyridin-3-yl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)cyclobutyl)acetamide (<b>22</b>)</h3><div class="NLM_p last">3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine hydrochloride (<b>21a</b>) (22 mg, 0.05 mmol) was dissolved in pyridine (1.0 mL), followed by the addition of acetic anhydride (4.7 μL, 0.05 mmol). The mixture was stirred overnight at room temperature, diluted with DCM/DMF (1:1, 2 mL), and then stirred for an additional 12 h. The mixture was diluted with DMSO, filtered, and purified by HPLC to afford <i>N</i>-(1-(4-(2-(2-aminopyridin-3-yl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)cyclobutyl)acetamide (<b>22</b>) (14 mg, 57%) as a white powder after freeze-drying. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.53 (1H, s), 8.27 (1H, d, <i>J</i> = 8.6 Hz), 8.03 (2H, d, <i>J</i> = 7.5 Hz), 8.00 (1H, dd, <i>J</i> = 5.2, 1.7 Hz), 7.98 (1H, d, <i>J</i> = 8.0 Hz), 7.54 (2H, d, <i>J</i> = 8.6 Hz), 7.48 (2H, t, <i>J</i> = 7.5 Hz), 7.43 (2H, d, <i>J</i> = 8.6 Hz), 7.40 (1H, t, <i>J</i> = 8.6 Hz), 7.13 (1H, dd, <i>J</i> = 8.0, 1.7 Hz), 6.99 (2H, s), 6.38 (1H, dd, <i>J</i> = 7. 5, 4.6 Hz), 2.51–2.45 (4H, m), 2.09–2.00 (1H, m), 1.92–1.83 (1H, m); MS <i>m</i>/<i>z</i> 475 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-(3-aminophenyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine Hydrochloride (<b>23</b>)</h3><div class="NLM_p last">HCl in dioxane (4.0 M, 1 mL) was added to a solution of <i>N</i>-(3-(3-(4-(1-aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-5-yl)phenyl)acetamide (<b>21b</b>) (0.180 g, 0.42 mmol) in dichloromethane (5 mL) and methanol (1 mL). The reaction was capped and heated at 50 °C for 3 days. Upon completion, the reaction was diluted with ether (20 mL), and 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-(3-aminophenyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amine hydrochloride (<b>23</b>) was filtered from the mixture as a yellow solid (0.162 g, 87%). Mp decomposed at 240 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.96 (bs, 3H), 8.44–8.30 (m, 3H), 8.16 (bs, 1H), 8.04 (d, <i>J</i> = 8.4 Hz, 1H), 8.01–8.79 (m, 2H), 7.89 (d, <i>J</i> = 5.2 Hz, 1H), 7.77 (d, <i>J</i> = 8.0 Hz, 2H), 7.68 (d, <i>J</i> = 8.0 Hz, 2H), 7.57–7.50 (m, 1H), 7.32–7.28 (m, 1H), 6.94–6.86 (m, 1H), 2.72–2.58 (m, 4H), 2.32–2.20 (m, 1H), 1.92–1.82 (m, 1H); MS <i>m</i>/<i>z</i> 448 [M + H]<sup>+</sup>. Anal. (C<sub>27</sub>H<sub>25</sub>N<sub>7</sub>·3.73HCl·0.17 dioxane·0.73CH<sub>2</sub>Cl<sub>2</sub>) calcd: C, 51.66; H, 4.81; N, 14.84. Found: C, 51.66; H, 4.81; N, 14.85.</div></div><div id="sec4_1_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Methyl 1-(4-((6-Chloro-3-nitropyridin-2-yl)amino)phenyl)cyclobutane-1-carboxylate (<b>24</b>)</h3><div class="NLM_p last"><b>24</b> was prepared as described for <b>2a</b> using <b>1e</b> and methyl 1-(4-aminophenyl)cyclobutane-1-carboxylate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.27 (s, 1H), 8.47 (dd, <i>J</i> = 8.6, 1.7 Hz, 1H), 7.63 (dd, <i>J</i> = 8.6, 1.1 Hz, 2H), 7.35 (dd, <i>J</i> = 8.6, 1.1 Hz, 2H), 6.81 (dd, <i>J</i> = 8.6, 1.1 Hz, 1H), 3.67 (d, <i>J</i> = 1.7 Hz, 3H), 2.88–2.83 (m, 2H), 2.56–2.49 (m, 2H), 2.10–2.00 (m, 1H), 1.94–1.85 (m, 1H); MS <i>m</i>/<i>z</i> 362 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Methyl 1-(4-((3-Nitro-6-phenylpyridin-2-yl)amino)phenyl)cyclobutane-1-carboxylate (<b>25</b>)</h3><div class="NLM_p last"><b>25</b> was prepared as described for <b>8a</b> using <b>24</b> and phenylboronic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.33 (s, 1H), 8.59 (d, <i>J</i> = 8.7 Hz, 1H), 8.08–8.03 (m, 2H), 7.76 (dt, <i>J</i> = 9.2, 2.4 Hz, 2H), 7.53–7.49 (m, 3H), 7.36 (dt, <i>J</i> = 8.9, 2.3 Hz, 2H), 7.31 (d, <i>J</i> = 8.7 Hz, 1H), 3.68 (s, 3H), 2.90–2.83 (m, 2H), 2.60–2.51 (m, 2H), 2.12–2.00 (m, 1H), 1.97–1.86 (m, 1H); MS <i>m</i>/<i>z</i> 404 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Methyl 1-(4-(2-(2-Aminopyridin-3-yl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)cyclobutane-1-carboxylate (<b>26</b>)</h3><div class="NLM_p last"><b>26</b> was prepared as described for <b>4a</b> using <b>25</b> and 2-aminonicotinaldehyde. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (d, <i>J</i> = 8.6 Hz, 1H), 8.04–8.02 (m, 2H), 8.01 (dd, <i>J</i> = 4.9, 2.0 Hz, 1H), 7.98 (d, <i>J</i> = 8.6 Hz, 1H), 7.57–7.50 (m, 1H), 7.50–7.44 (m, 6H), 7.40 (tt, <i>J</i> = 7.2, 1.5 Hz, 1H), 7.14 (dd, <i>J</i> = 7.4, 1.7 Hz, 1H), 6.98 (s, 2H), 6.40 (dd, <i>J</i> = 7.7, 4.9 Hz, 1H), 3.64 (s, 3H), 2.81–2.75 (m, 2H), 2.55–2.51 (m, 2H), 2.04–1.94 (m, 1H), 1.92–1.83 (m, 1H); MS <i>m</i>/<i>z</i> 476 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 1-(4-(2-(2-Aminopyridin-3-yl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)cyclobutane-1-carboxamide (<b>27</b>)</h3><div class="NLM_p">Methyl 1-(4-(2-(2-aminopyridin-3-yl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)cyclobutane-1-carboxylate (<b>26</b>) (209 mg, 0.44 mmol) was dissolved in THF/MeOH/aq NaOH 1 N (2:2:1 by volume, 25 mL), and the mixture was stirred for 1 h at 65 °C. The reaction mixture was cooled to 0 °C and acidified with 1 N HCl (5 mL). The mixture was diluted with water and extracted with CHCl<sub>3</sub>. The organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was treated with CH<sub>2</sub>Cl<sub>2</sub> and hexanes, producing 1-(4-(2-(2-aminopyridin-3-yl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)cyclobutane-1-carboxylic acid as a white powder (170 mg, 84%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.51 (br s, 1H), 8.30 (d, <i>J</i> = 8.0 Hz, 1H), 8.06–8.03 (m, 3H), 8.00 (d, <i>J</i> = 8.0 Hz, 1H), 7.51–7.44 (m, 7H), 7.41 (t, <i>J</i> = 8.0 Hz, 1H), 7.36 (d, <i>J</i> = 7.4 Hz, 2H), 6.53 (dd, <i>J</i> = 7.7, 5.4 Hz, 1H), 2.79–2.72 (m, 2H), 2.49–2.44 (m, 2H), 2.04–1.94 (m, 1H), 1.89–1.81 (m, 1H); MS <i>m</i>/<i>z</i> 462 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The carboxylic acid (35 mg, 0.076 mmol) was dissolved in DMF (1 mL) and then treated with HOBt (10.3 mg, 0.076 mmol), triethylamine (32 μL, 0.23 mmol), and EDC (29 mg, 0.15 mmol). The reaction mixture was stirred at room temperature for 8 h. An ammonia solution in MeOH (7 M, 10 equiv) was added, and the mixture was stirred at room temperature for 1 h. Water was then added, and the mixture was extracted with CHCl<sub>3</sub>. The organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The crude product was purified by HPLC (acetonitrile/HCOOH buffer). After evaporation, 1-(4-(2-(2-aminopyridin-3-yl)-5-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-3-yl)phenyl)cyclobutane-1-carboxamide (<b>27</b>) was obtained (15 mg, 43%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (d, <i>J</i> = 8.0 Hz, 1H), 8.03 (d, <i>J</i> = 8.0 Hz, 2H), 8.01 (dd, <i>J</i> = 4.6, 1.7 Hz, 1H), 7.98 (d, <i>J</i> = 8.0 Hz, 1H), 7.51–7.44 (m, 6H), 7.40 (tt, J = 7.2, 1.5 Hz, 1H), 7.29 (s, 1H), 7.17 (dd, <i>J</i> = 7.4, 1.7 Hz, 1H), 6.96 (s, 3H), 6.40 (dd, <i>J</i> = 7.7, 4.9 Hz, 1H), 2.78–2.71 (m, 2H), 2.42–2.36 (m, 2H), 1.91–1.73 (m, 2H); MS <i>m</i>/<i>z</i> 461 [M + H]<sup>+</sup>.</div></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> General Experimental Details. Interference Compounds</h3><div class="NLM_p last">All test compounds passed the PAINS filter. The screening was performed by Molecular Forecaster as part of a computational analysis of the entire ArQule compound library.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Protein Expression and Purification</h3><div class="NLM_p last">Full-length AKT isoform constructs (AKT1 (2–480), AKT2 (2–481), and AKT3 (2–479)) and ΔPH-AKT1 (144–480) were expressed in Sf9 cells using a baculovirus vector. The frozen cell pellets were thawed and resuspended in lysis buffer containing 25 mM Tris, pH 8.0, 100 mM NaCl, 25 mM imidazole, 10% glycerol, and protease inhibitors (Sigma no. S8820). Cells were lysed by sonication, the lysate was centrifuged, and the clarified supernatant was loaded onto a Ni-NTA affinity column. Following washing with buffer containing 25 mM Tris, pH 8.0, 500 mM NaCl, and 25 mM imidazole, the protein was eluted in buffer containing 25 mM Tris, 100 mM NaCl, and 400 mM imidazole, pH 8.0. The protein was concentrated and purified on a Superdex 200 gel-filtration column. The concentrated protein (10 mg/mL) was stored in buffer containing 25 mM Tris, pH 8.0, 100 mM NaCl, and 10% glycerol at −80 °C.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Protein Characterization (AKT1, AKT2, and AKT3)</h3><div class="NLM_p last">Phosphorylation at Thr308 and Ser473 in AKT1 (1–480) was analyzed as described below. The proteins were subjected to solution-phase digestion, and peptide phosphorylation was determined by LC/MS and LC/MS/MS analysis. Proteins (50 μg) were diluted in 50 mM ammonium bicarbonate buffer, pH 8, containing 5 mM DTT, 3 M urea, 5% acetonitrile, and endoprotease (trypsin, 1:20 w/w or GluC, 1:10 w/w ratio) and digested overnight. The digests were separated on a BEH C18 column (1.0 mm × 50 mm, 1.7 μm) equilibrated at 40 °C and mass analyzed on a QTOF mass spectrometer. Elution was performed using a water/acetonitrile gradient with a 0.1% formic acid modifier, starting from 2% and reaching 40% acetonitrile over 14 min, followed by 40% to 50% acetonitrile from 14 to 16 min, 50% to 80% acetonitrile from 16 to 18 min, held at 80% for 2 min, and re-equilibrated with 2% acetonitrile for another 3 min. The MS spectra of the peptides were deconvoluted using the MaxEnt3 software package (Masslynx, Waters). For the inactive AKT proteins, no phosphorylation was detected at Thr308/Thr309/Thr305, and less than 10% of Ser473/Ser474/Ser472 was detected as phosphorylated (in AKT1, AKT2, and AKT3, respectively). Following activation with PDK1 and MAPKAP2 in the presence of lipids, MS analysis identified 60% of Thr308 sites and 80% of Ser473 sites as being phosphorylated.</div></div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Assay Descriptions. Lipid Vesicle Preparation</h3><div class="NLM_p last">Lipid vesicles were prepared from PtdIns(3,4,5)P<sub>3</sub>, dipalmitoyl, and a synthetic phospholipid blend of DOPS/DOPC. A 1.0 mg/mL solution of PtdIns(3,4,5)P<sub>3</sub> and a 16.7 mg/mL suspension of DOPS/DOPC in 10 mM Hepes, pH 7.4, were prepared immediately before use. The DOPS/DOPC suspension (800 μL) and the PtdIns(3,4,5)P<sub>3</sub> solution (964 μL) were mixed and then diluted in 18.2 mL of 10 mM Hepes, pH 7.4, and mixed well. This mixture (400 μM DOPS/400 μM DOPC/40 μM PtdIns(3,4,5)P<sub>3</sub>) was sonicated on ice for 30 s at 75% power until the mixture clarified. Aliquots were prepared and frozen at −80 °C until use.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> AKT1 (1–480), AKT2 (1–481, and AKT3 (1–479) Alpha Screen Assays</h3><div class="NLM_p last">AKT activity was assayed using a GSK3-derived biotinylated peptide substrate, crosstide (biotin-GRPRTSSFAEG), and AlphaScreen (amplified luminescent proximity homogeneous assay) technology. Test compounds and controls were prepared in 10% DMSO at 10-fold the desired final concentration, and 2.5 μL of each compound was added to each well of a reaction plate (Corning 96-well half-area solid white nonbinding surface plate). Full-length unphosphorylated AKT was diluted in assay buffer (50 mM Tris, pH 8.0, 0.02 mg/mL BSA, 10 mM MgCl<sub>2</sub>, 1 mM EGTA, 10% glycerol, 0.2 mM Na<sub>3</sub>VO<sub>4</sub>, 1 mM DTT, 0.1 mM β-glycerophosphate, and 0.2 mM NaF) and added to each well at a volume of 17.5 μL for a final concentration of 8 nM (AKT1), 63 nM (AKT2), or 13 nM (AKT3) in the 25 μL reaction. After a 20 min preincubation at room temperature, the kinase reaction was initiated by the addition of 5 μL of the activation mixture diluted in assay buffer, containing biotinylated crosstide, PDK1, MAPKAPK2, DOPS/DOPC, PtdIns(3,4,5)P3, and ATP for a final concentration of 60 nM biotinylated crosstide, 0.1 nM (AKT1, AKT3) or 0.3 nM (AKT2) PDK1, 0.7 nM (AKT1), 1.3 nM (AKT2), or 0.4 nM (AKT3) MAPKAPK2, 5.5 μM DOPS, 5.5 μM DOPC, 0.5 μM PtdIns(3,4,5)P3, and 50 μM (AKT1, AKT2) or 18 μM (AKT3) ATP. The plates were incubated for 30 min at room temperature, and the reactions were stopped in the dark by the addition of 10 μL of stop/detection mixture prepared in assay buffer, containing EDTA, AlphaScreen streptavidin donor and protein A acceptor beads, and phospho-AKT substrate antibody at final concentrations of 10 mM EDTA, 500 ng/well of both AlphaScreen streptavidin donor beads and protein A acceptor beads, and phospho-AKT substrate antibody at a final dilution of 1:350. Assay plates were incubated for 90 min at room temperature in the dark, and the plates were read on a PerkinElmer Envision multilabel plate reader (excitation wavelength, 640 nm; emission wavelength, 570 nm). All IC<sub>50</sub> values reported are the geometric mean of at least <i>n</i> = 2 determinations.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> In Vitro Western Blot Pharmacodynamic Assay (p-Ser473, p-Thr308, p-PRAS40)</h3><div class="NLM_p last">Cellular activity was determined by measuring the phosphorylation status of Ser473, Thr308, and the AKT substrate p-PRAS40 using A2780 and AN3CA cell lines. A2780 and AN3CA cells were plated in six-well plates at 60–75% confluency and incubated at 37 °C overnight in 5% CO<sub>2</sub>. Upon reaching 75–90% confluency, the cells were treated with the test compound, following a 3-fold dilution scheme, for 1 h with a final DMSO concentration of less than 0.2% v/v. Cells were stimulated with 100 ng/mL EGF and 100 nM insulin for 15 min. The medium was removed, and 150 μL of 1× E-Page loading buffer (catalog no. EPBUF-01, Invitrogen) was added. Cells were scraped and transferred to a deep-well 96-well plate and lysed by sonication at medium power four to six times in 30 s bursts. Samples were run on EPage gels and transferred to PVDF membranes using the iBlot system (Invitrogen). Membranes were washed for 3 min in dH<sub>2</sub>O, blocked for 30 min in Odyssey blocking buffer (catalog no. 927-40000, LiCor), and then incubated overnight at 4 °C in Odyssey blocking/TBST buffer (50 mM Tris, pH 7.4, 150 mM NaCl, and 0.05% Tween 20) (1:3) with antibodies against p-AKT (catalog no. 9271 and catalog no. 9275, Cell Signaling Technology), phospho-PRAS40 (catalog no. 2640, Cell Signaling Technology), and β-actin (catalog no. A2228, Sigma). After three washes for 5 min each in TBST buffer, the membranes were incubated with the appropriate secondary antibodies labeled with near-infrared or Alexa Fluor dyes (catalog no. 611-132-122 goat anti-rabbit IgG H+L, catalog no. 610-132-121 goat anti-mouse IgG H+L, Rockland (catalog no. A21076 goat anti-rabbit IgG H+L, catalog no. A21057 goat anti-mouse IgG H+L, Molecular Probes). After a 1 h incubation, the membranes were washed three times for 5 min each and then scanned using an Odyssey infrared scanner (LiCor). The intensities of the bands were quantified using the accompanying software. The data were normalized to the untreated controls, the dose–response curves were fitted to a four-parameter logistic equation, and the IC<sub>50</sub> values were determined.</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Cellular Antiproliferation Assay (MTS)</h3><div class="NLM_p last">Antiproliferative cellular assays were conducted using the CellTiter nonradioactive cell proliferation assay developed by Promega, which utilizes the production of formazan from a tetrazolium compound by live cells. AN3CA and A2780 cells were obtained from the ATCC. AN3CA cells were cultured in DMEM, and A2780 cells were cultured in RPMI supplemented with 10% FBS, 100 units/mL penicillin, 100 μg/mL streptomycin, and 2 mM glutamine at 37 °C under 5% CO<sub>2</sub>. Cells were plated in 96-well plates at 2000–10 000 cells/well, cultured for 24 h, and treated with the test compound for 72 h at a final DMSO concentration no greater than 0.5% v/v. PMS stock reagent (0.92 mg/mL in DPBS) was diluted 20-fold in MTS stock reagent (2 mg/mL in DPBS), and this MTS/PMS mixture was diluted 5-fold into each well of the 96-well plate. The plates were incubated for 3–4 h, and the absorbance of formazan was measured at 490 nm. The data were normalized to the untreated controls, the dose–response curves were fit to a four-parameter logistic equation, and the IC<sub>50</sub> values were determined. All IC<sub>50</sub> values reported are the geometric mean of at least two independent determinations.</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> CYP450 Inhibition Assay</h3><div class="NLM_p last">Human liver microsomes (0.25 mg/mL), probe substrates [3 μM midazolam (3A4), 5 μM bufuralol (2D6), 100 μM tolbutamide (2C9), 10 μM paclitaxel (2C8), 80 μM S-mephenytoin (2C19), and 50 μM phenacetin (1A2)], 3.3 mM MgCl<sub>2</sub>, 1 mM NADPH, and the compound (0.1–10 μM) dissolved in DMSO (0.1% final) were incubated for 10 min, after which acetonitrile containing reserpine (internal standard) was used to stop the reaction. The solvents were evaporated under a constant stream of nitrogen gas at 35 °C, and the resulting compound was reconstituted in 100 μL of water for LC/MS/MS analysis. An inhibitors cocktail consisting of 0.5 μM ketoconazole (3A4), 1 μM sulfaphenazole (2C9), 1 μM quinidine (2D6), 2 μM quercetin (2C8), 1 μM nootkatone (2C19), and 0.5 μM α-naphthoflavone (1A2) was used as a positive control. Incubations containing only DMSO (no compound) served as the 100% activity control. The percent inhibition was calculated based on the signal for the 100% activity control, and the IC<sub>50</sub> values were either estimated or determined using fit-model 205 (one-site dose response) in XLfit4 (Guildford, Surrey, U.K.).</div></div><div id="sec5_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Cross-Species NADPH-Dependent Microsomal Stability Assay</h3><div class="NLM_p last">Human, CD-1 mouse, and Beagle dog liver microsomes (0.25 mg/mL), 3.3 mM MgCl<sub>2</sub>, and a NADPH-regenerating system (0.4 units/mL G6PDH, 1.3 mM NADP<sup>+</sup>, and 3.3 mM G6P) were incubated with 1 μM compound for 0, 3, 6, 10, 15, or 30 min. The incubations were stopped with acetonitrile containing warfarin (internal standard), and the samples were analyzed by LC/MS/MS. The peak area ratios were used to determine the percent remaining at each time point compared with time zero. The half-life values were estimated using the equation for monoexponential decay. Midazolam and propranolol (female mouse only) were used as positive controls.</div></div><div id="sec5_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Crystallization, Data Collection, and Refinement</h3><div class="NLM_p last">A 6xHis-AKT1 (2–446) with a TEV protease site construct was cloned in a baculovirus vector and expressed in Sf9 cells. To aid the crystallization, three mutations were introduced on the linker region (E114A, E115A, and E116A) in the AKT1 (2–446) construct. The protein was purified using a similar protocol as described above for the AKT isoforms and the 6xHis tag was removed using TEV protease. Cocrystals of <b>21a</b> were obtained with the following conditions: 16% butanol, 10 mM ammonium sulfate, 0.1% 2-mercaptoethanol, 15% ethylene glycol, 50 mM Tris, pH 7.5. Diffraction data were collected at NSLS on the X29 beamline, and the data were processed using Mosflm and scaled using Scala. The structure was solved by molecular replacement using the Phaser program with search models consisting of AKT2 (1MRV) and the AKT1 PH domain (2UVM). The initial model was built using ARP/wARP program, and the model was subsequently improved through iterative cycles of manual model building with Coot and refinement with ARP/wARP or Refmac5.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d2585e5607-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00619">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00619" class="ext-link">10.1021/acs.jmedchem.6b00619</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00619/suppl_file/jm6b00619_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00619/suppl_file/jm6b00619_si_001.csv">jm6b00619_si_001.csv (1.42 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code for <b>21a</b> bound to AKT1 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KCV">5KCV</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b00619" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12132" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12132" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Marc Lapierre</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a3c9cecfc2d3cac6d1d1c6e3c2d1d2d6cfc68dc0ccce"><span class="__cf_email__" data-cfemail="80eaedece1f0e9e5f2f2e5c0e1f2f1f5ece5aee3efed">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sudharshan Eathiraj</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Vensel</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanbin Liu</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cathy O. Bull</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan Cornell-Kennon</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shin Iimura</span> - <span class="hlFld-Affiliation affiliation">Daiichi Sankyo
Co., Shinagawa R&D Center, 1-2-58,
Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eugene W. Kelleher</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darin E. Kizer</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steffi Koerner</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sapna Makhija</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akihisa Matsuda</span> - <span class="hlFld-Affiliation affiliation">Daiichi Sankyo
Co., Shinagawa R&D Center, 1-2-58,
Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Magdi Moussa</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nivedita Namdev</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald E. Savage</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff Szwaya</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erika Volckova</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neil Westlund</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui Wu</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Schwartz</span> - <span class="hlFld-Affiliation affiliation">ArQule
Inc., One Wall Street, Burlington, Massachusetts 01803, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.-M.L. and S.E. contributed equally to the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i91" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i91"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i92" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i92"> Abbreviations Used</h2><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphatase and tensin homologue</p></td></tr><tr><td class="NLM_term">PH</td><td class="NLM_def"><p class="first last">pleckstrin homology</p></td></tr><tr><td class="NLM_term">PRAS40</td><td class="NLM_def"><p class="first last">proline-rich AKT substrate, 40 kDa</p></td></tr><tr><td class="NLM_term">PDK1</td><td class="NLM_def"><p class="first last">phosphoinositide-dependent kinase 1</p></td></tr><tr><td class="NLM_term">mTORC2</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin complex 2</p></td></tr><tr><td class="NLM_term">HM</td><td class="NLM_def"><p class="first last">hydrophobic motif</p></td></tr><tr><td class="NLM_term">MAPKAPK2</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase activated protein kinase 2</p></td></tr><tr><td class="NLM_term">ELSD</td><td class="NLM_def"><p class="first last">evaporative light scattering detector</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">HCl</td><td class="NLM_def"><p class="first last">hydrochloric acid</p></td></tr><tr><td class="NLM_term">QTOF</td><td class="NLM_def"><p class="first last">quadrupole-time-of-flight</p></td></tr><tr><td class="NLM_term">DOPS</td><td class="NLM_def"><p class="first last">1,2-dioleoyl-<i>sn</i>-glycero-3-phospho-<span class="smallcaps smallerCapital">l</span>-serine</p></td></tr><tr><td class="NLM_term">DOPC</td><td class="NLM_def"><p class="first last">1,2-dioleoyl-<i>sn</i>-glycero-3-phosphocholine</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">GSK-3</td><td class="NLM_def"><p class="first last">glycogen synthase kinase 3</p></td></tr><tr><td class="NLM_term">EGTA</td><td class="NLM_def"><p class="first last">ethylene glycol tetraacetic acid</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">MTS</td><td class="NLM_def"><p class="first last">(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium)</p></td></tr><tr><td class="NLM_term">PMS</td><td class="NLM_def"><p class="first last">phenazine methosulfate</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver mcrosome</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsome</p></td></tr><tr><td class="NLM_term">DLM</td><td class="NLM_def"><p class="first last">dog liver microsome</p></td></tr><tr><td class="NLM_term">M</td><td class="NLM_def"><p class="first last">male</p></td></tr><tr><td class="NLM_term">F</td><td class="NLM_def"><p class="first last">female</p></td></tr><tr><td class="NLM_term">DPBS</td><td class="NLM_def"><p class="first last">Dulbecco’s phosphate buffered saline</p></td></tr><tr><td class="NLM_term">TEV</td><td class="NLM_def"><p class="first last">tobacco etch virus</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 17 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Scheid, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">PKB/AKT: functional insights from genetic models</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span><span class="refDoi"> DOI: 10.1038/35096067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1038%2F35096067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=11584303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvVajsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=760-768&issue=10&author=M.+P.+Scheidauthor=J.+R.+Woodgett&title=PKB%2FAKT%3A+functional+insights+from+genetic+models&doi=10.1038%2F35096067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">PKB/AKT: Functional insights from genetic models</span></div><div class="casAuthors">Scheid, Michael P.; Woodgett, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">760-768</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since its discovery 10 yr ago, the potential functions of protein kinase B(PKB)/AKT have been cataloged with increasing efficiency.  The physiol. relevance of some of the proposed mechanisms by which PKB/AKT mediates many of its effects has been questioned, and recent work using new reagents and approaches has revealed some cracks in our understanding of this important mol., and also hinted that these effects may involve other players.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr44zDB4vDCrLVg90H21EOLACvtfcHk0lj9SFkYGYHXcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvVajsLY%253D&md5=a1d5b9ddf4920e3a5e4405735a8ff6cf</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2F35096067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35096067%26sid%3Dliteratum%253Aachs%26aulast%3DScheid%26aufirst%3DM.%2BP.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DPKB%252FAKT%253A%2520functional%2520insights%2520from%2520genetic%2520models%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2001%26volume%3D2%26issue%3D10%26spage%3D760%26epage%3D768%26doi%3D10.1038%2F35096067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Franke, T. F.</span><span> </span><span class="NLM_article-title">PI3K/Akt: getting it right matters</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">50</span><span class="NLM_x">) </span> <span class="NLM_fpage">6473</span><span class="NLM_x">–</span> <span class="NLM_lpage">6488</span><span class="refDoi"> DOI: 10.1038/onc.2008.313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1038%2Fonc.2008.313" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=6473-6488&issue=50&author=T.+F.+Franke&title=PI3K%2FAkt%3A+getting+it+right+matters&doi=10.1038%2Fonc.2008.313"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fonc.2008.313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2008.313%26sid%3Dliteratum%253Aachs%26aulast%3DFranke%26aufirst%3DT.%2BF.%26atitle%3DPI3K%252FAkt%253A%2520getting%2520it%2520right%2520matters%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26issue%3D50%26spage%3D6473%26epage%3D6488%26doi%3D10.1038%2Fonc.2008.313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Altomare, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. R.</span><span> </span><span class="NLM_article-title">Perturbations of the AKT signaling pathway in human cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">50</span><span class="NLM_x">) </span> <span class="NLM_fpage">7455</span><span class="NLM_x">–</span> <span class="NLM_lpage">7464</span><span class="refDoi"> DOI: 10.1038/sj.onc.1209085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1038%2Fsj.onc.1209085" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=7455-7464&issue=50&author=D.+A.+Altomareauthor=J.+R.+Testa&title=Perturbations+of+the+AKT+signaling+pathway+in+human+cancer&doi=10.1038%2Fsj.onc.1209085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1209085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1209085%26sid%3Dliteratum%253Aachs%26aulast%3DAltomare%26aufirst%3DD.%2BA.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26atitle%3DPerturbations%2520of%2520the%2520AKT%2520signaling%2520pathway%2520in%2520human%2520cancer%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26issue%3D50%26spage%3D7455%26epage%3D7464%26doi%3D10.1038%2Fsj.onc.1209085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Porta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paglino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosca, A.</span><span> </span><span class="NLM_article-title">Targeting PI3K/Akt/mTOR signaling in cancer</span> <span class="citation_source-journal">Front. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">64</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.3389/fonc.2014.00064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.3389%2Ffonc.2014.00064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=24478982" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=1-11&issue=64&author=C.+Portaauthor=C.+Paglinoauthor=A.+Mosca&title=Targeting+PI3K%2FAkt%2FmTOR+signaling+in+cancer&doi=10.3389%2Ffonc.2014.00064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2014.00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2014.00064%26sid%3Dliteratum%253Aachs%26aulast%3DPorta%26aufirst%3DC.%26aulast%3DPaglino%26aufirst%3DC.%26aulast%3DMosca%26aufirst%3DA.%26atitle%3DTargeting%2520PI3K%252FAkt%252FmTOR%2520signaling%2520in%2520cancer%26jtitle%3DFront.%2520Oncol.%26date%3D2014%26volume%3D4%26issue%3D64%26spage%3D1%26epage%3D11%26doi%3D10.3389%2Ffonc.2014.00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mayer, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, C. L.</span><span> </span><span class="NLM_article-title">The PI3K/AKT pathway as a target for cancer treatment</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1146/annurev-med-062913-051343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1146%2Fannurev-med-062913-051343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=26473415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1yjsL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2016&pages=11-28&author=I.+A.+Mayerauthor=C.+L.+Arteaga&title=The+PI3K%2FAKT+pathway+as+a+target+for+cancer+treatment&doi=10.1146%2Fannurev-med-062913-051343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">the PI3K/AKT pathway as a target for cancer treatment</span></div><div class="casAuthors">Mayer, Ingrid A.; Arteaga, Carlos L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-28</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">Anticancer targeted therapies are designed to exploit a particular vulnerability in the tumor, which in most cases results from its dependence on an oncogene and/or loss of a tumor suppressor.  Genes in the phosphoinositide 3-kinase (PI3K)/AKT pathway are the most frequently altered in human cancers.  Aberrant activation of this pathway, as a result of these somatic alterations, is assocd. with cellular transformation, tumorigenesis, cancer progression, and drug resistance.  Several drugs targeting PI3K/ATK are currently in clin. trials, alone or in combination, in both solid tumors and hematol. malignancies.  These drugs are the focus of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyfvNz6IpJ17Vg90H21EOLACvtfcHk0li28ArtB6LM8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1yjsL%252FM&md5=145c818d377155d01e2eaef8cf4d67a9</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-062913-051343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-062913-051343%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DI.%2BA.%26aulast%3DArteaga%26aufirst%3DC.%2BL.%26atitle%3DThe%2520PI3K%252FAKT%2520pathway%2520as%2520a%2520target%2520for%2520cancer%2520treatment%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2016%26volume%3D67%26spage%3D11%26epage%3D28%26doi%3D10.1146%2Fannurev-med-062913-051343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bhutani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niazi, A. K.</span><span> </span><span class="NLM_article-title">Akt inhibitors: mechanism of action and implications for anticancer therapeutics</span> <span class="citation_source-journal">Infect. Agents Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="refDoi"> DOI: 10.1186/1750-9378-8-49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1186%2F1750-9378-8-49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=24330834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFOqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=49&issue=1&author=J.+Bhutaniauthor=A.+Sheikhauthor=A.+K.+Niazi&title=Akt+inhibitors%3A+mechanism+of+action+and+implications+for+anticancer+therapeutics&doi=10.1186%2F1750-9378-8-49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Akt inhibitors: mechanism of action and implications for anticancer therapeutics</span></div><div class="casAuthors">Bhutani, Jaikrit; Sheikh, Asfandyar; Niazi, Asfandyar Khan</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Agents and Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49/1-49/4, 4 pp.</span>CODEN:
                <span class="NLM_cas:coden">IACNB4</span>;
        ISSN:<span class="NLM_cas:issn">1750-9378</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Akt, better known as protein kinase B (PKB), is a serine/threonine-specific protein kinase which acts as mediator via PI3K/Akt pathway in many biol. processes like glucose metab., apoptosis, cell differentiation and transcription.  Akt1 gene amplification has been implicated in gastric carcinoma while Akt2 amplification has been linked with ovarian, pancreas, breast and stomach tumors.  The use of Akt inhibitors as monotherapy or in combination with other anticancer drugs could be useful for combating drug resistance and improving response.  Thus, comprehensive understanding of Akt and its linked signaling pathways (PI3K, PKB, mTOR etc.) is necessary to lead to newer drug development and use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAePx0ZXGFzLVg90H21EOLACvtfcHk0li28ArtB6LM8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFOqsL8%253D&md5=3aa2481776541081ebe02c5273129ca6</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1186%2F1750-9378-8-49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-9378-8-49%26sid%3Dliteratum%253Aachs%26aulast%3DBhutani%26aufirst%3DJ.%26aulast%3DSheikh%26aufirst%3DA.%26aulast%3DNiazi%26aufirst%3DA.%2BK.%26atitle%3DAkt%2520inhibitors%253A%2520mechanism%2520of%2520action%2520and%2520implications%2520for%2520anticancer%2520therapeutics%26jtitle%3DInfect.%2520Agents%2520Cancer%26date%3D2013%26volume%3D8%26issue%3D1%26spage%3D49%26doi%3D10.1186%2F1750-9378-8-49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dienstmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabernero, J.</span><span> </span><span class="NLM_article-title">Picking the point of inhibition: a comparative review of PI3K/AKT/mTOR pathway inhibitors</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0639</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1158%2F1535-7163.MCT-13-0639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=24748656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=1021-1031&issue=5&author=R.+Dienstmannauthor=J.+Rodonauthor=V.+Serraauthor=J.+Tabernero&title=Picking+the+point+of+inhibition%3A+a+comparative+review+of+PI3K%2FAKT%2FmTOR+pathway+inhibitors&doi=10.1158%2F1535-7163.MCT-13-0639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors</span></div><div class="casAuthors">Dienstmann, Rodrigo; Rodon, Jordi; Serra, Violeta; Tabernero, Josep</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1021-1031</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The frequent activation of the PI3K/AKT/mTOR pathway in cancer, and its crucial role in cell growth and survival, has made it a much desired target for pharmacol. intervention.  Following the regulatory approval of the rapamycin analogs everolimus and temsirolimus, recent years have seen an explosion in the no. of phosphoinositide 3-kinase (PI3K) pathway inhibitors under clin. investigation.  These include: ATP-competitive, dual inhibitors of class I PI3K and mTORC1/2; "pan-PI3K" inhibitors, which inhibit all four isoforms of class I PI3K (α, β, δ, γ); isoform-specific inhibitors of the various PI3K isoforms; allosteric and catalytic inhibitors of AKT; and ATP-competitive inhibitors of mTOR only (and thus mTORC1 and mTORC2).  With so many agents in development, clinicians are currently faced with a wide array of clin. trials investigating a multitude of inhibitors with different mechanisms of action, being used both as single agents and in combination with other therapies.  Here, we provide a review of the literature, with the aim of differentiating the genomic contexts in which these various types of inhibitors may potentially have superior activity.  Mol Cancer Ther; 13(5); 1021-31. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3McPbkS5dm7Vg90H21EOLACvtfcHk0liV96T4wA6YQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWjs78%253D&md5=7b5ef12e83be522233ad403ce3040719</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0639%26sid%3Dliteratum%253Aachs%26aulast%3DDienstmann%26aufirst%3DR.%26aulast%3DRodon%26aufirst%3DJ.%26aulast%3DSerra%26aufirst%3DV.%26aulast%3DTabernero%26aufirst%3DJ.%26atitle%3DPicking%2520the%2520point%2520of%2520inhibition%253A%2520a%2520comparative%2520review%2520of%2520PI3K%252FAKT%252FmTOR%2520pathway%2520inhibitors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26issue%3D5%26spage%3D1021%26epage%3D1031%26doi%3D10.1158%2F1535-7163.MCT-13-0639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Nitulescu, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juzenas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olaru, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saloustros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spandidos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsatsakis, A. M.</span><span> </span><span class="NLM_article-title">Akt inhibitors in cancer treatment: the long journey from drug discovery to clinical use (Review)</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span><span class="refDoi"> DOI: 10.3892/ijo.2015.3306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.3892%2Fijo.2015.3306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=26698230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGnu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=869-885&issue=3&author=G.+M.+Nitulescuauthor=D.+Marginaauthor=P.+Juzenasauthor=Q.+Pengauthor=O.+T.+Olaruauthor=E.+Saloustrosauthor=C.+Fengaauthor=D.+Spandidosauthor=M.+Libraauthor=A.+M.+Tsatsakis&title=Akt+inhibitors+in+cancer+treatment%3A+the+long+journey+from+drug+discovery+to+clinical+use+%28Review%29&doi=10.3892%2Fijo.2015.3306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Akt inhibitors in cancer treatment: the long journey from drug discovery to clinical use (Review)</span></div><div class="casAuthors">Nitulescu, George Mihai; Margina, Denisa; Juzenas, Petras; Peng, Qian; Olaru, Octavian Tudorel; Saloustros, Emmanouil; Fenga, Concettina; Spandidos, Demetrios A.; Libra, Massimo; Tsatsakis, Aristidis M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">869-885</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1791-2423</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Targeted cancer therapies are used to inhibit the growth, progression, and metastasis of the tumor by interfering with specific mol. targets and are currently the focus of anticancer drug development.  Protein kinase B, also known as Akt, plays a central role in many types of cancer and has been validated as a therapeutic target nearly two decades ago.  This review summarizes the intracellular functions of Akt as a pivotal point of converging signaling pathways involved in cell growth, proliferation, apoptosis and neo-angiogenesis, and focuses on the drug design strategies to develop potent anticancer agents targeting Akt.  The discovery process of Akt inhibitors has evolved from ATP (ATP)-competitive agents to alternative approaches employing allosteric sites in order to overcome the high degree of structural similarity between Akt isoforms in the catalytic domain, and considerable structural analogy to the AGC kinase family.  This process has led to the discovery of inhibitors with greater specificity, reduced side-effects and lower toxicity.  A second generation of Akt has inhibitors emerged by incorporating a chem. reactive Michael acceptor template to target the nucleophile cysteines in the catalytic activation loop.  The review outlines the development of several promising drug candidates emphasizing the importance of each chem. scaffold.  We explore the pipeline of Akt inhibitors and their preclin. and clin. examn. status, presenting the potential clin. application of these agents as a monotherapy or in combination with ionizing radiation, other targeted therapies, or chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcUyrlk7Gp77Vg90H21EOLACvtfcHk0liV96T4wA6YQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGnu7fK&md5=39d4bf35feb3aa1e8e113315d57738d8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3892%2Fijo.2015.3306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2015.3306%26sid%3Dliteratum%253Aachs%26aulast%3DNitulescu%26aufirst%3DG.%2BM.%26aulast%3DMargina%26aufirst%3DD.%26aulast%3DJuzenas%26aufirst%3DP.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DOlaru%26aufirst%3DO.%2BT.%26aulast%3DSaloustros%26aufirst%3DE.%26aulast%3DFenga%26aufirst%3DC.%26aulast%3DSpandidos%26aufirst%3DD.%26aulast%3DLibra%26aufirst%3DM.%26aulast%3DTsatsakis%26aufirst%3DA.%2BM.%26atitle%3DAkt%2520inhibitors%2520in%2520cancer%2520treatment%253A%2520the%2520long%2520journey%2520from%2520drug%2520discovery%2520to%2520clinical%2520use%2520%2528Review%2529%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2016%26volume%3D48%26issue%3D3%26spage%3D869%26epage%3D885%26doi%3D10.3892%2Fijo.2015.3306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ashwell, M. A.; Brassard, C.; Filikov, A.; Hill, J.; Koerner, S.; Lapierre, J. M.; Liu, Y.; Namdev, N.; Nicewonger, R.; Palma, R.; Tandon, M.; Vensel, D.; Matsuda, A.; Iimura, S.; Yamamoto, Y.</span><span> </span><span class="NLM_article-title">Substituted imidazopyridinyl-aminopyridine compounds</span>. WO 2011082270, 2011.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ashwell%2C+M.+A.%3B+Brassard%2C+C.%3B+Filikov%2C+A.%3B+Hill%2C+J.%3B+Koerner%2C+S.%3B+Lapierre%2C+J.+M.%3B+Liu%2C+Y.%3B+Namdev%2C+N.%3B+Nicewonger%2C+R.%3B+Palma%2C+R.%3B+Tandon%2C+M.%3B+Vensel%2C+D.%3B+Matsuda%2C+A.%3B+Iimura%2C+S.%3B+Yamamoto%2C+Y.+Substituted+imidazopyridinyl-aminopyridine+compounds.+WO+2011082270%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DM.%2BA.%26atitle%3DSubstituted%2520imidazopyridinyl-aminopyridine%2520compounds" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eathiraj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wick, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbadessa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span> </span><span class="NLM_article-title">Targeting AKT1-E17K and the PI3K/AKT pathway with an allosteric AKT inhibitor, ARQ 092</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1371/journal.pone.0140479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1371%2Fjournal.pone.0140479" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1-26&issue=10&author=Y.+Yuauthor=R.+E.+Savageauthor=S.+Eathirajauthor=J.+Meadeauthor=M.+J.+Wickauthor=T.+Hallauthor=G.+Abbadessaauthor=B.+Schwartz&title=Targeting+AKT1-E17K+and+the+PI3K%2FAKT+pathway+with+an+allosteric+AKT+inhibitor%2C+ARQ+092&doi=10.1371%2Fjournal.pone.0140479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0140479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0140479%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DSavage%26aufirst%3DR.%2BE.%26aulast%3DEathiraj%26aufirst%3DS.%26aulast%3DMeade%26aufirst%3DJ.%26aulast%3DWick%26aufirst%3DM.%2BJ.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DAbbadessa%26aufirst%3DG.%26aulast%3DSchwartz%26aufirst%3DB.%26atitle%3DTargeting%2520AKT1-E17K%2520and%2520the%2520PI3K%252FAKT%2520pathway%2520with%2520an%2520allosteric%2520AKT%2520inhibitor%252C%2520ARQ%2520092%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26issue%3D10%26spage%3D1%26epage%3D26%26doi%3D10.1371%2Fjournal.pone.0140479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Lindhurst, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yourick, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesecker, L. G.</span><span> </span><span class="NLM_article-title">Repression of AKT signaling by ARQ 092 in cells and tissues from patients with Proteus syndrome</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">17162</span><span class="refDoi"> DOI: 10.1038/srep17162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1038%2Fsrep17162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=26657992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVWqsrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=17162&author=M.+J.+Lindhurstauthor=M.+R.+Yourickauthor=Y.+Yuauthor=R.+E.+Savageauthor=D.+Ferrariauthor=L.+G.+Biesecker&title=Repression+of+AKT+signaling+by+ARQ+092+in+cells+and+tissues+from+patients+with+Proteus+syndrome&doi=10.1038%2Fsrep17162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Repression of AKT signaling by ARQ 092 in cells and tissues from patients with Proteus syndrome</span></div><div class="casAuthors">Lindhurst, Marjorie J.; Yourick, Miranda R.; Yu, Yi; Savage, Ronald E.; Ferrari, Dora; Biesecker, Leslie G.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17162</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-pos. cells, is responsible for the mosaic overgrowth condition, Proteus syndrome.  ARQ 092 is an allosteric pan-AKT inhibitor under development for treatment in cancer.  We tested the efficacy of this drug for suppressing AKT signaling in cells and tissues from patients with Proteus syndrome.  ARQ 092 reduced phosphorylation of AKT and downstream targets of AKT in a concn.-dependent manner in as little as two hours.  While AKT signaling was suppressed with ARQ 092 treatment, cells retained their ability to respond to growth factor stimulation by increasing pAKT levels proportionally to untreated cells.  At concns. sufficient to decrease AKT signaling, little redn. in cell viability was seen.  These results indicate that ARQ 092 can suppress AKT signaling and warrants further development as a therapeutic option for patients with Proteus syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm2dj59D3J7Vg90H21EOLACvtfcHk0lim7-PAreA37w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVWqsrvP&md5=3caaf9fd7707ec949a7d41863ee334d4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsrep17162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep17162%26sid%3Dliteratum%253Aachs%26aulast%3DLindhurst%26aufirst%3DM.%2BJ.%26aulast%3DYourick%26aufirst%3DM.%2BR.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DSavage%26aufirst%3DR.%2BE.%26aulast%3DFerrari%26aufirst%3DD.%26aulast%3DBiesecker%26aufirst%3DL.%2BG.%26atitle%3DRepression%2520of%2520AKT%2520signaling%2520by%2520ARQ%2520092%2520in%2520cells%2520and%2520tissues%2520from%2520patients%2520with%2520Proteus%2520syndrome%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D17162%26doi%3D10.1038%2Fsrep17162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ashwell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapierre, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bresciano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornell-Kennon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eathiraj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">France, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanapurkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kizer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koerner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makhija, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namdev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicewonger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szwaya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tandon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppalapati, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vensel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volak, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volckova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlund, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. C.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a series of 3-(3-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">5291</span><span class="NLM_x">–</span> <span class="NLM_lpage">5310</span><span class="refDoi"> DOI: 10.1021/jm300276x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300276x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5291-5310&issue=11&author=M.+A.+Ashwellauthor=J.+M.+Lapierreauthor=C.+Brassardauthor=K.+Brescianoauthor=C.+Bullauthor=S.+Cornell-Kennonauthor=S.+Eathirajauthor=D.+S.+Franceauthor=T.+Hallauthor=J.+Hillauthor=E.+Kelleherauthor=S.+Khanapurkarauthor=D.+Kizerauthor=S.+Koernerauthor=J.+Linkauthor=Y.+Liuauthor=S.+Makhijaauthor=M.+Moussaauthor=N.+Namdevauthor=K.+Nguyenauthor=R.+Nicewongerauthor=R.+Palmaauthor=J.+Szwayaauthor=M.+Tandonauthor=U.+Uppalapatiauthor=D.+Venselauthor=L.+P.+Volakauthor=E.+Volckovaauthor=N.+Westlundauthor=H.+Wuauthor=R.+Y.+Yangauthor=T.+C.+Chan&title=Discovery+and+optimization+of+a+series+of+3-%283-phenyl-3H-imidazo%5B4%2C5-b%5Dpyridin-2-yl%29pyridin-2-amines%3A+orally+bioavailable%2C+selective%2C+and+potent+ATP-independent+Akt+inhibitors&doi=10.1021%2Fjm300276x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm300276x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300276x%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DM.%2BA.%26aulast%3DLapierre%26aufirst%3DJ.%2BM.%26aulast%3DBrassard%26aufirst%3DC.%26aulast%3DBresciano%26aufirst%3DK.%26aulast%3DBull%26aufirst%3DC.%26aulast%3DCornell-Kennon%26aufirst%3DS.%26aulast%3DEathiraj%26aufirst%3DS.%26aulast%3DFrance%26aufirst%3DD.%2BS.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DKelleher%26aufirst%3DE.%26aulast%3DKhanapurkar%26aufirst%3DS.%26aulast%3DKizer%26aufirst%3DD.%26aulast%3DKoerner%26aufirst%3DS.%26aulast%3DLink%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMakhija%26aufirst%3DS.%26aulast%3DMoussa%26aufirst%3DM.%26aulast%3DNamdev%26aufirst%3DN.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DNicewonger%26aufirst%3DR.%26aulast%3DPalma%26aufirst%3DR.%26aulast%3DSzwaya%26aufirst%3DJ.%26aulast%3DTandon%26aufirst%3DM.%26aulast%3DUppalapati%26aufirst%3DU.%26aulast%3DVensel%26aufirst%3DD.%26aulast%3DVolak%26aufirst%3DL.%2BP.%26aulast%3DVolckova%26aufirst%3DE.%26aulast%3DWestlund%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DR.%2BY.%26aulast%3DChan%26aufirst%3DT.%2BC.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520series%2520of%25203-%25283-phenyl-3H-imidazo%255B4%252C5-b%255Dpyridin-2-yl%2529pyridin-2-amines%253A%2520orally%2520bioavailable%252C%2520selective%252C%2520and%2520potent%2520ATP-independent%2520Akt%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D11%26spage%3D5291%26epage%3D5310%26doi%3D10.1021%2Fjm300276x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulabaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malamas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellestad, G.</span><span> </span><span class="NLM_article-title">Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1016/j.ab.2004.04.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1016%2Fj.ab.2004.04.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=15301960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVKhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2004&pages=153-159&issue=1&author=M.+C.+Loauthor=A.+Aulabaughauthor=G.+Jinauthor=R.+Cowlingauthor=J.+Bardauthor=M.+Malamasauthor=G.+Ellestad&title=Evaluation+of+fluorescence-based+thermal+shift+assays+for+hit+identification+in+drug+discovery&doi=10.1016%2Fj.ab.2004.04.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery</span></div><div class="casAuthors">Lo, Mei-Chu; Aulabaugh, Ann; Jin, Guixian; Cowling, Rebecca; Bard, Jonathan; Malamas, Michael; Ellestad, George</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-159</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The fluorescence-based thermal shift assay is a general method for identification of inhibitors of target proteins from compd. libraries.  Using an environmentally sensitive fluorescent dye to monitor protein thermal unfolding, the ligand-binding affinity can be assessed from the shift of the unfolding temp. (ΔTm) obtained in the presence of ligands relative to that obtained in the absence of ligands.  In this article, we report that the thermal shift assay can be conducted in an inexpensive, com. available device for temp. control and fluorescence detection.  The binding affinities obtained from thermal shift assays are compared with the binding affinities measured by isothermal titrn. calorimetry and with the IC50 values from enzymic assays.  The potential pitfalls in the data anal. of thermal shift assays are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1qMM9vchBGrVg90H21EOLACvtfcHk0lim7-PAreA37w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVKhu7g%253D&md5=bc10d980128340c79d7d2abc9a56463b</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.04.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.04.031%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DM.%2BC.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DMalamas%26aufirst%3DM.%26aulast%3DEllestad%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520fluorescence-based%2520thermal%2520shift%2520assays%2520for%2520hit%2520identification%2520in%2520drug%2520discovery%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D332%26issue%3D1%26spage%3D153%26epage%3D159%26doi%3D10.1016%2Fj.ab.2004.04.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pantoliano, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwasnoski, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobanov, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myslik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salemme, F. R.</span><span> </span><span class="NLM_article-title">High-density miniaturized thermal shift assays as a general strategy for drug discovery</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span><span class="refDoi"> DOI: 10.1177/108705710100600609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1177%2F108705710100600609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=11788061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVCntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=429-440&issue=6&author=M.+W.+Pantolianoauthor=E.+C.+Petrellaauthor=J.+D.+Kwasnoskiauthor=V.+S.+Lobanovauthor=J.+Myslikauthor=E.+Grafauthor=T.+Carverauthor=E.+Aselauthor=B.+A.+Springerauthor=P.+Laneauthor=F.+R.+Salemme&title=High-density+miniaturized+thermal+shift+assays+as+a+general+strategy+for+drug+discovery&doi=10.1177%2F108705710100600609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">High-density miniaturized thermal shift assays as a general strategy for drug discovery</span></div><div class="casAuthors">Pantoliano, Michael W.; Petrella, Eugene C.; Kwasnoski, Joseph D.; Lobanov, Victor S.; Myslik, James; Graf, Edward; Carver, Ted; Asel, Eric; Springer, Barry A.; Lane, Pamela; Salemme, F. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-440</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">More general and universally applicable drug discovery assay technologies are needed in order to keep pace with the recent advances in combinatorial chem. and genomics-based target generation.  Ligand-induced conformational stabilization of proteins is a well-understood phenomenon in which substrates, inhibitors, cofactors, and even other proteins provide enhanced stability to proteins on binding.  This phenomenon is based on the energetic coupling of the ligand-binding and protein-melting reactions.  In an attempt to harness these biophys. properties for drug discovery, fully automated instrumentation was designed and implemented to perform miniaturized fluorescence-based thermal shift assays in a microplate format for the high throughput screening of compd. libraries.  Validation of this process and instrumentation was achieved by investigating ligand binding to more than 100 protein targets.  The general applicability of the thermal shift screening strategy was found to be an important advantage because it circumvents the need to design and retool new assays with each new therapeutic target.  Moreover, the miniaturized thermal shift assay methodol. does not require any prior knowledge of a therapeutic target's function, making it ideally suited for the quant. high throughput drug screening and evaluation of targets derived from genomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp58y9R74HfiLVg90H21EOLACvtfcHk0ljZWbnSb_HANA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVCntg%253D%253D&md5=deef07e6683f632cd078214ad88d9999</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1177%2F108705710100600609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705710100600609%26sid%3Dliteratum%253Aachs%26aulast%3DPantoliano%26aufirst%3DM.%2BW.%26aulast%3DPetrella%26aufirst%3DE.%2BC.%26aulast%3DKwasnoski%26aufirst%3DJ.%2BD.%26aulast%3DLobanov%26aufirst%3DV.%2BS.%26aulast%3DMyslik%26aufirst%3DJ.%26aulast%3DGraf%26aufirst%3DE.%26aulast%3DCarver%26aufirst%3DT.%26aulast%3DAsel%26aufirst%3DE.%26aulast%3DSpringer%26aufirst%3DB.%2BA.%26aulast%3DLane%26aufirst%3DP.%26aulast%3DSalemme%26aufirst%3DF.%2BR.%26atitle%3DHigh-density%2520miniaturized%2520thermal%2520shift%2520assays%2520as%2520a%2520general%2520strategy%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2001%26volume%3D6%26issue%3D6%26spage%3D429%26epage%3D440%26doi%3D10.1177%2F108705710100600609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Scheid, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Unravelling the activation mechanisms of protein kinase B/Akt</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">546</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1016/S0014-5793(03)00562-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1016%2FS0014-5793%2803%2900562-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2003&pages=108-112&issue=1&author=M.+P.+Scheidauthor=J.+R.+Woodgett&title=Unravelling+the+activation+mechanisms+of+protein+kinase+B%2FAkt&doi=10.1016%2FS0014-5793%2803%2900562-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2803%2900562-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252803%252900562-3%26sid%3Dliteratum%253Aachs%26aulast%3DScheid%26aufirst%3DM.%2BP.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DUnravelling%2520the%2520activation%2520mechanisms%2520of%2520protein%2520kinase%2520B%252FAkt%26jtitle%3DFEBS%2520Lett.%26date%3D2003%26volume%3D546%26issue%3D1%26spage%3D108%26epage%3D112%26doi%3D10.1016%2FS0014-5793%2803%2900562-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bozulic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, B. A.</span><span> </span><span class="NLM_article-title">PIKKing on PKB: regulation of PKB activity by phosphorylation</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1016/j.ceb.2009.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1016%2Fj.ceb.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=19303758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVClu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=256-261&issue=2&author=L.+Bozulicauthor=B.+A.+Hemmings&title=PIKKing+on+PKB%3A+regulation+of+PKB+activity+by+phosphorylation&doi=10.1016%2Fj.ceb.2009.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">PIKKing on PKB: regulation of PKB activity by phosphorylation</span></div><div class="casAuthors">Bozulic, Lana; Hemmings, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-261</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein kinase B (PKB)/Akt kinase is a key regulator of a wide range of cellular processes including growth, proliferation and survival.  PKB is clearly a crucial signaling mol. and extensive research efforts aim to understand its regulation and action.  Recent studies of the regulation of PKB activity by hydrophobic motif phosphorylation have yielded several exciting findings about members of the phosphatidylinositol 3-kinase (PI3K)-like family of kinases (PIKKs) acting as PKB regulators.  Mammalian target of rapamycin complex 2 (mTORC2) and DNA-dependent protein kinase (DNA-PK) can both phosphorylate Ser-473 and activate PKB.  This review concerns PKB regulation by mTORC2 and DNA-PK in a stimulus-dependent and context-dependent manner and the possible implications of this for PKB activity, substrate specificity, and therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgDTdYbqJWtLVg90H21EOLACvtfcHk0ljZWbnSb_HANA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVClu7Y%253D&md5=0b7a3e6ea561f8479701a01133b5d30c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DBozulic%26aufirst%3DL.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DPIKKing%2520on%2520PKB%253A%2520regulation%2520of%2520PKB%2520activity%2520by%2520phosphorylation%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26issue%3D2%26spage%3D256%26epage%3D261%26doi%3D10.1016%2Fj.ceb.2009.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">All 3-(3-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2yl)pyridin-2-amine compounds tested for biochemical inhibition of PDK1 and MAPKAPK2 showed IC<sub>50</sub> between 10 and 100 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">The biochemical IC<sub>50</sub> determinations against full-length AKT1, AKT2, and AKT3 for the test compounds described in this paper were performed at Reaction Biology (Malvern, PA). The compounds were tested in duplicate in a 10-dose mode with 3-fold serial dilution starting at 10 or 100 μM (based on the IC<sub>50</sub> data generated internally with the unphosphorylated proteins), in the presence of 10 μM ATP. Curve fits were performed where the enzyme activities at the highest concentration of test compounds were less than 65% of enzyme activity relative to DMSO controls.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Chang, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Frijtag Drabbe Kunzel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder-Krieger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerhout, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangenberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span><span class="refDoi"> DOI: 10.1021/jm0607956</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0607956" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=828-834&issue=4&author=L.+C.+Changauthor=J.+K.+von+Frijtag+Drabbe+Kunzelauthor=T.+Mulder-Kriegerauthor=J.+Westerhoutauthor=T.+Spangenbergauthor=J.+Brusseeauthor=A.+P.+Ijzerman&title=2%2C6%2C8-trisubstituted+1-deazapurines+as+adenosine+receptor+antagonists&doi=10.1021%2Fjm0607956"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm0607956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0607956%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%2BC.%26aulast%3Dvon%2BFrijtag%2BDrabbe%2BKunzel%26aufirst%3DJ.%2BK.%26aulast%3DMulder-Krieger%26aufirst%3DT.%26aulast%3DWesterhout%26aufirst%3DJ.%26aulast%3DSpangenberg%26aufirst%3DT.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3D2%252C6%252C8-trisubstituted%25201-deazapurines%2520as%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D4%26spage%3D828%26epage%3D834%26doi%3D10.1021%2Fjm0607956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Nielsen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsay, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrydstrup, T.</span><span> </span><span class="NLM_article-title">Stereocontrolled synthesis of methyl silanediol peptide mimics</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">10035</span><span class="NLM_x">–</span> <span class="NLM_lpage">10044</span><span class="refDoi"> DOI: 10.1021/jo701907d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo701907d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=10035-10044&issue=26&author=L.+Nielsenauthor=K.+B.+Lindsayauthor=J.+Faberauthor=N.+C.+Nielsenauthor=T.+Skrydstrup&title=Stereocontrolled+synthesis+of+methyl+silanediol+peptide+mimics&doi=10.1021%2Fjo701907d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo701907d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo701907d%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DL.%26aulast%3DLindsay%26aufirst%3DK.%2BB.%26aulast%3DFaber%26aufirst%3DJ.%26aulast%3DNielsen%26aufirst%3DN.%2BC.%26aulast%3DSkrydstrup%26aufirst%3DT.%26atitle%3DStereocontrolled%2520synthesis%2520of%2520methyl%2520silanediol%2520peptide%2520mimics%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26issue%3D26%26spage%3D10035%26epage%3D10044%26doi%3D10.1021%2Fjo701907d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">The crystallographic data described here have been deposited with the Protein Data Bank (PDB code for <b>21a</b> bound to AKT1: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KCV">5KCV</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Eathiraj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volckova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakuci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">France, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, M. A.</span><span> </span><span class="NLM_article-title">A novel mode of protein kinase inhibition exploiting hydrophobic motifs of autoinhibited kinases: discovery of ATP-independent inhibitors of fibroblast growth factor receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">20677</span><span class="NLM_x">–</span> <span class="NLM_lpage">20687</span><span class="refDoi"> DOI: 10.1074/jbc.M110.213736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1074%2Fjbc.M110.213736" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=20677-20687&issue=23&author=S.+Eathirajauthor=R.+Palmaauthor=M.+Hirschiauthor=E.+Volckovaauthor=E.+Nakuciauthor=J.+Castroauthor=C.+R.+Chenauthor=T.+C.+Chanauthor=D.+S.+Franceauthor=M.+A.+Ashwell&title=A+novel+mode+of+protein+kinase+inhibition+exploiting+hydrophobic+motifs+of+autoinhibited+kinases%3A+discovery+of+ATP-independent+inhibitors+of+fibroblast+growth+factor+receptor&doi=10.1074%2Fjbc.M110.213736"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.213736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.213736%26sid%3Dliteratum%253Aachs%26aulast%3DEathiraj%26aufirst%3DS.%26aulast%3DPalma%26aufirst%3DR.%26aulast%3DHirschi%26aufirst%3DM.%26aulast%3DVolckova%26aufirst%3DE.%26aulast%3DNakuci%26aufirst%3DE.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BR.%26aulast%3DChan%26aufirst%3DT.%2BC.%26aulast%3DFrance%26aufirst%3DD.%2BS.%26aulast%3DAshwell%26aufirst%3DM.%2BA.%26atitle%3DA%2520novel%2520mode%2520of%2520protein%2520kinase%2520inhibition%2520exploiting%2520hydrophobic%2520motifs%2520of%2520autoinhibited%2520kinases%253A%2520discovery%2520of%2520ATP-independent%2520inhibitors%2520of%2520fibroblast%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26issue%3D23%26spage%3D20677%26epage%3D20687%26doi%3D10.1074%2Fjbc.M110.213736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b','cit2c'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':[],'ref13':[],'ref14':['cit14'],'ref15':['cit15'],'ref16':[],'ref17':['cit17']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 36 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xingye Chen, Haichun Liu, Wuchen Xie, Yan Yang, Yuchen Wang, Yuanrong Fan, Yi Hua, Lu Zhu, Junnan Zhao, Tao Lu, Yadong Chen, <span class="NLM_string-name hlFld-ContribAuthor">Yanmin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of Crystal Structures in Structure-Based Virtual Screening for Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (12)
                                     , 5244-5262. <a href="https://doi.org/10.1021/acs.jcim.9b00684" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00684%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DInvestigation%252Bof%252BCrystal%252BStructures%252Bin%252BStructure-Based%252BVirtual%252BScreening%252Bfor%252BProtein%252BKinase%252BInhibitors%26aulast%3DChen%26aufirst%3DXingye%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17082019%26date%3D15112019%26date%3D05112019%26volume%3D59%26issue%3D12%26spage%3D5244%26epage%3D5262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10030-10066. <a href="https://doi.org/10.1021/acs.jmedchem.6b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBrain%252BCancer%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D03082016%26date%3D23112016%26date%3D14072016%26volume%3D59%26issue%3D22%26spage%3D10030%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Pokorny</span>, <span class="hlFld-ContribAuthor ">Linda  Truebestein</span>, <span class="hlFld-ContribAuthor ">Kaelin D.  Fleming</span>, <span class="hlFld-ContribAuthor ">John E.  Burke</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Leonard</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro reconstitution of Sgk3 activation by phosphatidylinositol 3-phosphate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>297 </em>
                                    (2)
                                     , 100919. <a href="https://doi.org/10.1016/j.jbc.2021.100919" title="DOI URL">https://doi.org/10.1016/j.jbc.2021.100919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jbc.2021.100919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jbc.2021.100919%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DIn%2525C2%2525A0vitro%252Breconstitution%252Bof%252BSgk3%252Bactivation%252Bby%252Bphosphatidylinositol%252B3-phosphate%26aulast%3DPokorny%26aufirst%3DDaniel%26date%3D2021%26volume%3D297%26issue%3D2%26spage%3D100919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ricardo  Rivera-Soto</span>, <span class="hlFld-ContribAuthor ">Yi  Yu</span>, <span class="hlFld-ContribAuthor ">Dirk P.  Dittmer</span>, <span class="hlFld-ContribAuthor ">Blossom  Damania</span>. </span><span class="cited-content_cbyCitation_article-title">Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.670275" title="DOI URL">https://doi.org/10.3389/fonc.2021.670275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.670275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.670275%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DCombined%252BInhibition%252Bof%252BAkt%252Band%252BmTOR%252BIs%252BEffective%252BAgainst%252BNon-Hodgkin%252BLymphomas%26aulast%3DRivera-Soto%26aufirst%3DRicardo%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias R.  Bauer</span>, <span class="hlFld-ContribAuthor ">Paolo  Di Fruscia</span>, <span class="hlFld-ContribAuthor ">Simon C. C.  Lucas</span>, <span class="hlFld-ContribAuthor ">Iacovos N.  Michaelides</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Nelson</span>, <span class="hlFld-ContribAuthor ">R. Ian  Storer</span>, <span class="hlFld-ContribAuthor ">Benjamin C.  Whitehurst</span>. </span><span class="cited-content_cbyCitation_article-title">Put a ring on it: application of small aliphatic rings in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 448-471. <a href="https://doi.org/10.1039/D0MD00370K" title="DOI URL">https://doi.org/10.1039/D0MD00370K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00370K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00370K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPut%252Ba%252Bring%252Bon%252Bit%25253A%252Bapplication%252Bof%252Bsmall%252Baliphatic%252Brings%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DBauer%26aufirst%3DMatthias%2BR.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D4%26spage%3D448%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaotong  Chen</span>, <span class="hlFld-ContribAuthor ">Yunshuo  Zhao</span>, <span class="hlFld-ContribAuthor ">Yanfeng  Gao</span>, <span class="hlFld-ContribAuthor ">Yuanming  Qi</span>, <span class="hlFld-ContribAuthor ">Jiangfeng  Du</span>. </span><span class="cited-content_cbyCitation_article-title">GLUT1: a promising drug target for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Drugs</span><span> <strong>2021,</strong> <em>32 </em>
                                    (4)
                                     , 345-364. <a href="https://doi.org/10.1097/CAD.0000000000001029" title="DOI URL">https://doi.org/10.1097/CAD.0000000000001029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/CAD.0000000000001029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FCAD.0000000000001029%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Drugs%26atitle%3DGLUT1%25253A%252Ba%252Bpromising%252Bdrug%252Btarget%252Bfor%252Bcancer%252Btreatment%26aulast%3DChen%26aufirst%3DXiaotong%26date%3D2021%26volume%3D32%26issue%3D4%26spage%3D345%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia-Qi  Di</span>, <span class="hlFld-ContribAuthor ">Mo  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu-Xuan  Chen</span>, <span class="hlFld-ContribAuthor ">Jin-Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Shan-Shan  Geng</span>, <span class="hlFld-ContribAuthor ">Jia-Qi  Tang</span>, <span class="hlFld-ContribAuthor ">Zhan-Hui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper anchored on phosphorus g-C
              3
              N
              4
              as a highly efficient photocatalyst for the synthesis of
              N
              -arylpyridin-2-amines. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2021,</strong> <em>23 </em>
                                    (2)
                                     , 1041-1049. <a href="https://doi.org/10.1039/D0GC03400B" title="DOI URL">https://doi.org/10.1039/D0GC03400B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0GC03400B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0GC03400B%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DCopper%252Banchored%252Bon%252Bphosphorus%252Bg-C%252B3%252BN%252B4%252Bas%252Ba%252Bhighly%252Befficient%252Bphotocatalyst%252Bfor%252Bthe%252Bsynthesis%252Bof%252BN%252B-arylpyridin-2-amines%26aulast%3DDi%26aufirst%3DJia-Qi%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D2%26spage%3D1041%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xi  Gu</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Mingxing  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Ning  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Computational investigation of imidazopyridine analogs as protein kinase B (Akt1) allosteric inhibitors by using 3D-QSAR, molecular docking and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (1)
                                     , 63-78. <a href="https://doi.org/10.1080/07391102.2019.1705185" title="DOI URL">https://doi.org/10.1080/07391102.2019.1705185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1705185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1705185%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DComputational%252Binvestigation%252Bof%252Bimidazopyridine%252Banalogs%252Bas%252Bprotein%252Bkinase%252BB%252B%252528Akt1%252529%252Ballosteric%252Binhibitors%252Bby%252Busing%252B3D-QSAR%25252C%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DGu%26aufirst%3DXi%26date%3D2021%26date%3D2019%26volume%3D39%26issue%3D1%26spage%3D63%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tania  Maffucci</span>, <span class="hlFld-ContribAuthor ">Marco  Falasca</span>. </span><span class="cited-content_cbyCitation_article-title">Inositol Polyphosphate-Based Compounds as Inhibitors of Phosphoinositide 3-Kinase-Dependent Signaling. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (19)
                                     , 7198. <a href="https://doi.org/10.3390/ijms21197198" title="DOI URL">https://doi.org/10.3390/ijms21197198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21197198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21197198%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DInositol%252BPolyphosphate-Based%252BCompounds%252Bas%252BInhibitors%252Bof%252BPhosphoinositide%252B3-Kinase-Dependent%252BSignaling%26aulast%3DMaffucci%26aufirst%3DTania%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D19%26spage%3D7198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Narittira  Ornnork</span>, <span class="hlFld-ContribAuthor ">Duangnapa  Kiriwan</span>, <span class="hlFld-ContribAuthor ">Kriengsak  Lirdprapamongkol</span>, <span class="hlFld-ContribAuthor ">Kiattawee  Choowongkomon</span>, <span class="hlFld-ContribAuthor ">Jisnuson  Svasti</span>, <span class="hlFld-ContribAuthor ">Chatchakorn  Eurtivong</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2020,</strong> <em>99 </em>, 107639. <a href="https://doi.org/10.1016/j.jmgm.2020.107639" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107639</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107639%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DMolecular%252Bdynamics%25252C%252BMM%25252FPBSA%252Band%252Bin%2525C2%2525A0vitro%252Bvalidation%252Bof%252Ba%252Bnovel%252Bquinazoline-based%252BEGFR%252Btyrosine%252Bkinase%252Binhibitor%252Bidentified%252Busing%252Bstructure-based%252Bin%252Bsilico%252Bscreening%26aulast%3DOrnnork%26aufirst%3DNarittira%26date%3D2020%26volume%3D99%26spage%3D107639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleftherios  Kostaras</span>, <span class="hlFld-ContribAuthor ">Teresa  Kaserer</span>, <span class="hlFld-ContribAuthor ">Glorianne  Lazaro</span>, <span class="hlFld-ContribAuthor ">Sara Farrah  Heuss</span>, <span class="hlFld-ContribAuthor ">Aasia  Hussain</span>, <span class="hlFld-ContribAuthor ">Pedro  Casado</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Cihangir  Yandim</span>, <span class="hlFld-ContribAuthor ">Nicolaos  Palaskas</span>, <span class="hlFld-ContribAuthor ">Yi  Yu</span>, <span class="hlFld-ContribAuthor ">Brian  Schwartz</span>, <span class="hlFld-ContribAuthor ">Florence  Raynaud</span>, <span class="hlFld-ContribAuthor ">Yuen-Li  Chung</span>, <span class="hlFld-ContribAuthor ">Pedro R.  Cutillas</span>, <span class="hlFld-ContribAuthor ">Igor  Vivanco</span>. </span><span class="cited-content_cbyCitation_article-title">A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2020,</strong> <em>123 </em>
                                    (4)
                                     , 542-555. <a href="https://doi.org/10.1038/s41416-020-0889-4" title="DOI URL">https://doi.org/10.1038/s41416-020-0889-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-020-0889-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-020-0889-4%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DA%252Bsystematic%252Bmolecular%252Band%252Bpharmacologic%252Bevaluation%252Bof%252BAKT%252Binhibitors%252Breveals%252Bnew%252Binsight%252Binto%252Btheir%252Bbiological%252Bactivity%26aulast%3DKostaras%26aufirst%3DEleftherios%26date%3D2020%26date%3D2020%26volume%3D123%26issue%3D4%26spage%3D542%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Allosterische Kinaseinhibitoren – Erwartungen und Chancen. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (33)
                                     , 13868-13881. <a href="https://doi.org/10.1002/ange.201914525" title="DOI URL">https://doi.org/10.1002/ange.201914525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201914525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201914525%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DAllosterische%252BKinaseinhibitoren%252B%2525E2%252580%252593%252BErwartungen%252Bund%252BChancen%26aulast%3DLu%26aufirst%3DXiaoyun%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D33%26spage%3D13868%26epage%3D13881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">New Promise and Opportunities for Allosteric Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (33)
                                     , 13764-13776. <a href="https://doi.org/10.1002/anie.201914525" title="DOI URL">https://doi.org/10.1002/anie.201914525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201914525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201914525%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DNew%252BPromise%252Band%252BOpportunities%252Bfor%252BAllosteric%252BKinase%252BInhibitors%26aulast%3DLu%26aufirst%3DXiaoyun%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D33%26spage%3D13764%26epage%3D13776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nam  Chu</span>, <span class="hlFld-ContribAuthor ">Thibault  Viennet</span>, <span class="hlFld-ContribAuthor ">Hwan  Bae</span>, <span class="hlFld-ContribAuthor ">Antonieta  Salguero</span>, <span class="hlFld-ContribAuthor ">Andras  Boeszoermenyi</span>, <span class="hlFld-ContribAuthor ">Haribabu  Arthanari</span>, <span class="hlFld-ContribAuthor ">Philip A  Cole</span>. </span><span class="cited-content_cbyCitation_article-title">The structural determinants of PH domain-mediated regulation of Akt revealed by segmental labeling. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2020,</strong> <em>9 </em><a href="https://doi.org/10.7554/eLife.59151" title="DOI URL">https://doi.org/10.7554/eLife.59151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.59151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.59151%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DThe%252Bstructural%252Bdeterminants%252Bof%252BPH%252Bdomain-mediated%252Bregulation%252Bof%252BAkt%252Brevealed%252Bby%252Bsegmental%252Blabeling%26aulast%3DChu%26aufirst%3DNam%26date%3D2020%26date%3D2020%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy D.  Le Cras</span>, <span class="hlFld-ContribAuthor ">Jillian  Goines</span>, <span class="hlFld-ContribAuthor ">Nora  Lakes</span>, <span class="hlFld-ContribAuthor ">Patricia  Pastura</span>, <span class="hlFld-ContribAuthor ">Adrienne M.  Hammill</span>, <span class="hlFld-ContribAuthor ">Denise M.  Adams</span>, <span class="hlFld-ContribAuthor ">Elisa  Boscolo</span>. </span><span class="cited-content_cbyCitation_article-title">Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation. </span><span class="cited-content_cbyCitation_journal-name">Angiogenesis</span><span> <strong>2020,</strong> <em>23 </em>
                                    (3)
                                     , 425-442. <a href="https://doi.org/10.1007/s10456-020-09722-0" title="DOI URL">https://doi.org/10.1007/s10456-020-09722-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10456-020-09722-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10456-020-09722-0%26sid%3Dliteratum%253Aachs%26jtitle%3DAngiogenesis%26atitle%3DConstitutively%252Bactive%252BPIK3CA%252Bmutations%252Bare%252Bexpressed%252Bby%252Blymphatic%252Band%252Bvascular%252Bendothelial%252Bcells%252Bin%252Bcapillary%252Blymphatic%252Bvenous%252Bmalformation%26aulast%3DLe%2BCras%26aufirst%3DTimothy%2BD.%26date%3D2020%26date%3D2020%26volume%3D23%26issue%3D3%26spage%3D425%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jintong  Du</span>, <span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Jianbing  Wu</span>, <span class="hlFld-ContribAuthor ">Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>, <span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>, <span class="hlFld-ContribAuthor ">Guobo  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>, <span class="hlFld-ContribAuthor ">Li  Rao</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">New techniques and strategies in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2020,</strong> <em>31 </em>
                                    (7)
                                     , 1695-1708. <a href="https://doi.org/10.1016/j.cclet.2020.03.028" title="DOI URL">https://doi.org/10.1016/j.cclet.2020.03.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2020.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2020.03.028%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DNew%252Btechniques%252Band%252Bstrategies%252Bin%252Bdrug%252Bdiscovery%26aulast%3DDu%26aufirst%3DJintong%26date%3D2020%26volume%3D31%26issue%3D7%26spage%3D1695%26epage%3D1708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramon  Martinez</span>, <span class="hlFld-ContribAuthor ">Amy  Defnet</span>, <span class="hlFld-ContribAuthor ">Paul  Shapiro</span>. </span><span class="cited-content_cbyCitation_article-title">Avoiding or Co-Opting ATP Inhibition: Overview of Type III, IV, V, and VI Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 29-59. <a href="https://doi.org/10.1007/978-3-030-48283-1_3" title="DOI URL">https://doi.org/10.1007/978-3-030-48283-1_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-48283-1_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-48283-1_3%26sid%3Dliteratum%253Aachs%26atitle%3DAvoiding%252Bor%252BCo-Opting%252BATP%252BInhibition%25253A%252BOverview%252Bof%252BType%252BIII%25252C%252BIV%25252C%252BV%25252C%252Band%252BVI%252BKinase%252BInhibitors%26aulast%3DMartinez%26aufirst%3DRamon%26date%3D2020%26date%3D2020%26spage%3D29%26epage%3D59%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNext%252BGeneration%252BKinase%252BInhibitors%26aulast%3DShapiro%26aufirst%3DPaul%26date%3D2020%26volume%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lena  Quambusch</span>, <span class="hlFld-ContribAuthor ">Ina  Landel</span>, <span class="hlFld-ContribAuthor ">Laura  Depta</span>, <span class="hlFld-ContribAuthor ">Jörn  Weisner</span>, <span class="hlFld-ContribAuthor ">Niklas  Uhlenbrock</span>, <span class="hlFld-ContribAuthor ">Matthias P.  Müller</span>, <span class="hlFld-ContribAuthor ">Franziska  Glanemann</span>, <span class="hlFld-ContribAuthor ">Kristina  Althoff</span>, <span class="hlFld-ContribAuthor ">Jens T.  Siveke</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (52)
                                     , 18999-19005. <a href="https://doi.org/10.1002/ange.201909857" title="DOI URL">https://doi.org/10.1002/ange.201909857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201909857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201909857%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DCovalent%2525E2%252580%252590Allosteric%252BInhibitors%252Bto%252BAchieve%252BAkt%252BIsoform%2525E2%252580%252590Selectivity%26aulast%3DQuambusch%26aufirst%3DLena%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D52%26spage%3D18999%26epage%3D19005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lena  Quambusch</span>, <span class="hlFld-ContribAuthor ">Ina  Landel</span>, <span class="hlFld-ContribAuthor ">Laura  Depta</span>, <span class="hlFld-ContribAuthor ">Jörn  Weisner</span>, <span class="hlFld-ContribAuthor ">Niklas  Uhlenbrock</span>, <span class="hlFld-ContribAuthor ">Matthias P.  Müller</span>, <span class="hlFld-ContribAuthor ">Franziska  Glanemann</span>, <span class="hlFld-ContribAuthor ">Kristina  Althoff</span>, <span class="hlFld-ContribAuthor ">Jens T.  Siveke</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (52)
                                     , 18823-18829. <a href="https://doi.org/10.1002/anie.201909857" title="DOI URL">https://doi.org/10.1002/anie.201909857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201909857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201909857%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DCovalent%2525E2%252580%252590Allosteric%252BInhibitors%252Bto%252BAchieve%252BAkt%252BIsoform%2525E2%252580%252590Selectivity%26aulast%3DQuambusch%26aufirst%3DLena%26date%3D2019%26volume%3D58%26issue%3D52%26spage%3D18823%26epage%3D18829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Shariati</span>, <span class="hlFld-ContribAuthor ">Funda  Meric-Bernstam</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting AKT for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2019,</strong> <em>28 </em>
                                    (11)
                                     , 977-988. <a href="https://doi.org/10.1080/13543784.2019.1676726" title="DOI URL">https://doi.org/10.1080/13543784.2019.1676726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2019.1676726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2019.1676726%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DTargeting%252BAKT%252Bfor%252Bcancer%252Btherapy%26aulast%3DShariati%26aufirst%3DMaryam%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D11%26spage%3D977%26epage%3D988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisa  Boscolo</span>, <span class="hlFld-ContribAuthor ">Patricia  Pastura</span>, <span class="hlFld-ContribAuthor ">Kathryn  Glaser</span>, <span class="hlFld-ContribAuthor ">Jillian  Goines</span>, <span class="hlFld-ContribAuthor ">Adrienne M.  Hammill</span>, <span class="hlFld-ContribAuthor ">Denise M.  Adams</span>, <span class="hlFld-ContribAuthor ">Peter  Dickie</span>, <span class="hlFld-ContribAuthor ">Belinda  Hsi Dickie</span>, <span class="hlFld-ContribAuthor ">Timothy D.  Cras</span>. </span><span class="cited-content_cbyCitation_article-title">Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosis. </span><span class="cited-content_cbyCitation_journal-name">Pediatric Blood & Cancer</span><span> <strong>2019,</strong> <em>66 </em>
                                    (8)
                                     <a href="https://doi.org/10.1002/pbc.27790" title="DOI URL">https://doi.org/10.1002/pbc.27790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pbc.27790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpbc.27790%26sid%3Dliteratum%253Aachs%26jtitle%3DPediatric%2520Blood%2520%2526%2520Cancer%26atitle%3DSignaling%252Bpathways%252Band%252Binhibitors%252Bof%252Bcells%252Bfrom%252Bpatients%252Bwith%252Bkaposiform%252Blymphangiomatosis%26aulast%3DBoscolo%26aufirst%3DElisa%26date%3D2019%26date%3D2019%26volume%3D66%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chinthasagar  Bastian</span>, <span class="hlFld-ContribAuthor ">John  Quinn</span>, <span class="hlFld-ContribAuthor ">Ajai  Tripathi</span>, <span class="hlFld-ContribAuthor ">Danielle  Aquila</span>, <span class="hlFld-ContribAuthor ">Andrew  McCray</span>, <span class="hlFld-ContribAuthor ">Ranjan  Dutta</span>, <span class="hlFld-ContribAuthor ">Selva  Baltan</span>, <span class="hlFld-ContribAuthor ">Sylvain  Brunet</span>. </span><span class="cited-content_cbyCitation_article-title">CK2 inhibition confers functional protection to young and aging axons against ischemia by differentially regulating the CDK5 and AKT signaling pathways. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Disease</span><span> <strong>2019,</strong> <em>126 </em>, 47-61. <a href="https://doi.org/10.1016/j.nbd.2018.05.011" title="DOI URL">https://doi.org/10.1016/j.nbd.2018.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nbd.2018.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nbd.2018.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Disease%26atitle%3DCK2%252Binhibition%252Bconfers%252Bfunctional%252Bprotection%252Bto%252Byoung%252Band%252Baging%252Baxons%252Bagainst%252Bischemia%252Bby%252Bdifferentially%252Bregulating%252Bthe%252BCDK5%252Band%252BAKT%252Bsignaling%252Bpathways%26aulast%3DBastian%26aufirst%3DChinthasagar%26date%3D2019%26volume%3D126%26spage%3D47%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daoxin  Wu</span>, <span class="hlFld-ContribAuthor ">Minhua  Liu</span>, <span class="hlFld-ContribAuthor ">Zhong  Li</span>, <span class="hlFld-ContribAuthor ">Mingming  Dang</span>, <span class="hlFld-ContribAuthor ">Xingping  Liu</span>, <span class="hlFld-ContribAuthor ">Jianming  Li</span>, <span class="hlFld-ContribAuthor ">Lu  Huang</span>, <span class="hlFld-ContribAuthor ">Yeguo  Ren</span>, <span class="hlFld-ContribAuthor ">Zai  Zhang</span>, <span class="hlFld-ContribAuthor ">Weidong  Liu</span>, <span class="hlFld-ContribAuthor ">Aiping  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and fungicidal activity of novel imidazo[4, 5-b]pyridine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Heterocyclic Communications</span><span> <strong>2019,</strong> <em>25 </em>
                                    (1)
                                     , 8-14. <a href="https://doi.org/10.1515/hc-2019-0003" title="DOI URL">https://doi.org/10.1515/hc-2019-0003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hc-2019-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhc-2019-0003%26sid%3Dliteratum%253Aachs%26jtitle%3DHeterocyclic%2520Communications%26atitle%3DSynthesis%252Band%252Bfungicidal%252Bactivity%252Bof%252Bnovel%252Bimidazo%25255B4%25252C%252B5-b%25255Dpyridine%252Bderivatives%26aulast%3DWu%26aufirst%3DDaoxin%26date%3D2019%26volume%3D25%26issue%3D1%26spage%3D8%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niklas  Uhlenbrock</span>, <span class="hlFld-ContribAuthor ">Steven  Smith</span>, <span class="hlFld-ContribAuthor ">Jörn  Weisner</span>, <span class="hlFld-ContribAuthor ">Ina  Landel</span>, <span class="hlFld-ContribAuthor ">Marius  Lindemann</span>, <span class="hlFld-ContribAuthor ">Thien Anh  Le</span>, <span class="hlFld-ContribAuthor ">Julia  Hardick</span>, <span class="hlFld-ContribAuthor ">Rajesh  Gontla</span>, <span class="hlFld-ContribAuthor ">Rebekka  Scheinpflug</span>, <span class="hlFld-ContribAuthor ">Paul  Czodrowski</span>, <span class="hlFld-ContribAuthor ">Petra  Janning</span>, <span class="hlFld-ContribAuthor ">Laura  Depta</span>, <span class="hlFld-ContribAuthor ">Lena  Quambusch</span>, <span class="hlFld-ContribAuthor ">Matthias P.  Müller</span>, <span class="hlFld-ContribAuthor ">Bernd  Engels</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2019,</strong> <em>10 </em>
                                    (12)
                                     , 3573-3585. <a href="https://doi.org/10.1039/C8SC05212C" title="DOI URL">https://doi.org/10.1039/C8SC05212C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8SC05212C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8SC05212C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DStructural%252Band%252Bchemical%252Binsights%252Binto%252Bthe%252Bcovalent-allosteric%252Binhibition%252Bof%252Bthe%252Bprotein%252Bkinase%252BAkt%26aulast%3DUhlenbrock%26aufirst%3DNiklas%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D12%26spage%3D3573%26epage%3D3585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tom  Baladi</span>, <span class="hlFld-ContribAuthor ">Jessy  Aziz</span>, <span class="hlFld-ContribAuthor ">Florent  Dufour</span>, <span class="hlFld-ContribAuthor ">Valentina  Abet</span>, <span class="hlFld-ContribAuthor ">Véronique  Stoven</span>, <span class="hlFld-ContribAuthor ">François  Radvanyi</span>, <span class="hlFld-ContribAuthor ">Florent  Poyer</span>, <span class="hlFld-ContribAuthor ">Ting-Di  Wu</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Guerquin-Kern</span>, <span class="hlFld-ContribAuthor ">Isabelle  Bernard-Pierrot</span>, <span class="hlFld-ContribAuthor ">Sergio Marco  Garrido</span>, <span class="hlFld-ContribAuthor ">Sandrine  Piguel</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation and cellular imaging of imidazo[4,5-b]pyridine derivatives as potent and selective TAM inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (20)
                                     , 5510-5530. <a href="https://doi.org/10.1016/j.bmc.2018.09.031" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.09.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.09.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bcellular%252Bimaging%252Bof%252Bimidazo%25255B4%25252C5-b%25255Dpyridine%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252BTAM%252Binhibitors%26aulast%3DBaladi%26aufirst%3DTom%26date%3D2018%26volume%3D26%26issue%3D20%26spage%3D5510%26epage%3D5530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Selva  Baltan</span>, <span class="hlFld-ContribAuthor ">Chinthasagar  Bastian</span>, <span class="hlFld-ContribAuthor ">John  Quinn</span>, <span class="hlFld-ContribAuthor ">Danielle  Aquila</span>, <span class="hlFld-ContribAuthor ">Andrew  McCray</span>, <span class="hlFld-ContribAuthor ">Sylvain  Brunet</span>. </span><span class="cited-content_cbyCitation_article-title">CK2 inhibition protects white matter from ischemic injury. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience Letters</span><span> <strong>2018,</strong> <em>687 </em>, 37-42. <a href="https://doi.org/10.1016/j.neulet.2018.08.021" title="DOI URL">https://doi.org/10.1016/j.neulet.2018.08.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neulet.2018.08.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neulet.2018.08.021%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520Letters%26atitle%3DCK2%252Binhibition%252Bprotects%252Bwhite%252Bmatter%252Bfrom%252Bischemic%252Binjury%26aulast%3DBaltan%26aufirst%3DSelva%26date%3D2018%26volume%3D687%26spage%3D37%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minhua  Liu</span>, <span class="hlFld-ContribAuthor ">Chunsheng  Quan</span>, <span class="hlFld-ContribAuthor ">Mingming  Dang</span>, <span class="hlFld-ContribAuthor ">Yeguo  Ren</span>, <span class="hlFld-ContribAuthor ">Jianwei  Ren</span>, <span class="hlFld-ContribAuthor ">Jun  Xiang</span>, <span class="hlFld-ContribAuthor ">Xingping  Liu</span>, <span class="hlFld-ContribAuthor ">Lian  He</span>, <span class="hlFld-ContribAuthor ">Weidong  Liu</span>, <span class="hlFld-ContribAuthor ">Aiping  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Fungicidal Activity of Novel Imidazo[4,5-
              b
              ]pyridine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2018,</strong> <em>55 </em>
                                    (9)
                                     , 2061-2068. <a href="https://doi.org/10.1002/jhet.3243" title="DOI URL">https://doi.org/10.1002/jhet.3243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3243%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BFungicidal%252BActivity%252Bof%252BNovel%252BImidazo%25255B4%25252C5-%252Bb%252B%25255Dpyridine%252BDerivatives%26aulast%3DLiu%26aufirst%3DMinhua%26date%3D2018%26date%3D2018%26volume%3D55%26issue%3D9%26spage%3D2061%26epage%3D2068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexey  Sarapultsev</span>, <span class="hlFld-ContribAuthor ">Pavel  Vassiliev</span>, <span class="hlFld-ContribAuthor ">Petr  Sarapultsev</span>, <span class="hlFld-ContribAuthor ">Oleg  Chupakhin</span>, <span class="hlFld-ContribAuthor ">Laura  Ianalieva</span>, <span class="hlFld-ContribAuthor ">Larisa  Sidorova</span>. </span><span class="cited-content_cbyCitation_article-title">Immunomodulatory Action of Substituted 1,3,4-Thiadiazines on the Course of Myocardial Infarction. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1611. <a href="https://doi.org/10.3390/molecules23071611" title="DOI URL">https://doi.org/10.3390/molecules23071611</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071611%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DImmunomodulatory%252BAction%252Bof%252BSubstituted%252B1%25252C3%25252C4-Thiadiazines%252Bon%252Bthe%252BCourse%252Bof%252BMyocardial%252BInfarction%26aulast%3DSarapultsev%26aufirst%3DAlexey%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iva  Lučić</span>, <span class="hlFld-ContribAuthor ">Manoj K.  Rathinaswamy</span>, <span class="hlFld-ContribAuthor ">Linda  Truebestein</span>, <span class="hlFld-ContribAuthor ">David J.  Hamelin</span>, <span class="hlFld-ContribAuthor ">John E.  Burke</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Leonard</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational sampling of membranes by Akt controls its activation and inactivation. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (17)
                                     , E3940-E3949. <a href="https://doi.org/10.1073/pnas.1716109115" title="DOI URL">https://doi.org/10.1073/pnas.1716109115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1716109115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1716109115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DConformational%252Bsampling%252Bof%252Bmembranes%252Bby%252BAkt%252Bcontrols%252Bits%252Bactivation%252Band%252Binactivation%26aulast%3DLu%25C4%258Di%25C4%2587%26aufirst%3DIva%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D17%26spage%3DE3940%26epage%3DE3949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro E.  Leroux</span>, <span class="hlFld-ContribAuthor ">Jörg O.  Schulze</span>, <span class="hlFld-ContribAuthor ">Ricardo M.  Biondi</span>. </span><span class="cited-content_cbyCitation_article-title">AGC kinases, mechanisms of regulation ‎and innovative drug development. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2018,</strong> <em>48 </em>, 1-17. <a href="https://doi.org/10.1016/j.semcancer.2017.05.011" title="DOI URL">https://doi.org/10.1016/j.semcancer.2017.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2017.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2017.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DAGC%252Bkinases%25252C%252Bmechanisms%252Bof%252Bregulation%252B%2525E2%252580%25258Eand%252Binnovative%252Bdrug%252Bdevelopment%26aulast%3DLeroux%26aufirst%3DAlejandro%2BE.%26date%3D2018%26volume%3D48%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiarong  Feng</span>, <span class="hlFld-ContribAuthor ">Lei  He</span>, <span class="hlFld-ContribAuthor ">Yuqian  Li</span>, <span class="hlFld-ContribAuthor ">Fei  Xiao</span>, <span class="hlFld-ContribAuthor ">Guang  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Modeling of PH Domains and Phosphoinositides Interactions and Beyond. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 19-32. <a href="https://doi.org/10.1007/5584_2018_236" title="DOI URL">https://doi.org/10.1007/5584_2018_236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/5584_2018_236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F5584_2018_236%26sid%3Dliteratum%253Aachs%26atitle%3DModeling%252Bof%252BPH%252BDomains%252Band%252BPhosphoinositides%252BInteractions%252Band%252BBeyond%26aulast%3DFeng%26aufirst%3DJiarong%26date%3D2018%26date%3D2018%26spage%3D19%26epage%3D32%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProtein%252BReviews%252B%2525E2%252580%252593%252BPurinergic%252BReceptors%26aulast%3DAtassi%26aufirst%3DM.%2BZouhair%26date%3D2019%26volume%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gaël S.  Roth</span>, <span class="hlFld-ContribAuthor ">Zuzana  Macek Jilkova</span>, <span class="hlFld-ContribAuthor ">Ayca  Zeybek Kuyucu</span>, <span class="hlFld-ContribAuthor ">Keerthi  Kurma</span>, <span class="hlFld-ContribAuthor ">Séyédéh Tayébéh  Ahmad Pour</span>, <span class="hlFld-ContribAuthor ">Giovanni  Abbadessa</span>, <span class="hlFld-ContribAuthor ">Yi  Yu</span>, <span class="hlFld-ContribAuthor ">Benoit  Busser</span>, <span class="hlFld-ContribAuthor ">Patrice N.  Marche</span>, <span class="hlFld-ContribAuthor ">Vincent  Leroy</span>, <span class="hlFld-ContribAuthor ">Thomas  Decaens</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2017,</strong> <em>16 </em>
                                    (10)
                                     , 2157-2165. <a href="https://doi.org/10.1158/1535-7163.MCT-16-0602-T" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-16-0602-T</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-16-0602-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-16-0602-T%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DEfficacy%252Bof%252BAKT%252BInhibitor%252BARQ%252B092%252BCompared%252Bwith%252BSorafenib%252Bin%252Ba%252BCirrhotic%252BRat%252BModel%252Bwith%252BHepatocellular%252BCarcinoma%26aulast%3DRoth%26aufirst%3DGa%25C3%25ABl%2BS.%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D10%26spage%3D2157%26epage%3D2165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bayard R.  Huck</span>, <span class="hlFld-ContribAuthor ">Igor  Mochalkin</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress towards clinically relevant ATP-competitive Akt inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (13)
                                     , 2838-2848. <a href="https://doi.org/10.1016/j.bmcl.2017.04.090" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.04.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.04.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.04.090%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRecent%252Bprogress%252Btowards%252Bclinically%252Brelevant%252BATP-competitive%252BAkt%252Binhibitors%26aulast%3DHuck%26aufirst%3DBayard%2BR.%26date%3D2017%26volume%3D27%26issue%3D13%26spage%3D2838%26epage%3D2848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brendan D.  Manning</span>, <span class="hlFld-ContribAuthor ">Alex  Toker</span>. </span><span class="cited-content_cbyCitation_article-title">AKT/PKB Signaling: Navigating the Network. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2017,</strong> <em>169 </em>
                                    (3)
                                     , 381-405. <a href="https://doi.org/10.1016/j.cell.2017.04.001" title="DOI URL">https://doi.org/10.1016/j.cell.2017.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2017.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2017.04.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3DAKT%25252FPKB%252BSignaling%25253A%252BNavigating%252Bthe%252BNetwork%26aulast%3DManning%26aufirst%3DBrendan%2BD.%26date%3D2017%26volume%3D169%26issue%3D3%26spage%3D381%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica S.  Brown</span>, <span class="hlFld-ContribAuthor ">Udai  Banerji</span>. </span><span class="cited-content_cbyCitation_article-title">Maximising the potential of AKT inhibitors as anti-cancer treatments. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2017,</strong> <em>172 </em>, 101-115. <a href="https://doi.org/10.1016/j.pharmthera.2016.12.001" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2016.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2016.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2016.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DMaximising%252Bthe%252Bpotential%252Bof%252BAKT%252Binhibitors%252Bas%252Banti-cancer%252Btreatments%26aulast%3DBrown%26aufirst%3DJessica%2BS.%26date%3D2017%26volume%3D172%26spage%3D101%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steffi K.  Koerner</span>, <span class="hlFld-ContribAuthor ">Jun-ichi  Hanai</span>, <span class="hlFld-ContribAuthor ">Sha  Bai</span>, <span class="hlFld-ContribAuthor ">Finith E.  Jernigan</span>, <span class="hlFld-ContribAuthor ">Miwa  Oki</span>, <span class="hlFld-ContribAuthor ">Chieko  Komaba</span>, <span class="hlFld-ContribAuthor ">Emi  Shuto</span>, <span class="hlFld-ContribAuthor ">Vikas P.  Sukhatme</span>, <span class="hlFld-ContribAuthor ">Lijun  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>126 </em>, 920-928. <a href="https://doi.org/10.1016/j.ejmech.2016.12.018" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.12.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.12.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bemodin%252Bderivatives%252Bas%252Bnovel%252Binhibitors%252Bof%252BATP-citrate%252Blyase%26aulast%3DKoerner%26aufirst%3DSteffi%2BK.%26date%3D2017%26volume%3D126%26spage%3D920%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) substituted anilines, DIEA, DMSO or 1,4-dioxane, 80 °C, overnight; (b) 2-aminonicotinaldehyde, Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, DMSO, MeOH, 100 °C, overnight; (c) 4.0 M HCl in 1,4-dioxane, 1,4-dioxane, room temperature, overnight.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>tert</i>-butyl (4-aminobenzyl)carbamate, DIEA, DMSO or 1,4-dioxane, 80 °C, overnight; (b) 2-aminonicotinaldehyde, Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, DMSO, MeOH, 100 °C, overnight; (c) 4.0 M HCl in 1,4-dioxane, 1,4-dioxane, room temperature, overnight.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) aryl/heteroarylboronic acid, toluene, EtOH, aq NaHCO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 100 °C, overnight; (b) 4.0 M HCl in 1,4-dioxane, 1,4-dioxane, room temperature, overnight.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a)Ti(OEt)<sub>4</sub>, acetone, THF; (b) 4-bromo-<i>N</i>,<i>N</i>-bis(trimethylsilyl)aniline, BuLi, THF, −78 °C; (c) <b>1e</b>, Et<sub>3</sub>N, DMA, 0–20 °C, overnight; (d) 4.0 M HCl in 1,4-dioxane, DCM, 30 min.; (e) di-<i>tert</i>-butyl dicarbonate, NaHCO<sub>3</sub>, THF; (f) 2-aminonicotinaldehyde, Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, DMSO, MeOH, 100 °C, overnight; (g) phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3 aq</sub>, EtOH, toluene, 100 °C, overnight; (h) 4.0 M HCl in 1,4-dioxane, 1,4-dioxane, room temperature, 1 h.</p></p></figure><figure data-id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>tert</i>-butyl (1-(4-aminophenyl)cyclobutyl)carbamate, DIEA, DMSO or 1,4-dioxane, 80 °C, overnight; (b) 2-aminonicotinaldehyde, Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, DMSO, MeOH, 100 °C, overnight; (c) substituted phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3 aq.</sub>, EtOH, toluene, 100 °C, overnight; (d) 4.0 M HCl in 1,4-dioxane, 1,4-dioxane, room temperature, overnight; (e) Ac<sub>2</sub>O, pyridine, room temperature, overnight; (f) 4.0 M HCl in 1,4-dioxane, 1,4-dioxane, MeOH, 50 °C, 3 days.</p></p></figure><figure data-id="sch6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl 1-(4-aminophenyl)cyclobutane-1-carboxylate, DIEA, EtOH, 45 °C, overnight; (b) phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3 aq.</sub>, EtOH, toluene, 100 °C, overnight; (c) 2-aminonicotinaldehyde, Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, DMSO, MeOH, 100 °C, overnight; (d) NaOH 1N, THF, MeOH, 65 °C; (e) EDC, HOBt, TEA, ammonia, DMF.</p></p></figure><figure data-id="fig1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/medium/jm-2016-00619w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cocrystal structure of <b>21a</b> with AKT1 (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KCV">5KCV</a>). Compound <b>21a</b> binds to the allosteric pocket formed by the kinase and PH domains. The aminopyrimidine group of the core moiety forms a bidentate hydrogen bonding interaction with the main chain atoms of loop of β4-strand and αC-helix. The phenylcyclobutylamine side chain associates with the conserved YRD motif of kinase domain by polar and nonpolar interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00619/20160708/images/large/jm-2016-00619w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00619&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25734" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25734" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 17 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Scheid, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">PKB/AKT: functional insights from genetic models</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span><span class="refDoi"> DOI: 10.1038/35096067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1038%2F35096067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=11584303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvVajsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=760-768&issue=10&author=M.+P.+Scheidauthor=J.+R.+Woodgett&title=PKB%2FAKT%3A+functional+insights+from+genetic+models&doi=10.1038%2F35096067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">PKB/AKT: Functional insights from genetic models</span></div><div class="casAuthors">Scheid, Michael P.; Woodgett, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">760-768</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since its discovery 10 yr ago, the potential functions of protein kinase B(PKB)/AKT have been cataloged with increasing efficiency.  The physiol. relevance of some of the proposed mechanisms by which PKB/AKT mediates many of its effects has been questioned, and recent work using new reagents and approaches has revealed some cracks in our understanding of this important mol., and also hinted that these effects may involve other players.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr44zDB4vDCrLVg90H21EOLACvtfcHk0lj9SdyDh2ixTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvVajsLY%253D&md5=a1d5b9ddf4920e3a5e4405735a8ff6cf</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2F35096067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35096067%26sid%3Dliteratum%253Aachs%26aulast%3DScheid%26aufirst%3DM.%2BP.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DPKB%252FAKT%253A%2520functional%2520insights%2520from%2520genetic%2520models%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2001%26volume%3D2%26issue%3D10%26spage%3D760%26epage%3D768%26doi%3D10.1038%2F35096067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Franke, T. F.</span><span> </span><span class="NLM_article-title">PI3K/Akt: getting it right matters</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">50</span><span class="NLM_x">) </span> <span class="NLM_fpage">6473</span><span class="NLM_x">–</span> <span class="NLM_lpage">6488</span><span class="refDoi"> DOI: 10.1038/onc.2008.313</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1038%2Fonc.2008.313" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=6473-6488&issue=50&author=T.+F.+Franke&title=PI3K%2FAkt%3A+getting+it+right+matters&doi=10.1038%2Fonc.2008.313"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fonc.2008.313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2008.313%26sid%3Dliteratum%253Aachs%26aulast%3DFranke%26aufirst%3DT.%2BF.%26atitle%3DPI3K%252FAkt%253A%2520getting%2520it%2520right%2520matters%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26issue%3D50%26spage%3D6473%26epage%3D6488%26doi%3D10.1038%2Fonc.2008.313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Altomare, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. R.</span><span> </span><span class="NLM_article-title">Perturbations of the AKT signaling pathway in human cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">50</span><span class="NLM_x">) </span> <span class="NLM_fpage">7455</span><span class="NLM_x">–</span> <span class="NLM_lpage">7464</span><span class="refDoi"> DOI: 10.1038/sj.onc.1209085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1038%2Fsj.onc.1209085" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=7455-7464&issue=50&author=D.+A.+Altomareauthor=J.+R.+Testa&title=Perturbations+of+the+AKT+signaling+pathway+in+human+cancer&doi=10.1038%2Fsj.onc.1209085"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1209085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1209085%26sid%3Dliteratum%253Aachs%26aulast%3DAltomare%26aufirst%3DD.%2BA.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26atitle%3DPerturbations%2520of%2520the%2520AKT%2520signaling%2520pathway%2520in%2520human%2520cancer%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26issue%3D50%26spage%3D7455%26epage%3D7464%26doi%3D10.1038%2Fsj.onc.1209085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Porta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paglino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosca, A.</span><span> </span><span class="NLM_article-title">Targeting PI3K/Akt/mTOR signaling in cancer</span> <span class="citation_source-journal">Front. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">64</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.3389/fonc.2014.00064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.3389%2Ffonc.2014.00064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=24478982" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=1-11&issue=64&author=C.+Portaauthor=C.+Paglinoauthor=A.+Mosca&title=Targeting+PI3K%2FAkt%2FmTOR+signaling+in+cancer&doi=10.3389%2Ffonc.2014.00064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2014.00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2014.00064%26sid%3Dliteratum%253Aachs%26aulast%3DPorta%26aufirst%3DC.%26aulast%3DPaglino%26aufirst%3DC.%26aulast%3DMosca%26aufirst%3DA.%26atitle%3DTargeting%2520PI3K%252FAkt%252FmTOR%2520signaling%2520in%2520cancer%26jtitle%3DFront.%2520Oncol.%26date%3D2014%26volume%3D4%26issue%3D64%26spage%3D1%26epage%3D11%26doi%3D10.3389%2Ffonc.2014.00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mayer, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, C. L.</span><span> </span><span class="NLM_article-title">The PI3K/AKT pathway as a target for cancer treatment</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1146/annurev-med-062913-051343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1146%2Fannurev-med-062913-051343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=26473415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1yjsL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2016&pages=11-28&author=I.+A.+Mayerauthor=C.+L.+Arteaga&title=The+PI3K%2FAKT+pathway+as+a+target+for+cancer+treatment&doi=10.1146%2Fannurev-med-062913-051343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">the PI3K/AKT pathway as a target for cancer treatment</span></div><div class="casAuthors">Mayer, Ingrid A.; Arteaga, Carlos L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-28</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">Anticancer targeted therapies are designed to exploit a particular vulnerability in the tumor, which in most cases results from its dependence on an oncogene and/or loss of a tumor suppressor.  Genes in the phosphoinositide 3-kinase (PI3K)/AKT pathway are the most frequently altered in human cancers.  Aberrant activation of this pathway, as a result of these somatic alterations, is assocd. with cellular transformation, tumorigenesis, cancer progression, and drug resistance.  Several drugs targeting PI3K/ATK are currently in clin. trials, alone or in combination, in both solid tumors and hematol. malignancies.  These drugs are the focus of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyfvNz6IpJ17Vg90H21EOLACvtfcHk0lg9TkqOHYYl6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1yjsL%252FM&md5=145c818d377155d01e2eaef8cf4d67a9</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-062913-051343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-062913-051343%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DI.%2BA.%26aulast%3DArteaga%26aufirst%3DC.%2BL.%26atitle%3DThe%2520PI3K%252FAKT%2520pathway%2520as%2520a%2520target%2520for%2520cancer%2520treatment%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2016%26volume%3D67%26spage%3D11%26epage%3D28%26doi%3D10.1146%2Fannurev-med-062913-051343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bhutani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niazi, A. K.</span><span> </span><span class="NLM_article-title">Akt inhibitors: mechanism of action and implications for anticancer therapeutics</span> <span class="citation_source-journal">Infect. Agents Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="refDoi"> DOI: 10.1186/1750-9378-8-49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1186%2F1750-9378-8-49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=24330834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFOqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=49&issue=1&author=J.+Bhutaniauthor=A.+Sheikhauthor=A.+K.+Niazi&title=Akt+inhibitors%3A+mechanism+of+action+and+implications+for+anticancer+therapeutics&doi=10.1186%2F1750-9378-8-49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Akt inhibitors: mechanism of action and implications for anticancer therapeutics</span></div><div class="casAuthors">Bhutani, Jaikrit; Sheikh, Asfandyar; Niazi, Asfandyar Khan</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Agents and Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49/1-49/4, 4 pp.</span>CODEN:
                <span class="NLM_cas:coden">IACNB4</span>;
        ISSN:<span class="NLM_cas:issn">1750-9378</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Akt, better known as protein kinase B (PKB), is a serine/threonine-specific protein kinase which acts as mediator via PI3K/Akt pathway in many biol. processes like glucose metab., apoptosis, cell differentiation and transcription.  Akt1 gene amplification has been implicated in gastric carcinoma while Akt2 amplification has been linked with ovarian, pancreas, breast and stomach tumors.  The use of Akt inhibitors as monotherapy or in combination with other anticancer drugs could be useful for combating drug resistance and improving response.  Thus, comprehensive understanding of Akt and its linked signaling pathways (PI3K, PKB, mTOR etc.) is necessary to lead to newer drug development and use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAePx0ZXGFzLVg90H21EOLACvtfcHk0lg9TkqOHYYl6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFOqsL8%253D&md5=3aa2481776541081ebe02c5273129ca6</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1186%2F1750-9378-8-49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-9378-8-49%26sid%3Dliteratum%253Aachs%26aulast%3DBhutani%26aufirst%3DJ.%26aulast%3DSheikh%26aufirst%3DA.%26aulast%3DNiazi%26aufirst%3DA.%2BK.%26atitle%3DAkt%2520inhibitors%253A%2520mechanism%2520of%2520action%2520and%2520implications%2520for%2520anticancer%2520therapeutics%26jtitle%3DInfect.%2520Agents%2520Cancer%26date%3D2013%26volume%3D8%26issue%3D1%26spage%3D49%26doi%3D10.1186%2F1750-9378-8-49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dienstmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabernero, J.</span><span> </span><span class="NLM_article-title">Picking the point of inhibition: a comparative review of PI3K/AKT/mTOR pathway inhibitors</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0639</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1158%2F1535-7163.MCT-13-0639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=24748656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=1021-1031&issue=5&author=R.+Dienstmannauthor=J.+Rodonauthor=V.+Serraauthor=J.+Tabernero&title=Picking+the+point+of+inhibition%3A+a+comparative+review+of+PI3K%2FAKT%2FmTOR+pathway+inhibitors&doi=10.1158%2F1535-7163.MCT-13-0639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors</span></div><div class="casAuthors">Dienstmann, Rodrigo; Rodon, Jordi; Serra, Violeta; Tabernero, Josep</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1021-1031</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The frequent activation of the PI3K/AKT/mTOR pathway in cancer, and its crucial role in cell growth and survival, has made it a much desired target for pharmacol. intervention.  Following the regulatory approval of the rapamycin analogs everolimus and temsirolimus, recent years have seen an explosion in the no. of phosphoinositide 3-kinase (PI3K) pathway inhibitors under clin. investigation.  These include: ATP-competitive, dual inhibitors of class I PI3K and mTORC1/2; "pan-PI3K" inhibitors, which inhibit all four isoforms of class I PI3K (α, β, δ, γ); isoform-specific inhibitors of the various PI3K isoforms; allosteric and catalytic inhibitors of AKT; and ATP-competitive inhibitors of mTOR only (and thus mTORC1 and mTORC2).  With so many agents in development, clinicians are currently faced with a wide array of clin. trials investigating a multitude of inhibitors with different mechanisms of action, being used both as single agents and in combination with other therapies.  Here, we provide a review of the literature, with the aim of differentiating the genomic contexts in which these various types of inhibitors may potentially have superior activity.  Mol Cancer Ther; 13(5); 1021-31. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3McPbkS5dm7Vg90H21EOLACvtfcHk0lg9TkqOHYYl6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWjs78%253D&md5=7b5ef12e83be522233ad403ce3040719</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0639%26sid%3Dliteratum%253Aachs%26aulast%3DDienstmann%26aufirst%3DR.%26aulast%3DRodon%26aufirst%3DJ.%26aulast%3DSerra%26aufirst%3DV.%26aulast%3DTabernero%26aufirst%3DJ.%26atitle%3DPicking%2520the%2520point%2520of%2520inhibition%253A%2520a%2520comparative%2520review%2520of%2520PI3K%252FAKT%252FmTOR%2520pathway%2520inhibitors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26issue%3D5%26spage%3D1021%26epage%3D1031%26doi%3D10.1158%2F1535-7163.MCT-13-0639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Nitulescu, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juzenas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olaru, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saloustros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spandidos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsatsakis, A. M.</span><span> </span><span class="NLM_article-title">Akt inhibitors in cancer treatment: the long journey from drug discovery to clinical use (Review)</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span><span class="refDoi"> DOI: 10.3892/ijo.2015.3306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.3892%2Fijo.2015.3306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=26698230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGnu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=869-885&issue=3&author=G.+M.+Nitulescuauthor=D.+Marginaauthor=P.+Juzenasauthor=Q.+Pengauthor=O.+T.+Olaruauthor=E.+Saloustrosauthor=C.+Fengaauthor=D.+Spandidosauthor=M.+Libraauthor=A.+M.+Tsatsakis&title=Akt+inhibitors+in+cancer+treatment%3A+the+long+journey+from+drug+discovery+to+clinical+use+%28Review%29&doi=10.3892%2Fijo.2015.3306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Akt inhibitors in cancer treatment: the long journey from drug discovery to clinical use (Review)</span></div><div class="casAuthors">Nitulescu, George Mihai; Margina, Denisa; Juzenas, Petras; Peng, Qian; Olaru, Octavian Tudorel; Saloustros, Emmanouil; Fenga, Concettina; Spandidos, Demetrios A.; Libra, Massimo; Tsatsakis, Aristidis M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">869-885</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1791-2423</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Targeted cancer therapies are used to inhibit the growth, progression, and metastasis of the tumor by interfering with specific mol. targets and are currently the focus of anticancer drug development.  Protein kinase B, also known as Akt, plays a central role in many types of cancer and has been validated as a therapeutic target nearly two decades ago.  This review summarizes the intracellular functions of Akt as a pivotal point of converging signaling pathways involved in cell growth, proliferation, apoptosis and neo-angiogenesis, and focuses on the drug design strategies to develop potent anticancer agents targeting Akt.  The discovery process of Akt inhibitors has evolved from ATP (ATP)-competitive agents to alternative approaches employing allosteric sites in order to overcome the high degree of structural similarity between Akt isoforms in the catalytic domain, and considerable structural analogy to the AGC kinase family.  This process has led to the discovery of inhibitors with greater specificity, reduced side-effects and lower toxicity.  A second generation of Akt has inhibitors emerged by incorporating a chem. reactive Michael acceptor template to target the nucleophile cysteines in the catalytic activation loop.  The review outlines the development of several promising drug candidates emphasizing the importance of each chem. scaffold.  We explore the pipeline of Akt inhibitors and their preclin. and clin. examn. status, presenting the potential clin. application of these agents as a monotherapy or in combination with ionizing radiation, other targeted therapies, or chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcUyrlk7Gp77Vg90H21EOLACvtfcHk0lifZjdvbgQD2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGnu7fK&md5=39d4bf35feb3aa1e8e113315d57738d8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3892%2Fijo.2015.3306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2015.3306%26sid%3Dliteratum%253Aachs%26aulast%3DNitulescu%26aufirst%3DG.%2BM.%26aulast%3DMargina%26aufirst%3DD.%26aulast%3DJuzenas%26aufirst%3DP.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DOlaru%26aufirst%3DO.%2BT.%26aulast%3DSaloustros%26aufirst%3DE.%26aulast%3DFenga%26aufirst%3DC.%26aulast%3DSpandidos%26aufirst%3DD.%26aulast%3DLibra%26aufirst%3DM.%26aulast%3DTsatsakis%26aufirst%3DA.%2BM.%26atitle%3DAkt%2520inhibitors%2520in%2520cancer%2520treatment%253A%2520the%2520long%2520journey%2520from%2520drug%2520discovery%2520to%2520clinical%2520use%2520%2528Review%2529%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2016%26volume%3D48%26issue%3D3%26spage%3D869%26epage%3D885%26doi%3D10.3892%2Fijo.2015.3306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ashwell, M. A.; Brassard, C.; Filikov, A.; Hill, J.; Koerner, S.; Lapierre, J. M.; Liu, Y.; Namdev, N.; Nicewonger, R.; Palma, R.; Tandon, M.; Vensel, D.; Matsuda, A.; Iimura, S.; Yamamoto, Y.</span><span> </span><span class="NLM_article-title">Substituted imidazopyridinyl-aminopyridine compounds</span>. WO 2011082270, 2011.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ashwell%2C+M.+A.%3B+Brassard%2C+C.%3B+Filikov%2C+A.%3B+Hill%2C+J.%3B+Koerner%2C+S.%3B+Lapierre%2C+J.+M.%3B+Liu%2C+Y.%3B+Namdev%2C+N.%3B+Nicewonger%2C+R.%3B+Palma%2C+R.%3B+Tandon%2C+M.%3B+Vensel%2C+D.%3B+Matsuda%2C+A.%3B+Iimura%2C+S.%3B+Yamamoto%2C+Y.+Substituted+imidazopyridinyl-aminopyridine+compounds.+WO+2011082270%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DM.%2BA.%26atitle%3DSubstituted%2520imidazopyridinyl-aminopyridine%2520compounds" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eathiraj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wick, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbadessa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span> </span><span class="NLM_article-title">Targeting AKT1-E17K and the PI3K/AKT pathway with an allosteric AKT inhibitor, ARQ 092</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1371/journal.pone.0140479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1371%2Fjournal.pone.0140479" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1-26&issue=10&author=Y.+Yuauthor=R.+E.+Savageauthor=S.+Eathirajauthor=J.+Meadeauthor=M.+J.+Wickauthor=T.+Hallauthor=G.+Abbadessaauthor=B.+Schwartz&title=Targeting+AKT1-E17K+and+the+PI3K%2FAKT+pathway+with+an+allosteric+AKT+inhibitor%2C+ARQ+092&doi=10.1371%2Fjournal.pone.0140479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0140479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0140479%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DSavage%26aufirst%3DR.%2BE.%26aulast%3DEathiraj%26aufirst%3DS.%26aulast%3DMeade%26aufirst%3DJ.%26aulast%3DWick%26aufirst%3DM.%2BJ.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DAbbadessa%26aufirst%3DG.%26aulast%3DSchwartz%26aufirst%3DB.%26atitle%3DTargeting%2520AKT1-E17K%2520and%2520the%2520PI3K%252FAKT%2520pathway%2520with%2520an%2520allosteric%2520AKT%2520inhibitor%252C%2520ARQ%2520092%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26issue%3D10%26spage%3D1%26epage%3D26%26doi%3D10.1371%2Fjournal.pone.0140479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Lindhurst, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yourick, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesecker, L. G.</span><span> </span><span class="NLM_article-title">Repression of AKT signaling by ARQ 092 in cells and tissues from patients with Proteus syndrome</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">17162</span><span class="refDoi"> DOI: 10.1038/srep17162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1038%2Fsrep17162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=26657992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVWqsrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=17162&author=M.+J.+Lindhurstauthor=M.+R.+Yourickauthor=Y.+Yuauthor=R.+E.+Savageauthor=D.+Ferrariauthor=L.+G.+Biesecker&title=Repression+of+AKT+signaling+by+ARQ+092+in+cells+and+tissues+from+patients+with+Proteus+syndrome&doi=10.1038%2Fsrep17162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Repression of AKT signaling by ARQ 092 in cells and tissues from patients with Proteus syndrome</span></div><div class="casAuthors">Lindhurst, Marjorie J.; Yourick, Miranda R.; Yu, Yi; Savage, Ronald E.; Ferrari, Dora; Biesecker, Leslie G.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17162</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-pos. cells, is responsible for the mosaic overgrowth condition, Proteus syndrome.  ARQ 092 is an allosteric pan-AKT inhibitor under development for treatment in cancer.  We tested the efficacy of this drug for suppressing AKT signaling in cells and tissues from patients with Proteus syndrome.  ARQ 092 reduced phosphorylation of AKT and downstream targets of AKT in a concn.-dependent manner in as little as two hours.  While AKT signaling was suppressed with ARQ 092 treatment, cells retained their ability to respond to growth factor stimulation by increasing pAKT levels proportionally to untreated cells.  At concns. sufficient to decrease AKT signaling, little redn. in cell viability was seen.  These results indicate that ARQ 092 can suppress AKT signaling and warrants further development as a therapeutic option for patients with Proteus syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm2dj59D3J7Vg90H21EOLACvtfcHk0lifZjdvbgQD2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVWqsrvP&md5=3caaf9fd7707ec949a7d41863ee334d4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsrep17162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep17162%26sid%3Dliteratum%253Aachs%26aulast%3DLindhurst%26aufirst%3DM.%2BJ.%26aulast%3DYourick%26aufirst%3DM.%2BR.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DSavage%26aufirst%3DR.%2BE.%26aulast%3DFerrari%26aufirst%3DD.%26aulast%3DBiesecker%26aufirst%3DL.%2BG.%26atitle%3DRepression%2520of%2520AKT%2520signaling%2520by%2520ARQ%2520092%2520in%2520cells%2520and%2520tissues%2520from%2520patients%2520with%2520Proteus%2520syndrome%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D17162%26doi%3D10.1038%2Fsrep17162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ashwell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapierre, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bresciano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornell-Kennon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eathiraj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">France, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanapurkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kizer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koerner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makhija, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namdev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicewonger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szwaya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tandon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppalapati, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vensel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volak, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volckova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlund, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. C.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a series of 3-(3-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">5291</span><span class="NLM_x">–</span> <span class="NLM_lpage">5310</span><span class="refDoi"> DOI: 10.1021/jm300276x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300276x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5291-5310&issue=11&author=M.+A.+Ashwellauthor=J.+M.+Lapierreauthor=C.+Brassardauthor=K.+Brescianoauthor=C.+Bullauthor=S.+Cornell-Kennonauthor=S.+Eathirajauthor=D.+S.+Franceauthor=T.+Hallauthor=J.+Hillauthor=E.+Kelleherauthor=S.+Khanapurkarauthor=D.+Kizerauthor=S.+Koernerauthor=J.+Linkauthor=Y.+Liuauthor=S.+Makhijaauthor=M.+Moussaauthor=N.+Namdevauthor=K.+Nguyenauthor=R.+Nicewongerauthor=R.+Palmaauthor=J.+Szwayaauthor=M.+Tandonauthor=U.+Uppalapatiauthor=D.+Venselauthor=L.+P.+Volakauthor=E.+Volckovaauthor=N.+Westlundauthor=H.+Wuauthor=R.+Y.+Yangauthor=T.+C.+Chan&title=Discovery+and+optimization+of+a+series+of+3-%283-phenyl-3H-imidazo%5B4%2C5-b%5Dpyridin-2-yl%29pyridin-2-amines%3A+orally+bioavailable%2C+selective%2C+and+potent+ATP-independent+Akt+inhibitors&doi=10.1021%2Fjm300276x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm300276x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300276x%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DM.%2BA.%26aulast%3DLapierre%26aufirst%3DJ.%2BM.%26aulast%3DBrassard%26aufirst%3DC.%26aulast%3DBresciano%26aufirst%3DK.%26aulast%3DBull%26aufirst%3DC.%26aulast%3DCornell-Kennon%26aufirst%3DS.%26aulast%3DEathiraj%26aufirst%3DS.%26aulast%3DFrance%26aufirst%3DD.%2BS.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DKelleher%26aufirst%3DE.%26aulast%3DKhanapurkar%26aufirst%3DS.%26aulast%3DKizer%26aufirst%3DD.%26aulast%3DKoerner%26aufirst%3DS.%26aulast%3DLink%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMakhija%26aufirst%3DS.%26aulast%3DMoussa%26aufirst%3DM.%26aulast%3DNamdev%26aufirst%3DN.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DNicewonger%26aufirst%3DR.%26aulast%3DPalma%26aufirst%3DR.%26aulast%3DSzwaya%26aufirst%3DJ.%26aulast%3DTandon%26aufirst%3DM.%26aulast%3DUppalapati%26aufirst%3DU.%26aulast%3DVensel%26aufirst%3DD.%26aulast%3DVolak%26aufirst%3DL.%2BP.%26aulast%3DVolckova%26aufirst%3DE.%26aulast%3DWestlund%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DR.%2BY.%26aulast%3DChan%26aufirst%3DT.%2BC.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520series%2520of%25203-%25283-phenyl-3H-imidazo%255B4%252C5-b%255Dpyridin-2-yl%2529pyridin-2-amines%253A%2520orally%2520bioavailable%252C%2520selective%252C%2520and%2520potent%2520ATP-independent%2520Akt%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D11%26spage%3D5291%26epage%3D5310%26doi%3D10.1021%2Fjm300276x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulabaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malamas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellestad, G.</span><span> </span><span class="NLM_article-title">Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1016/j.ab.2004.04.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1016%2Fj.ab.2004.04.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=15301960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVKhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2004&pages=153-159&issue=1&author=M.+C.+Loauthor=A.+Aulabaughauthor=G.+Jinauthor=R.+Cowlingauthor=J.+Bardauthor=M.+Malamasauthor=G.+Ellestad&title=Evaluation+of+fluorescence-based+thermal+shift+assays+for+hit+identification+in+drug+discovery&doi=10.1016%2Fj.ab.2004.04.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery</span></div><div class="casAuthors">Lo, Mei-Chu; Aulabaugh, Ann; Jin, Guixian; Cowling, Rebecca; Bard, Jonathan; Malamas, Michael; Ellestad, George</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-159</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The fluorescence-based thermal shift assay is a general method for identification of inhibitors of target proteins from compd. libraries.  Using an environmentally sensitive fluorescent dye to monitor protein thermal unfolding, the ligand-binding affinity can be assessed from the shift of the unfolding temp. (ΔTm) obtained in the presence of ligands relative to that obtained in the absence of ligands.  In this article, we report that the thermal shift assay can be conducted in an inexpensive, com. available device for temp. control and fluorescence detection.  The binding affinities obtained from thermal shift assays are compared with the binding affinities measured by isothermal titrn. calorimetry and with the IC50 values from enzymic assays.  The potential pitfalls in the data anal. of thermal shift assays are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1qMM9vchBGrVg90H21EOLACvtfcHk0ljk30wJG2ARnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVKhu7g%253D&md5=bc10d980128340c79d7d2abc9a56463b</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.04.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.04.031%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DM.%2BC.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DMalamas%26aufirst%3DM.%26aulast%3DEllestad%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520fluorescence-based%2520thermal%2520shift%2520assays%2520for%2520hit%2520identification%2520in%2520drug%2520discovery%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D332%26issue%3D1%26spage%3D153%26epage%3D159%26doi%3D10.1016%2Fj.ab.2004.04.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pantoliano, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwasnoski, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobanov, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myslik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carver, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salemme, F. R.</span><span> </span><span class="NLM_article-title">High-density miniaturized thermal shift assays as a general strategy for drug discovery</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span><span class="refDoi"> DOI: 10.1177/108705710100600609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1177%2F108705710100600609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=11788061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVCntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=429-440&issue=6&author=M.+W.+Pantolianoauthor=E.+C.+Petrellaauthor=J.+D.+Kwasnoskiauthor=V.+S.+Lobanovauthor=J.+Myslikauthor=E.+Grafauthor=T.+Carverauthor=E.+Aselauthor=B.+A.+Springerauthor=P.+Laneauthor=F.+R.+Salemme&title=High-density+miniaturized+thermal+shift+assays+as+a+general+strategy+for+drug+discovery&doi=10.1177%2F108705710100600609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">High-density miniaturized thermal shift assays as a general strategy for drug discovery</span></div><div class="casAuthors">Pantoliano, Michael W.; Petrella, Eugene C.; Kwasnoski, Joseph D.; Lobanov, Victor S.; Myslik, James; Graf, Edward; Carver, Ted; Asel, Eric; Springer, Barry A.; Lane, Pamela; Salemme, F. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-440</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">More general and universally applicable drug discovery assay technologies are needed in order to keep pace with the recent advances in combinatorial chem. and genomics-based target generation.  Ligand-induced conformational stabilization of proteins is a well-understood phenomenon in which substrates, inhibitors, cofactors, and even other proteins provide enhanced stability to proteins on binding.  This phenomenon is based on the energetic coupling of the ligand-binding and protein-melting reactions.  In an attempt to harness these biophys. properties for drug discovery, fully automated instrumentation was designed and implemented to perform miniaturized fluorescence-based thermal shift assays in a microplate format for the high throughput screening of compd. libraries.  Validation of this process and instrumentation was achieved by investigating ligand binding to more than 100 protein targets.  The general applicability of the thermal shift screening strategy was found to be an important advantage because it circumvents the need to design and retool new assays with each new therapeutic target.  Moreover, the miniaturized thermal shift assay methodol. does not require any prior knowledge of a therapeutic target's function, making it ideally suited for the quant. high throughput drug screening and evaluation of targets derived from genomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp58y9R74HfiLVg90H21EOLACvtfcHk0ljk30wJG2ARnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVCntg%253D%253D&md5=deef07e6683f632cd078214ad88d9999</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1177%2F108705710100600609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705710100600609%26sid%3Dliteratum%253Aachs%26aulast%3DPantoliano%26aufirst%3DM.%2BW.%26aulast%3DPetrella%26aufirst%3DE.%2BC.%26aulast%3DKwasnoski%26aufirst%3DJ.%2BD.%26aulast%3DLobanov%26aufirst%3DV.%2BS.%26aulast%3DMyslik%26aufirst%3DJ.%26aulast%3DGraf%26aufirst%3DE.%26aulast%3DCarver%26aufirst%3DT.%26aulast%3DAsel%26aufirst%3DE.%26aulast%3DSpringer%26aufirst%3DB.%2BA.%26aulast%3DLane%26aufirst%3DP.%26aulast%3DSalemme%26aufirst%3DF.%2BR.%26atitle%3DHigh-density%2520miniaturized%2520thermal%2520shift%2520assays%2520as%2520a%2520general%2520strategy%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2001%26volume%3D6%26issue%3D6%26spage%3D429%26epage%3D440%26doi%3D10.1177%2F108705710100600609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Scheid, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Unravelling the activation mechanisms of protein kinase B/Akt</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">546</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1016/S0014-5793(03)00562-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1016%2FS0014-5793%2803%2900562-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2003&pages=108-112&issue=1&author=M.+P.+Scheidauthor=J.+R.+Woodgett&title=Unravelling+the+activation+mechanisms+of+protein+kinase+B%2FAkt&doi=10.1016%2FS0014-5793%2803%2900562-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2803%2900562-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252803%252900562-3%26sid%3Dliteratum%253Aachs%26aulast%3DScheid%26aufirst%3DM.%2BP.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DUnravelling%2520the%2520activation%2520mechanisms%2520of%2520protein%2520kinase%2520B%252FAkt%26jtitle%3DFEBS%2520Lett.%26date%3D2003%26volume%3D546%26issue%3D1%26spage%3D108%26epage%3D112%26doi%3D10.1016%2FS0014-5793%2803%2900562-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bozulic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, B. A.</span><span> </span><span class="NLM_article-title">PIKKing on PKB: regulation of PKB activity by phosphorylation</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1016/j.ceb.2009.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1016%2Fj.ceb.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=19303758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVClu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=256-261&issue=2&author=L.+Bozulicauthor=B.+A.+Hemmings&title=PIKKing+on+PKB%3A+regulation+of+PKB+activity+by+phosphorylation&doi=10.1016%2Fj.ceb.2009.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">PIKKing on PKB: regulation of PKB activity by phosphorylation</span></div><div class="casAuthors">Bozulic, Lana; Hemmings, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-261</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein kinase B (PKB)/Akt kinase is a key regulator of a wide range of cellular processes including growth, proliferation and survival.  PKB is clearly a crucial signaling mol. and extensive research efforts aim to understand its regulation and action.  Recent studies of the regulation of PKB activity by hydrophobic motif phosphorylation have yielded several exciting findings about members of the phosphatidylinositol 3-kinase (PI3K)-like family of kinases (PIKKs) acting as PKB regulators.  Mammalian target of rapamycin complex 2 (mTORC2) and DNA-dependent protein kinase (DNA-PK) can both phosphorylate Ser-473 and activate PKB.  This review concerns PKB regulation by mTORC2 and DNA-PK in a stimulus-dependent and context-dependent manner and the possible implications of this for PKB activity, substrate specificity, and therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgDTdYbqJWtLVg90H21EOLACvtfcHk0ljMHcN5D3mZvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVClu7Y%253D&md5=0b7a3e6ea561f8479701a01133b5d30c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DBozulic%26aufirst%3DL.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DPIKKing%2520on%2520PKB%253A%2520regulation%2520of%2520PKB%2520activity%2520by%2520phosphorylation%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26issue%3D2%26spage%3D256%26epage%3D261%26doi%3D10.1016%2Fj.ceb.2009.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">All 3-(3-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2yl)pyridin-2-amine compounds tested for biochemical inhibition of PDK1 and MAPKAPK2 showed IC<sub>50</sub> between 10 and 100 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">The biochemical IC<sub>50</sub> determinations against full-length AKT1, AKT2, and AKT3 for the test compounds described in this paper were performed at Reaction Biology (Malvern, PA). The compounds were tested in duplicate in a 10-dose mode with 3-fold serial dilution starting at 10 or 100 μM (based on the IC<sub>50</sub> data generated internally with the unphosphorylated proteins), in the presence of 10 μM ATP. Curve fits were performed where the enzyme activities at the highest concentration of test compounds were less than 65% of enzyme activity relative to DMSO controls.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Chang, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Frijtag Drabbe Kunzel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder-Krieger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerhout, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangenberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span><span class="refDoi"> DOI: 10.1021/jm0607956</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0607956" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=828-834&issue=4&author=L.+C.+Changauthor=J.+K.+von+Frijtag+Drabbe+Kunzelauthor=T.+Mulder-Kriegerauthor=J.+Westerhoutauthor=T.+Spangenbergauthor=J.+Brusseeauthor=A.+P.+Ijzerman&title=2%2C6%2C8-trisubstituted+1-deazapurines+as+adenosine+receptor+antagonists&doi=10.1021%2Fjm0607956"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm0607956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0607956%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DL.%2BC.%26aulast%3Dvon%2BFrijtag%2BDrabbe%2BKunzel%26aufirst%3DJ.%2BK.%26aulast%3DMulder-Krieger%26aufirst%3DT.%26aulast%3DWesterhout%26aufirst%3DJ.%26aulast%3DSpangenberg%26aufirst%3DT.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3D2%252C6%252C8-trisubstituted%25201-deazapurines%2520as%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D4%26spage%3D828%26epage%3D834%26doi%3D10.1021%2Fjm0607956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Nielsen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsay, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrydstrup, T.</span><span> </span><span class="NLM_article-title">Stereocontrolled synthesis of methyl silanediol peptide mimics</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">10035</span><span class="NLM_x">–</span> <span class="NLM_lpage">10044</span><span class="refDoi"> DOI: 10.1021/jo701907d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo701907d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=10035-10044&issue=26&author=L.+Nielsenauthor=K.+B.+Lindsayauthor=J.+Faberauthor=N.+C.+Nielsenauthor=T.+Skrydstrup&title=Stereocontrolled+synthesis+of+methyl+silanediol+peptide+mimics&doi=10.1021%2Fjo701907d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo701907d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo701907d%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DL.%26aulast%3DLindsay%26aufirst%3DK.%2BB.%26aulast%3DFaber%26aufirst%3DJ.%26aulast%3DNielsen%26aufirst%3DN.%2BC.%26aulast%3DSkrydstrup%26aufirst%3DT.%26atitle%3DStereocontrolled%2520synthesis%2520of%2520methyl%2520silanediol%2520peptide%2520mimics%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26issue%3D26%26spage%3D10035%26epage%3D10044%26doi%3D10.1021%2Fjo701907d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">The crystallographic data described here have been deposited with the Protein Data Bank (PDB code for <b>21a</b> bound to AKT1: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KCV">5KCV</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Eathiraj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volckova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakuci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">France, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, M. A.</span><span> </span><span class="NLM_article-title">A novel mode of protein kinase inhibition exploiting hydrophobic motifs of autoinhibited kinases: discovery of ATP-independent inhibitors of fibroblast growth factor receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">20677</span><span class="NLM_x">–</span> <span class="NLM_lpage">20687</span><span class="refDoi"> DOI: 10.1074/jbc.M110.213736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;key=10.1074%2Fjbc.M110.213736" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=20677-20687&issue=23&author=S.+Eathirajauthor=R.+Palmaauthor=M.+Hirschiauthor=E.+Volckovaauthor=E.+Nakuciauthor=J.+Castroauthor=C.+R.+Chenauthor=T.+C.+Chanauthor=D.+S.+Franceauthor=M.+A.+Ashwell&title=A+novel+mode+of+protein+kinase+inhibition+exploiting+hydrophobic+motifs+of+autoinhibited+kinases%3A+discovery+of+ATP-independent+inhibitors+of+fibroblast+growth+factor+receptor&doi=10.1074%2Fjbc.M110.213736"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.213736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.213736%26sid%3Dliteratum%253Aachs%26aulast%3DEathiraj%26aufirst%3DS.%26aulast%3DPalma%26aufirst%3DR.%26aulast%3DHirschi%26aufirst%3DM.%26aulast%3DVolckova%26aufirst%3DE.%26aulast%3DNakuci%26aufirst%3DE.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BR.%26aulast%3DChan%26aufirst%3DT.%2BC.%26aulast%3DFrance%26aufirst%3DD.%2BS.%26aulast%3DAshwell%26aufirst%3DM.%2BA.%26atitle%3DA%2520novel%2520mode%2520of%2520protein%2520kinase%2520inhibition%2520exploiting%2520hydrophobic%2520motifs%2520of%2520autoinhibited%2520kinases%253A%2520discovery%2520of%2520ATP-independent%2520inhibitors%2520of%2520fibroblast%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26issue%3D23%26spage%3D20677%26epage%3D20687%26doi%3D10.1074%2Fjbc.M110.213736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KCV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KCV','PDB','5KCV'); return false;">PDB: 5KCV</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d2585e5607-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i78"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00619">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_22104"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00619">10.1021/acs.jmedchem.6b00619</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00619/suppl_file/jm6b00619_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00619/suppl_file/jm6b00619_si_001.csv">jm6b00619_si_001.csv (1.42 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code for <b>21a</b> bound to AKT1 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KCV">5KCV</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00619&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00619" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00619" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c58f59fd3d88","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
